Purdue University

Purdue e-Pubs
Open Access Dissertations

Theses and Dissertations

Fall 2013

Patient Perceptions of Physicians and Medication
Adherence Among Medicare Part D Beneficiaries
Lori Marquinne Ward
Purdue University

Follow this and additional works at: https://docs.lib.purdue.edu/open_access_dissertations
Part of the Family, Life Course, and Society Commons, Other Psychiatry and Psychology
Commons, and the Pharmacy and Pharmaceutical Sciences Commons
Recommended Citation
Ward, Lori Marquinne, "Patient Perceptions of Physicians and Medication Adherence Among Medicare Part D Beneficiaries" (2013).
Open Access Dissertations. 16.
https://docs.lib.purdue.edu/open_access_dissertations/16

This document has been made available through Purdue e-Pubs, a service of the Purdue University Libraries. Please contact epubs@purdue.edu for
additional information.

Graduate School ETD Form 9
(Revised 12/07)

PURDUE UNIVERSITY
GRADUATE SCHOOL
Thesis/Dissertation Acceptance
This is to certify that the thesis/dissertation prepared
By Lori Marquinne Ward
Entitled
Patient Perceptions of Physicians and Medication Adherence Among Medicare Part D
Beneficiaries

For the degree of

Doctor of Philosophy

Is approved by the final examining committee:
Joseph Thomas III
Chair

Kenneth F. Ferraro

Bruce A. Craig

Sharon A. DeVaney

To the best of my knowledge and as understood by the student in the Research Integrity and
Copyright Disclaimer (Graduate School Form 20), this thesis/dissertation adheres to the provisions of
Purdue University’s “Policy on Integrity in Research” and the use of copyrighted material.

Joseph Thomas III
Approved by Major Professor(s): ____________________________________

____________________________________
Approved by: Joseph Thomas III
Head of the Graduate Program

12/06/13
Date

PATIENT PERCEPTIONS OF PHYSICIANS AND MEDICATION ADHERENCE
AMONG MEDICARE PART D BENEFICIARIES

A Dissertation
Submitted to the Faculty
of
Purdue University
by
Lori Marquinne Ward

In Partial Fulfillment of the
Requirements for the Degree
of
Doctor of Philosophy

December 2013
Purdue University
West Lafayette, Indiana

ii

“For the vision is yet for an appointed time, but at the end it shall speak, and not lie:
though it tarry, wait for it; because it will surely come, it will not tarry.” Habakkuk 2:3

iii

ACKNOWLEDGEMENTS

I would like to thank God for all He has done for me. I am so grateful and
honored that He chose me for this purpose. It is definitely more than I ever imagined.
Thank You.
I want to thank my major professor, Dr. Joseph Thomas III, for his guidance and
encouragement throughout my graduate studies. He is a great mentor, and I am
appreciative of his tutelage through this process. Because of his guidance, I have become
a better researcher and scholar. I would like to thank my committee members, Dr.
Kenneth F. Ferraro, Dr. Bruce A. Craig, and Dr. Sharon A. DeVaney for their time and
assistance throughout this process. All of you have taught me research skills and
methods that I will continue to use throughout my career. I would like to thank my
statistical consultant Han Wang for his assistance with the analysis.
I would like to thank Mindy Schultz for her time and help during my graduate
studies. Thank you to the Thomas group and my fellow graduate students in the
department of pharmacy practice for making this an enjoyable experience.
I would like to thank my father, the late William Ward, for teaching me the value
of hard work and independence. Thank you to my mother (Gloria Massey Ward),
grandmother (Irene Phillips Massey), sister (LaTonya Ward-Lane Lacy), past and current
brother-in-laws (Derrick Lane & Calvin Lacy) for believing in me, encouraging and
assisting me as I pursued the dual-title PhD. I want to thank my nephew (Derrick Lane

iv
II) and niece (LaToria M. Lane) for always asking about “What do you do?” and “When
will you graduate?” This was great motivation for me to keep moving forward. I pray
that I am a great example to you of what you can accomplish in life.
Bennie & Erma Williams, Marian Hunter, Lillie Hughey, Lucy Stansbury, Dr.
Helen Broughton, Rev. and Mrs. Lawrence Twiggs, Donald Young Jr., Dr. Crystal
Henderson, Dr. Lisa Watts, Dr. Angela Lanier, Merilee Hughey, E. Carlton Denson,
Kenneth, Doris, and David Clark, the late Dora Johnson, and the late Hattie Gilton-Thank you for your support and encouraging words throughout this process.
Tifini, thank you for being an inspiration and wonderful friend. Celena, thank
you for motivating me by telling me that I was an example to you. Nalin and Suwanna, I
am so glad I met you along this journey.
I want to thank the Richard Allen Young Adult Council Writers Group past
members for being a great support system. Dr. Cordelia Brown, Dr. Neil Bynum, Dr.
Kellie Green, Dr. LaShara Davis, Dr. Natasha Brown, and Dr. Sean Colbert-Kelly, I
appreciate your truthfulness and constructive criticism. Thanks a million!
Special thanks to Rev. Roxie McKee, Daison McKee, Dr. Toetta Taul, David and
Florence Hubbard, Cordelia Brown, Joseph, Renee, and Lauren Thomas for being my
adopted family away from home. I feel like I have known you all a lifetime. Thank you
for making Greater Lafayette a warm “3rd home.” Thank you Rev. Deborah Scott for
your prayers, words of encouragement and kindness. And finally, thanks Bethel AME
Lafayette for being my place of spiritual growth during my time here. I would not have
made it without each of you all. Thank you, thank you, thank you.

v

TABLE OF CONTENTS
Page
LIST OF TABLES ............................................................................................................ xv
LIST OF FIGURES ......................................................................................................... xix
ABSTRACT...................................................................................................................... xx
INTRODUCTION .............................................................................................................. 1
Background ..................................................................................................................... 1
Medication Adherence .................................................................................................1
Hypertension ................................................................................................................2
Patient Physician Relationships ...................................................................................2
Patient Perceptions of Physicians ................................................................................3
Literature Review............................................................................................................ 5
Patient Perceptions of Physician Communication and Medication Adherence...........5
Patient Perception of Physician Knowledge and Medication Adherence ...................7
Patient Perception of Physician Competence and Medication Adherence ..................8
Demographics and Medication Adherence ..................................................................9
Age and Medication Adherence .............................................................................. 9
Age and Not Filling Prescriptions or Refills ........................................................ 9
Age and Nonadherence combining Unfilled Prescriptions, Skipping Doses,
and Taking Smaller Doses.................................................................................. 13
Race and Medication Adherence ........................................................................... 14
Race and Not Filling Prescriptions or Refills..................................................... 14

vi
Page
Race and Nonadherence combining Unfilled Prescriptions, Skipping
Doses, and Taking Smaller Doses ...................................................................... 16
Gender and Medication Adherence ....................................................................... 17
Gender and Not Filling Prescriptions or Refills ................................................. 17
Gender and Nonadherence combining Unfilled Prescriptions, Skipping
Doses, and Taking Smaller Doses ...................................................................... 19
Marital Status and Medication Adherence............................................................. 20
Marital Status and Not Filling Prescriptions or Refills ...................................... 20
Marital Status and Nonadherence combining Unfilled Prescriptions, Skipping
Doses, and Taking Smaller Doses ...................................................................... 20
Education and Medication Adherence ................................................................... 21
Education and Not Filling Prescriptions or Refills ............................................ 21
Education and Nonadherence combining Unfilled Prescriptions, Skipping
Doses, and Taking Smaller Doses ...................................................................... 22
Income and Medication Adherence ....................................................................... 23
Income and Not Filling Prescriptions or Refills ................................................ 23
Income and Nonadherence combining Unfilled Prescriptions, Skipping
Doses, and Taking Smaller Doses ..................................................................... 24
Perceived Health Status and Medication Adherence ............................................. 25
Perceived Health Status and Not Filling Prescriptions or Refills ...................... 25
Perceived Health Status and Nonadherence combining Unfilled Prescriptions,
Skipping Doses, and Taking Smaller Doses ...................................................... 25
Insurance Coverage and Medication Adherence ................................................... 26

vii
Page
Insurance Coverage and Not Filling Prescriptions or Refills ............................. 26
Insurance Coverage and Nonadherence combining Unfilled Prescriptions,
Skipping Doses, and Taking Smaller Doses ...................................................... 28
Number of Medications and Medication Adherence ............................................. 28
Number of Medications and Not Filling Prescriptions or Refills ...................... 28
Number of Medications and Nonadherence combining Unfilled Prescriptions,
Skipping Doses, and Taking Smaller Doses ...................................................... 29
Out of Pocket Prescription Costs and Medication Adherence ............................... 29
Out of Pocket Prescription Costs and Not Filling Prescriptions or Refills ........ 30
Number of Doctor Visits and Medication Adherence ........................................... 31
Number of Doctor Visits and Not Filling Prescriptions or Refills ..................... 31
Comorbidities and Medication Adherence ............................................................ 32
Comorbidities and Not Filling Prescriptions or Refills...................................... 32
Comorbidities and Nonadherence combining Unfilled Prescriptions, Skipping
Doses, and Taking Smaller Doses ...................................................................... 33
Need for Research ......................................................................................................... 33
Objectives ..................................................................................................................... 34
Notes ............................................................................................................................. 35
METHODS ....................................................................................................................... 41
Objectives ..................................................................................................................... 41
Data Sources ................................................................................................................. 41
Ethical Considerations ...............................................................................................42

viii
Page
Study Design ................................................................................................................. 42
Study Sample ................................................................................................................ 43
Inclusion Criteria .......................................................................................................43
Exclusion Criteria ......................................................................................................43
Identification of Hypertension ...................................................................................44
Identification of Antihypertensive Medications ........................................................44
Study Variables ............................................................................................................. 45
Patient Perceptions of Physicians ..............................................................................45
Medication Adherence (Proportion of Days Covered) ..............................................52
Demographic Variables .............................................................................................55
Clinical Variables ......................................................................................................57
Statistical Analysis ........................................................................................................ 58
Sample Characteristics...............................................................................................59
Development of Patient Perceptions of Physicians Scale…………………………..60
Item-total Correlation and Reliability........................................................................61
Factor Analysis ...................................................................................................... 61
Convergent Validity ............................................................................................... 62
Bivariate Associations between Patient Perceptions of Physicians and
Demographic Variables ......................................................................................... 62
Bivariate Associations between Patient Perceptions of Physicians and
Clinical Variables .................................................................................................. 62
Medication Adherence ...............................................................................................63

ix
Page
Bivariate Associations between Medication Adherence and Demographic
Variables ................................................................................................................ 64
Bivariate Associations between Medication Adherence and Clinical Variables ... 64
Association between Patient Perceptions of Physicians and Medication
Adherence ................................................................................................................. 64
Bivariate Associations between Patient Perceptions of Physicians and
Medication Adherence ........................................................................................... 64
Overall Patient Perception of Physicians Scale.................................................. 64
Subscales ............................................................................................................ 64
Association between Patient Perception of Physicians and Medication
Adherence after Adjusting for Risk Factors .......................................................... 65
Overall Patient Perception of Physicians Scale.................................................. 65
Notes ............................................................................................................................. 66
RESULTS ......................................................................................................................... 68
Study Sample ................................................................................................................ 68
Sample Demographic Characteristics ........................................................................69
Age ......................................................................................................................... 69
Gender .................................................................................................................... 69
Race ....................................................................................................................... 69
Marital Status ......................................................................................................... 69
Education ............................................................................................................... 69
Income ................................................................................................................... 76
Sample Clinical Characteristics .................................................................................78

x
Page
Supplemental Insurance ......................................................................................... 78
Medicare Part D Prescription Coverage Gap ......................................................... 78
Perceived Health Status ......................................................................................... 82
Number of Unique Medications ............................................................................ 82
Number of Doctor Visits........................................................................................ 82
Clinical Conditions ................................................................................................ 86
Charlson Comorbidity Index ................................................................................. 86
Patient Perceptions of Physicians ................................................................................. 90
Development of Patient Perceptions of Physician Scale ...........................................90
Sample ................................................................................................................... 90
Item-total Correlation and Reliability .................................................................... 90
Overall Patient Perceptions of Physician Scale ..................................................... 90
Factor Analysis and Subscale Identification .......................................................... 91
Factor 1 (Perceived physician knowledge about the patient subscale) .............. 91
Factor 2 (Perceived concern subscale) ............................................................... 93
Examination of Overall Patient Perception of Physician Scale Convergent
Validity ..................................................................................................................... 93
Distribution of Convergent Validity Variables ...................................................... 93
Overall Patient Perceptions of Physicians .......................................................... 95
Patient Perception of Physicians Subscales ....................................................... 95
Bivariate Associations between Demographic Variables and Patient Perceptions
of Physicians ............................................................................................................. 98

xi
Page
Bivariate Association between Age and Patient Perceptions of Physicians .......... 98
Bivariate Association between Gender and Patient Perceptions of Physicians ... 101
Bivariate Association between Race and Patient Perceptions of Physicians ....... 101
Bivariate Association between Marital Status and Patient Perceptions of
Physicians ............................................................................................................ 104
Bivariate Association between Education and Patient Perceptions of
Physicians ............................................................................................................ 104
Bivariate Association between Income and Patient Perceptions of Physicians... 108
Bivariate Associations between Clinical Variables and Patient Perceptions of
Physicians ............................................................................................................... 108
Bivariate Association between Insurance and Patient Perceptions of
Physicians ............................................................................................................ 108
Bivariate Association between Medicare Part D Prescription Coverage Gap
and Patient Perceptions of Physicians ................................................................. 111
Bivariate Association between Perceived Health Status and Patient
Perceptions of Physicians .................................................................................... 111
Bivariate Association between Number of Doctor Visits and Patient
Perceptions of Physicians .................................................................................... 112
Bivariate Association between Number of Unique Medications and Patient
Perceptions of Physicians .................................................................................... 112
Bivariate Association between Clinical Conditions and Patient Perceptions
of Physicians ........................................................................................................ 117
Bivariate Association between Charlson Comorbidity Scale and Patient
Perceptions of Physicians .................................................................................... 117
Medication Adherence .............................................................................................123
Sample ................................................................................................................. 123

xii
Page
Proportion of Days Covered (PDC) ..................................................................... 123
Bivariate Associations between Demographic Variables and Medication
Adherence ............................................................................................................ 125
Bivariate Association between Age and Medication Adherence ......................... 125
Bivariate Association between Gender and Medication Adherence.................... 125
Bivariate Association between Race and Medication Adherence ....................... 125
Bivariate Association between Marital Status and Medication Adherence ......... 129
Bivariate Association between Education and Medication Adherence ............... 129
Bivariate Association between Income and Medication Adherence ................... 133
Bivariate Associations between Demographic Variables and Medication
Adherence ............................................................................................................... 135
Bivariate Association between Insurance Coverage and Medication
Adherence ............................................................................................................ 135
Bivariate Association between Medicare Part D Prescription Coverage Gap
and Medication Adherence .................................................................................. 137
Bivariate Association between Perceived Health Status and Medication
Adherence ............................................................................................................ 137
Bivariate Association between Number of Unique Medications and
Medication Adherence ......................................................................................... 140
Bivariate Association between Number of Doctor Visits and Medication
Adherence ............................................................................................................ 140
Bivariate Association between Charlson Comorbidity Index and Medication
Adherence ............................................................................................................ 147
Association between Patient Perception of Physicians and Medication
Adherence ............................................................................................................... 147

xiii
Page
Bivariate Association between Patient Perceptions of Physicians and
Medication Adherence ......................................................................................... 147
Overall Patient Perception of Physicians Scale ................................................... 147
Association between Patient Perception of Physicians and Medication
Adherence after Adjusting for Risk Factors ........................................................ 151
Overall Patient Perception of Physicians Scale................................................ 151
Notes ........................................................................................................................... 159
SUMMARY AND CONCLUSIONS ............................................................................. 160
Background ................................................................................................................. 160
Objectives ................................................................................................................... 160
Methods....................................................................................................................... 160
Patient Perceptions of Physicians ........................................................................ 161
Medication Adherence (Proportion of Days Covered) ........................................ 162
Demographic Variables ....................................................................................... 162
Clinical Variables ................................................................................................ 163
Statistical Analysis ...................................................................................................... 163
Medication Adherence .............................................................................................164
Association between Patient Perception of Physicians and Medication
Adherence ............................................................................................................ 165
Results and Discussion ............................................................................................... 166
Sample Characteristics.............................................................................................166
Patient Perceptions of Physician Scale Development .............................................166

xiv
Page
Bivariate Association between Patient Perception of Physicians and
Demographic and Clinical Variables ................................................................... 168
Medication Adherence .............................................................................................168
Bivariate Association between Medication Adherence and Demographic and
Clinical Variables ................................................................................................ 169
Association between Patient Perceptions of Physicians and Medication
Adherence ............................................................................................................... 170
Bivariate Association between Patient Perceptions of Physicians and Medication
Adherence ............................................................................................................... 170
Overall Patient Perceptions of Physician Scale................................................ 170
Subscales .......................................................................................................... 170
Association between Patient Perception of Physicians and Medication
Adherence after Adjusting for Risk Factors ........................................................ 171
Overall Patient Perceptions of Physician Scale................................................ 171
Study Limitations ........................................................................................................ 173
Conclusions and Implications ..................................................................................... 173
Notes ........................................................................................................................... 175
BIBLIOGRAPHY ........................................................................................................... 177
APPENDICES
Appendix A. Bivariate Association between Patient Perceptions of Physician
Subscales and Medication Adherence ........................................................................ 185
Appendix B. Association between Patient Perceptions of Physician Subscales
and Medication Adherence after Adjusting for Risk Factors ..................................... 188
VITA………………………………………………………………………………........193

xv

LIST OF TABLES

Table

Page

1. Antihypertensive Medications ................................................................................... 47
2. Questions Used to Develop Patient Perception of Physician Scale ........................... 51
3. Sample Distribution by Age...................................................................................... 72
4. Sample Distribution by Gender ................................................................................ 73
5. Sample Distribution by Race .................................................................................... 74
6. Sample Distribution by Marital Status ...................................................................... 75
7. Sample Distribution by Education ............................................................................ 77
8. Sample Distribution by Income ................................................................................ 78
9. Sample Distribution by Supplemental Insurance Type ............................................ 80
10. Sample Distribution by Medicare Part D Prescription Coverage Gap ..................... 81
11. Sample Distribution by Beneficiary Perceived Health Status .................................. 83
12. Sample Distribution by Number of Unique Medications ......................................... 84
13. Sample Distribution by Number of Doctor Visits .................................................... 85
14. Sample Distribution by Individual Clinical Conditions............................................ 87
15. Sample Distribution by Charlson Comorbidity Index .............................................. 89
16. Mean, Standard Deviation, Cronbach’s Alpha Reliability, and Item-Total
Correlation Range for the Overall Perception of Physicians Scale, Perceived
Physician Knowledge about the Patient Subscale (Factor 1), and Perceived
Concern Subscale (Factor 2) ..................................................................................... 92

xvi
Table

Page

17. Factor Loading for Patient Perceptions of Physician Subscales ............................... 94
18. Sample Characteristics for Convergent Validity Variables ...................................... 96
19. Spearman Correlation Coefficients for Association between the Overall Patient
Perceptions of Physicians Scale and Convergent Validity Variables ....................... 97
20. Spearman Correlation Coefficients for Association between Perceived
Physician Knowledge of Patient Subscale (Factor 1) and Convergent Validity
Variables ................................................................................................................... 99
21. Spearman Correlation Coefficients for Association between the Perceived
Concern Subscale (Factor 2) and Convergent Validity Variables .......................... 100
22. Bivariate Association between Age and Overall Patient Perceptions of
Physicians Scale ...................................................................................................... 102
23. Bivariate Association between Gender and Overall Patient Perceptions of
Physicians Scale ...................................................................................................... 103
24. Bivariate Association between Race and Overall Patient Perceptions of
Physicians Scale ...................................................................................................... 105
25. Bivariate Association between Marital Status and Overall Patient Perceptions
of Physicians Scale ................................................................................................. 106
26. Bivariate Association between Education and Overall Patient Perceptions of
Physicians Scale ...................................................................................................... 107
27. Bivariate Association between Income and Overall Patient Perceptions of
Physicians Scale ...................................................................................................... 109
28. Bivariate Association between Insurance and Overall Patient Perceptions of
Physicians Scale ...................................................................................................... 110
29. Bivariate Association between Medicare Part D Prescription Coverage Gap
and Overall Patient Perceptions of Physicians Scale .............................................. 112
30. Bivariate Association between Perceived Health Status and Overall Patient
Perceptions of Physicians Scale .............................................................................. 113
31. Bivariate Association between Number of Doctor Visits and Overall Patient
Perceptions of Physicians Scale .............................................................................. 115

xvii
Table

Page

32. Bivariate Association between Number of Unique Medications and Overall
Patient Perceptions of Physicians Scale .................................................................. 116
33. Bivariate Association between Clinical Conditions and Overall Patient
Perceptions of Physicians Scale .............................................................................. 118
34. Bivariate Association between Charlson Comorbidity Index and Overall
Patient Perceptions of Physicians Scale .................................................................. 122
35. Distribution of Proportion of Days Covered........................................................... 124
36. Distribution of Medication Adherence ................................................................... 126
37. Bivariate Association between Age Category and Medication Adherence ............ 127
38. Bivariate Association between Gender and Medication Adherence....................... 128
39. Bivariate Association between Race and Medication Adherence .......................... 130
40. Bivariate Association between Marital Status and Medication Adherence ............ 131
41. Bivariate Association between Education and Medication Adherence .................. 132
42. Bivariate Association between Income and Medication Adherence ...................... 134
43. Bivariate Association between Insurance and Medication Adherence ................... 136
44. Bivariate Association between Medicare Part D Prescription Coverage Gap
and Medication Adherence ..................................................................................... 138
45. Bivariate Association between Perceived Health Status and Medication
Adherence ............................................................................................................... 139
46. Bivariate Association between Number of Unique Medications and Medication
Adherence ............................................................................................................... 141
47. Bivariate Association between Number of Doctor Visits and Medication
Adherence ............................................................................................................... 142
48. Bivariate Association between Clinical Conditions and Medication Adherence ... 144
49. Bivariate Association between Charlson Comorbidity Index and Medication
Adherence ............................................................................................................... 148

xviii

Table

Page

50. Bivariate Association between the Overall Patient Perceptions of Physicians
Scale and Medication Adherence............................................................................ 150
51. Multiple Logistic Regression Examining Association between the Overall
Patient Perceptions of Physicians Scale and Medication Adherence ..................... 154
A1. Bivariate Association between the Perceived Physician Knowledge of Patient
(Factor 1) Subscale and Medication Adherence ..................................................... 186
A2. Bivariate Association between the Perceived Concern (Factor 2) Subscale and
Medication Adherence ............................................................................................ 187
B1. Multiple Logistic Regression Examining Association between Perceived
Physician Knowledge about the Patient (Factor 1) Subscale and Medication
Adherence ............................................................................................................... 189
B2. Multiple Logistic Regression Examining Association between Perceived
Concern Subscale (Factor 2) Subscale and Medication Adherence ....................... 191

xix

LIST OF FIGURES
Figure

Page

1. Sample Selection Results ............................................................................................ 70

xx

ABSTRACT

Ward, Lori Marquinne. Ph.D., Purdue University, December, 2013. Patient Perceptions
of Physicians and Medication Adherence Among Medicare Part D Beneficiaries. Major
Professor: Joseph Thomas III.
An observational database analysis using Medicare Current Beneficiary Survey data was
conducted to examine patient perceptions of physicians and associations with adherence
to antihypertensive medication among Medicare beneficiaries enrolled in Medicare
Part D. The study sample included beneficiaries if they were 65 years or older, dwelling
in the community, had a diagnosis of hypertension in 2007, were enrolled in Medicare
Part D all 12 months in 2008, and had Medicare Part D claims for antihypertensive
medication in 2008. Beneficiaries were excluded if their Medicare eligibility was due to
end-stage renal disease or disability, if they resided in a long term care facility, if they
had a proxy responder, or if they had a diagnosis of Alzheimer’s disease or dementia.
Among 2,510 beneficiaries that passed inclusion and exclusion criteria, 44 percent were
in their seventies, 65 percent were female, and 83 percent were White. An overall patient
perceptions of physicians scale was created using MCBS items. The overall patient
perceptions of physicians had good reliability, Cronbach’s alpha=0.92. Factor analysis
was used to determine if there were any subscales within the patient perception of
physician scale, and yielded two factors: perceived physician knowledge about the

xxi
patient (Factor 1) and perceived concern (Factor 2). Medication adherence was assessed
using proportion of days covered (PDC) for antihypertensive medications. Beneficiaries
with a PDC of 0.80 or greater were considered to be adherent, and beneficiaries with a
PDC less than 0.80 were considered to be nonadherent. Thirty-five percent of the
beneficiaries were not adherent to their antihypertensive medications. Association
between patient perceptions of physicians and medication adherence was assessed using
stepwise multiple logistic regression that adjusted for risk factors including age, gender,
race, education, income, private insurance, Medicaid, reaching the Medicare Part D
prescription coverage gap, perceived health status, number of unique medications,
number of doctor visits, Charlson Comorbidity Index, and clinical conditions (heart
disease, heart failure, diabetes, stroke, non-skin cancers, rheumatoid arthritis, depression,
Parkinson’s disease, osteoporosis, and respiratory conditions). Beneficiaries with patient
perceptions of physician scale scores of 37 or higher were more likely to be adherent to
antihypertensive medications in comparison to beneficiaries with scores less than 37
(Odds ratio=1.341, 95% CI=1.101-1.632, p-value=0.0035). These findings indicate that
patient perceptions of their physician have an impact on the patient to adhere to
medication therapy.

1

INTRODUCTION

Background
Older adults, age 65 years or older, make up about 13 percent of the US
population and are expected to reach approximately 20 percent of the population by 2030
(Administration on Aging 2010, 2011; Howden and Meyer 2011). Approximately 90
percent of adults age 65 years or older take prescription drugs (Families USA 2000), and
older adults may face physical, mental, social, or financial challenges which can lead
them to alter their medication therapy and not adhere as prescribed (Gu et al. 2010;
Safran et al. 2005).
Medication Adherence
Between 4 and 27 percent of Medicare beneficiaries have reported not adhering to
medication therapy (Gellad et al. 2007; Kennedy et al. 2008; Wilson et al. 2007). In
2003, approximately 16 percent of Medicare beneficiaries reported skipping doses to
make medication last longer, and approximately 13 percent of Medicare beneficiaries
reported taking smaller doses to make medication last longer (Wilson et al. 2007).
Not filling prescriptions/refills or not adhering to medication as prescribed can
lead to worsened disease states or health complications (Miller 1997). The complications
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from not taking medication or not using medications properly can lead to increased use of
healthcare resources, such as hospitalizations, doctor visits, and emergency department
visits, but proper medication use can potentially decrease medical spending and
healthcare resource use (Balkrishnan, Christensen, and Bowton 2002; Conwell et al.
2011; Sokol et al. 2005).
Hypertension
Hypertension is a major contributor to morbidity and mortality due to
cardiovascular disease (Fields et al. 2004; Hajjar and Kotchen 2003). Approximately 67
percent of older adults age 60 or older report having hypertension with highest rates
reported among nonwhites and women (Aslam et al. 2010; Yoon 2012). Among patients
with such chronic diseases, the patient provider relationship has been identified as a
potential barrier to optimal treatment (Stewart 1995).
Patient Physician Relationships
The patient provider relationship has been identified as a barrier to medication
adherence among older patients (American Society on Aging and American Society of
Consultant Pharmacists Foundation 2006). The quality of the patient physician
relationship has been considered to be an important healthcare system related factor that
may impact on medication adherence (Krueger, Berger, and Felkey 2005). Positive
patient physician relationships have been described as important in improving patient
outcomes and medication behavior use among those with chronic medical conditions
(Kaplan et al. 1989; Roter and Hall 2009; Von Korff et al. 1997), and positive patient
physician relationships may impact a patient’s willingness to comply with a physician’s
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instructions (Graham and Lavicka 2010). Some recommended key strategies to achieve
good physician-patient relationships are (1) establishing a positive trustworthy and
supportive relationship with the patient, (2) involving family as a support mechanism,
clearly communicating the benefits of treatment with the patient, and (3) identifying and
dialoguing with the patient about any barriers to adherence that may exist and developing
plans to overcome them (Krueger et al. 2005).
Patient Perceptions of Physicians
Not filling prescriptions can result from differences in perception between the
patient and physician on importance of therapy, ability to self regulate therapy, or cost
(Miller 1997). DeGeest and Sabate reported that primary care attributes such as
interpersonal communication, accumulated knowledge of the patient, and trust are
important in having consistent patient-provider relationships (DeGeest and Sabate 2003).
Zolnierek and DiMatteo reported that risk of not adhering to medical treatment or
prevention measures was almost 20 percent higher among patients who have poor
communication with their physician in comparison to patients who communicate well
with their physician (Zolnierek and DiMatteo 2009). Negative perceptions regarding
physician communication can affect whether a patient will follow the physician’s advice
and/or seek care when needed (Blanchard and Lurie 2004). Patient provider
communication can be improved by several strategies, such as (1) spending time
conversing with the patient about non-medical topics, (2) providing clear instructions
verbally and written (be specific and detailed), and (3) developing a friendly relationship
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versus a business relationships (American Society on Aging and American Society of
Consultant Pharmacists Foundation 2006).
Accumulated knowledge of the patient is a primary care attribute that has been
identified as important in having a good patient provider relationship (DeGeest and
Sabate 2003). Healthcare consumers feel their doctor should know their medical history
and be familiar with their medical problems as well as their personal lives (Goff et al.
2008; Pittsburgh Regional Health Initiative 2009). More than 80 percent of a sample of
Southwestern Pennsylvanian healthcare consumers felt their doctor knew their medical
history (Pittsburgh Regional Health Initiative 2009). Among consumers who did not
have a regular doctor but sought care through the emergency room or medical clinics, 44
percent were not confident at all that the doctor knew their medical history. In addition,
patients feel their doctor should be familiar with their medical problems as well as their
home and work situation (Goff et al. 2008). Being familiar with the patient’s health and
them as a person can help to develop a friendly relationship between the patient and
provider (American Society on Aging and American Society of Consultant Pharmacists
Foundation 2006).
Physician competence or expertise is often valued more by older patients (50 or
older) than patients in their twenties and thirties (Wagner, Warren, and Moseley 2010).
However, patients receiving contradictory information from the Internet or other reliable
sources questioned the expertise of the physician (Ledford et al. 2010). Additionally,
physician “trial and error” to find the most appropriate prescription for the patient was
viewed as a lack of physician expertise (Ledford et al. 2010).
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Therefore, when a patient perceives a physician as having high knowledge and
competence, there is potential to improve patient adherence to medical treatment
(Bar-Tal, Stasiuk, and Maksymiuk 2013). However, translating this knowledge into
improvements in clinical practice can be a challenge. Researchers continue to try to
determine specific patient and provider factors that are associated with positive outcomes
(Ciechanowski et al. 2001).

Literature Review
Patient Perceptions of Physician Communication and Medication Adherence
Turner and associates examined the relationship between doctor-patient
communication about blood pressure and adherence to blood pressure medication during
a three month period among older adults (Turner et al. 2009). Patients who felt it was
very or somewhat unimportant to talk with doctor or nurse about blood pressure at their
last visit were less likely to adhere of their antihypertensive medication (Odds ratio=0.32,
95% CI=0.12-0.84, p-value=0.021). No association was reported between a patient
feeling that the doctor listened to them sometimes or not at all and adhering to
antihypertensive medication (Odds ratio=1.04; 95% CI=0.31-3.39, p-value=0.94).
Daniels and associates examined the relationship between physician
communication about hypertension and adhering to antihypertension medication among
403 African Americans with hypertension who completed the National Health and
Nutrition Examination Survey (NHANES II) (Daniels et al. 1994). Daniels and
associates reported no association between time talked with the doctor about
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hypertension and adherence to antihypertensive medication (Daniels, René, and Daniels
1994).
Cohen and associates examined the relationship between physician
communication and medication adherence among 1,611 adults aged 60 or older from
Australia and Europe (Cohen, Burke, and Beilin 1998). Cohen and associates reported
that nonadherence was associated a greater likelihood of not having an explanation about
the drug (OR=1.45, CI=1.08-1.96) (Cohen et al. 1998).
Wilson and associates examined patient physician communication and medication
adherence among Medicare beneficiaries. Among beneficiaries who reported not
adhering to medication, almost 30 percent had not discussed it with their physician
(Wilson et al. 2007).
Schoenthaler and associates examined the effect of patients' perceptions of
physicians' communication and medication adherence among hypertensive African
Americans. Communication that was less collaborative between the patient and
physician was associated with medication nonadherence (β= -0.11, p=.03) (Schoenthaler
et al. 2009).
Schoenthaler and associates examined if race concordance influenced the
association between physician communication and medication adherence. Less
collaborative patient-physician communication was associated with nonadherence (β= 0.46, p=.04). However, no association was reported between adherence and
communication in race-concordant relationships (Schoenthaler et al. 2012).
Muntner and associates examined adherence to clopidogrel at 30 days after
percutaneous coronary intervention and reported that patients with low adherence to
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clopidogrel were three times more likely to report not adhering to medication due to cost
in comparison to patients with high adherence to clopidogrel (Muntner et al. 2011).
Additionally, patients with low adherence were three times more likely to be
uncomfortable asking their doctor for instructions on their medication in comparison to
patients with high adherence to clopidogrel (OR=3.06, CI=0.99-11.4).
In summary, seven studies were found that examined associations between patient
perceptions of physician communication and adhering to prescription medication (Cohen
et al. 1998; Daniels et al. 1994; Muntner et al. 2011; Schoenthaler et al. 2009;
Schoenthaler et al. 2012; Turner et al. 2009; Wilson et al. 2007). Five of the seven
studies reported that poor physician communication about medication was associated
with decreased likelihood of adhering to medications (Cohen et al. 1998; Muntner et al.
2011; Schoenthaler et al. 2009; Schoenthaler et al. 2012; Wilson et al. 2007). However,
the remaining two studies reported no statistically significant association between patient
perceptions of physician communication and medication adherence (Daniels et al. 1994;
Turner et al. 2009).

Patient Perception of Physician Knowledge and Medication Adherence
Beach, Keruly, and Moore examined associations between patient perceptions of
physician knowledge and adherence to highly active antiretroviral therapy among HIV
patients (Beach, Keruly, and Moore 2006). Patients who felt their physician was not
knowledgeable about their health and them as a person were less likely to adhere to
medication (Beach et al. 2006).
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Ledford and associates conducted a qualitative study to understand patient
perceptions of physician knowledge regarding prescription medications (Ledford et al.
2010). Patients who identified themselves as adherent stated their physicians’ knowledge
was a reason for their medication adherence (Ledford et al. 2010).
Goff and associates, in a qualitative study, examined patients’ beliefs and
preferences about medication prescribing to understand factors that might affect
medication adherence and reported that participants wanted their doctor to be familiar
with their medical problems, health beliefs, as well as home and work circumstances
(Goff et al. 2008). Additionally, they hoped that the physician being knowledgeable of
them as a whole would inform the doctor’s recommendation (Goff et al. 2008).
In summary, one study was found that examined association between patient
perceptions of physician knowledge and adherence (Beach et al. 2006). Two studies
were found that qualitatively examined patient perceptions of physician knowledge about
their health (Goff et al. 2008; Ledford et al. 2010).

Patient Perception of Physician Competence and Medication Adherence
Ledford and associates conducted a qualitative study to understand patient
perceptions of physician competence regarding prescription medications and reported
that patients described the prescribing physician’s level of expertise as a determinant of
their medication adherence, especially regarding filling prescriptions (Ledford et al.
2010).
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Karlson and associates, in a qualitative study, examined preferences regarding
total joint replacement surgery in patients with moderate to severe osteoarthritis of the
knee and hip and reported that men were more confident about the competency of their
surgeon (Karlson et al. 1997). Women were more suspicious and had distrust of the
medical institution. Also, women were concerned with finding the most experienced
surgeon (Karlson et al. 1997).
Goff and associates, in a qualitative study, examined patient beliefs and
preferences about medication prescribing to understand factors that might affect
medication adherence and reported that patients believed that professional expertise and
experience contribute to a doctor’s medication recommendation (Goff et al. 2008).
Additionally, specific medication knowledge was believed to be important in making
medication recommendations (Goff et al. 2008).
In summary, three qualitative studies were found that assessed patient perception
of physician competence (Goff et al. 2008; Karlson et al. 1997; Ledford et al. 2010).
However, no studies were found that assessed the association between patient perception
of physician competence and medication adherence.

Demographics and Medication Adherence
Age and Medication Adherence
Age and Not Filling Prescriptions or Refills
Kennedy and Morgan assessed the association between age and not filling a
prescription due to cost using the 2002/2003 Joint Canada-US Survey of Health with a
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sample of over 21 million respondents (Kennedy and Morgan 2006). They reported that
respondents aged 75 or older were less likely to not fill a prescription due to cost in
comparison to adults aged 18 to 34 years old (Odds ratio=0.2; 95% CI=0.1-0.3)
(Kennedy and Morgan 2006). In a second study, Kennedy, Tulue, and Mackay examined
failure to fill or refill one or more prescriptions among 2004 Medicare beneficiaries
(Kennedy et al. 2008). It was reported that rates for not filling a prescription or refill
were higher among beneficiaries ages 18-64 in comparison to beneficiaries ages 65 or
older (10.4% versus 3.3 percent, p<0.0001) (Kennedy et al. 2008).
Monane and associates examined the association of age and having
antihypertensive medications 80 percent or more days during a one-year period among
New Jersey Medicaid beneficiaries 65 or older (Monane et al. 1996). Patients ages 65 to
74 were more likely to not fill their antihypertensive medications in comparison to
patients ages 74-84 years of age (Odds ratio=1.29; 95% CI=1.10-1.53). Additionally
patients, ages 65 to 74 were twice as likely to not fill their antihypertensive medication in
comparison to patients ages 85 or older (Odds ratio=2.12; 95% CI=1.72-2.64) (Monane et
al. 1996).
Lagu and associates examined the relationship between age and failure to fill
antihypertensive prescriptions and refills (waiting more than 30 days) in 327 hypertensive
African Americans in a Medicaid managed care plan (Lagu et al. 2009). Patients who
were older than 50 years of age were less likely to not fill or refill antihypertensive
medications in comparison to patients 50 years or younger (Odds ratio=0.58; 95%
CI=0.37±0.91) (Lagu et al. 2009).
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Venturini and associates examined the association between age and not filling
prescriptions for sulfonylureas among 786 patients in a Southern California health
maintenance organization (HMO) (Venturini et al. 1999). Venturini and associates
reported that as age increased rates for filling sulfonylureas prescriptions increased by 0.2
percent (β=0.002, SE=0.0001) (Venturini et al. 1999).
Xing and associates examined the relationship between age and rate of unfilled
electronic prescriptions for antidepressants among 267 patients enrolled in a mid-Atlantic
managed care organization from 2006-2009 (Xing et al. 2011). Patients who were age 50
to 64 years old were almost four times less likely to have unfilled electronic prescriptions
for antidepressants in comparison to patients age 18 to34 years old (Odds ratio=3.72;
95% CI=1.81-7.67; p<0.001) (Xing et al. 2011).
Dunlay and associates examined the association between age and not filling
prescriptions or refills for conventional heart failure therapy over a six month period
among 209 community dwelling patients with heart failure in Olmstead County,
Minnesota (Dunlay et al. 2011). Dunlay and associates reported that patients with less
than 80 percent of days covered of angiotensin-converting-enzyme inhibitors/angiotensin
receptor blockers (ACEIs/ARBs) therapy were younger than patients with more than 80
percent of days covered of ACEIs/ARBs therapy (67.9±11.0 years versus
73.4±13.5years; p=0.05) (Dunlay et al. 2011). Patients with less than 80 percent of days
covered of statin therapy were younger than patients with more than 80 percent of days
covered to statin therapy (68.2 percent versus 75.1%; p=0.03) (Dunlay et al. 2011).
Sharkness and Snow examined the relationship between age and not refilling
antihypertensive medication among 125 patients at the Baltimore Veterans
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Administration Medical Center Hypertension Clinic (Sharkness and Snow 1992). No
association was reported between age and not refilling prescriptions.
Shah and associates examined the relationship between age and not filling firstfill prescriptions within 30 days of the medication being prescribed among patients aged
18 or older who frequented the Geisinger Clinic in Pennsylvania (Shah et al. 2009).
Older patients were more likely to not fill a first prescription in comparison to younger
patients (ten year increase in age) (Odds ratio=0.91, 95% CI=0.84-0.98, p=0.016) (Shah
et al. 2009).
In summary, nine studies were found that examined relationships between age and
not filling prescriptions or refills (Dunlay et al. 2011; Kennedy and Morgan 2006;
Kennedy et al. 2008; Lagu et al. 2009; Monane et al. 1996; Shah et al. 2009; Sharkness
and Snow, 1992; Venturini et al. 1999; Xing et al. 2011). Seven out of nine studies
examined association between age and not filling prescriptions or refills and reported that
increased age was associated with a decreased likelihood of not filling or refilling
prescriptions (Dunlay et al. 2011; Kennedy and Morgan 2006; Kennedy et al. 2008; Lagu
et al. 2009; Monane et al. 1996; Venturini et al. 1999; Xing et al. 2011). Of the
remaining two studies, one found an association between increased age and likelihood of
not filling prescriptions (Shah et al. 2009), and the other found no association between
age and not filling or refilling prescriptions (Sharkness and Snow 1992). The opposing
findings in the Shah et al. 2009 study may be due to examining electronic first fill
prescriptions within 30 days of prescribing. Other studies contrasted with that examined
prescription fills and refills over longer periods of time.
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Age and Nonadherence combining Unfilled Prescriptions, Skipping Doses, and Taking
Smaller Doses
Some studies assessed age and nonadherence to medication therapy by examining
any form of nonadherence including unfilled prescriptions, skipped doses, and taking
smaller doses (Soumerai et al. 2006; Stavropoulou 2011). Soumerai and associates
examined cost related medication nonadherence among 2004 Medicare beneficiaries.
Cost related nonadherence was defined as any of the following three measures: (1) not
filling prescription or refill, (2) skipping doses to make medication last longer, or (3)
smaller doses to make medication last longer (Soumerai et al. 2006). Medicare
beneficiaries (75 to 84 years old) were associated with lower odds of not filling
prescription or refill, skipping doses to make medication last longer, or smaller doses to
make medication last longer in comparison to beneficiaries aged 65 to 74 years (Odds
ratio=0.8, 95% CI=0.7-0.9). Also Medicare beneficiaries ages 85 yearsor older were
associated with lower odds of not filling prescription or refill, skipping doses to make
medication last longer, or smaller doses to make medication last longer in comparison to
beneficiaries age 65 to 74 years (Odds ratio=0.6, 95% CI=0.5-0.8) (Soumerai et al. 2006).
Stavropoulou also examined age and nonadherence to prescribed medication
among participants in the 2004/2005 European Social Survey. Medication use behavior
was measured by asking patients which response best described their medication taking
behavior (Stavropoulou 2011). Responses regarding not filling or refilling, skipping, or
taking smaller doses included: (1) I did not collect the medicine from the pharmacy, (2) I
collected the medicine but did not use any of it, and (3) I used some or all of the medicine
but not exactly as prescribed. Although no association was reported, age squared was
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negatively associated with nonadherence indicating that as age increased patients were
less likely to be nonadherent to their prescribed drug regimen (mfx=-0.0001, p<0.05)
(Stavropoulou 2011).
Daniels and associates examined the relationship between age and adherence to
antihypertensive medication among 403 black hypertensive National Health and
Nutrition Examination Survey (NHANES II) respondents (Daniels et al. 1994).
Adherence was defined by the question, “How often do you take your medicine when
you are supposed to?” Daniels and associates reported that patients 58 years or older
were more adherent with their medications in comparison to patients who were 25 years
old and younger (88 percent versus 20 percent, p=0.000) (Daniels et al. 1994).
In summary, three studies were found that examined associations between age and
unfilled prescriptions and refills, skipping doses or taking smaller doses (Daniel et al.
1994; Soumerai et al. 2006; Stavropoulou 2011). All three studies reported that younger
patients were more likely to not fill, skip doses or take smaller doses (Daniels et al. 1994;
Soumerai et al. 2006; Stavropoulou 2011). Although the study by Stavropoulou (2011)
was conducted throughout Europe, the findings were the same as those of the studies
conducted in the US.
Race and Medication Adherence
Race and Not Filling Prescriptions or Refills
Sharkness and Snow examined the relationship between race and adherence
hypertension medication among 125 patients at the Baltimore Veterans Administration
Medical Center Hypertension Clinic (Sharkness and Snow 1992). Using an alpha level of
0.10, Sharkness and Snow reported that refills of less than 80 percent were more common
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among Blacks in comparison to other racial/ethnic groups (82 percent versus 67 percent,
p=0.10) (Sharkness and Snow 1992).
Monane and associates examined the association betweenrace and not filling or
refilling antihypertensive medication among New Jersey Medicaid beneficiaries 65 or
older over a one-year period (Monane et al. 1996). African Americans were less likely to
fill or refill their antihypertensive medication prescriptions in comparison to Whites
(Odds ratio=0.55, 95% CI=0.44-0.68) (Monane et al. 1996).
Gellad and associates examined variations in rates of not filling prescriptions and
refills by race/ethnicity among 2003 Medicare beneficiaries. Self-assessed medication
nonadherence was assessed by asking if the beneficiary (1) did not fill a prescription
because they did not think the medication was needed and (2) did not fill a prescription
because they were taking too many medications (Gellad et al. 2007). No association was
reported between race and not filling or refilling prescriptions (Gellad et al. 2007).
Kennedy and Morgan assessed the association between age and not filling a
prescription due to cost using the 2002/2003 Joint Canada-US Survey of Health. In a
sample of over 21 million respondents, no association was found between race and not
filling a prescription due to cost (Odds ratio=0.2; 95% CI=0.1-0.3) (Kennedy and Morgan
2006).
In summary, four studies examined relationships between race and not filling
prescriptions or refills (Gellad et al. 2007; Kennedy and Morgan 2006; Monane et al.
1996; Sharkness and Snow 1992). Two out of the four studies reported an association
between African American race and increased likelihood of not filling or refilling
prescriptions for antihypertensive medications (Monane et al. 1996; Sharkness and Snow
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1992). However, the remaining two studies reported no association between race and not
filling or refilling prescriptions (Gellad et al. 2007; Kennedy and Morgan 2006).
Race and Nonadherence combining Unfilled Prescriptions, Skipping Doses, and Taking
Smaller Doses
Gellad and associates examined rates of not filling a prescription or refill due to
cost, skipping to make medication last longer and taking smaller doses to make
medication last longer by race/ethnicity among 2003 Medicare beneficiaries (Gellad et al.
2007). They reported that African Americans and Hispanics were more likely to report
cost related nonadherence in comparison to Whites (35.1 percent, 36.5 percent and 26.7
percent, p<0.001) (Gellad et al. 2007). Additionally, Gellad and associates examined
rates of skipping or stopping medication because it made them feel worse or felt it was
not helping them. However, no association was reported between race and skipping or
stopping medication because it made them feel worse or was not helping (Gellad et al.
2007).
Soumerai and associates examined the prevalence of not filling prescriptions or
refills, skipping doses to make medication last longer, or smaller doses to make
medication last longer (Soumerai et al. 2006). Soumerai and associates reported that
African Americans had higher odds of cost related nonadherence in comparison to
Whites (Odds ratio=1.4, 95%CI=1.1-1.7) (Soumerai et al. 2006).
In summary, two studies were found that examined race and not filling
prescription or refill, skipping doses to make medication last longer or smaller doses to
make medication last longer (Gellad et al. 2007; Soumerai et al; 2006). Both reported
that African Americans and/or Hispanics Medicare beneficiaries were more likely to be
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nonadherent to medication therapy in comparison to Whites (Gellad et al. 2007;
Soumerai et al. 2006). Additionally, Gellad and associates reported no association
between race and skipping or stopping medication because it made them feel worse or
was not helping (Gellad et al. 2007).
Gender and Medication Adherence
Gender and Not Filling Prescriptions or Refills
Monane and associates assessed associations between gender and not filling or
refilling prescriptions for antihypertensive medication over a one-year period among New
Jersey Medicaid beneficiaries (Monane et al. 1996). No association was reported
between gender and having 80 percent or more days of having antihypertensive
medication during the 1one-year period (Monane et al. 1996).
Kennedy and Morgan assessed the association between age and not filling a
prescription due to cost using the 2002/2003 Joint Canada-US Survey of Health with a
sample of over 21 million respondents (Kennedy and Morgan 2006). No association was
reported between gender and not filling or refilling a prescription due to cost (Kennedy
and Morgan 2006).
Dunlay and associates examined associations between gender and not filling or
refilling conventional heart failure therapy for a six month period among 209 community
dwelling patients with heart failure in Olmstead County, Minnesota (Dunlay et al. 2011).
They reported that males had a higher percentage of not filling or refilling prescriptions
for ACEIs/ARBs therapy than women (79 percent versus 57 percent; p=0.04) (Dunlay et
al. 2011).
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Lagu and associates examined the association between gender and filling an
antihypertensive medication among Medicaid managed care beneficiaries with
hypertension who were treated at least three times in one of six primary care practices in
Philadelphia (Lagu et al. 2009). They reported that African American hypertensive
females were less likely to fill their antihypertensive medication in comparison to African
American hypertensive males (Odds ratio=0.97, 95% CI=0.60-1.56) (Lagu et al. 2009).
Kennedy and associates examined the relationship between gender and failure to
fill at least one prescription medication among 2004 Medicare beneficiaries (Kennedy et
al. 2008). Failure to fill rates were slightly higher for women than men (5.0 percent
versus 3.6 percent, p=0.001) (Kennedy et al. 2008).
Shah and associates examined the relationship between gender and first fill
prescriptions for antihypertensive medications within 30 days of the medication being
prescribed. Females were less likely to fill a first prescription within 30 days in
comparison to males (81 percent versus 85 percent, p<0.014) (Shah et al. 2009).
In summary, six studies were found that examined association between gender
and not filling a prescription or refill. Two out of the six studies reported that females
had higherlikelihood of not filling prescriptions or refills in comparison to males
(Kennedy et al. 2008; Shah et al. 2009). Two out of the six studies reported males had
higher likelihood of not filling or refilling a prescription in comparison to females
(Dunlay et al. 2011; Lagu et al. 2009). The two remaining studies reported no
statistically significant association between gender and not filling or refilling a
prescription (Kennedy and Morgan 2006; Monane et al. 1996).
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Gender and Nonadherence combining Unfilled Prescriptions, Skipping Doses, and
Taking Smaller Doses
Soumerai and associates examined the prevalence of not filling a prescription or
refill, skipping doses to make medication last longer, or taking smaller doses to make
medication last longer among Medicare beneficiaries prior to the implementation of
Medicare Part D (Soumerai et al. 2006). They reported that women were more likely to
not fill a prescription or refill, skip doses to make medication last longer, or take smaller
doses to make medication last longer in comparison to males (Odds ratio=1.2; 95%
CI=1.1-1.4) (Soumerai et al. 2006).
Stavropoulou examined gender and nonadherence to prescribed medication (did
not fill prescription or refill, skipped doses or took smaller doses) among participants in
the 2004/2005 European Social Survey and reported that females were less likely to be
adherent to medication than males (mfx=0.0205, p<0.05) (Stavropoulou 2011).
Daniels and associates examined the relationship between gender and adherence
to antihypertensive medication among 403 Black hypertensive National Health and
Nutrition Examination Survey (NHANES II) respondents and reported that a higher
percentage of males filled their prescriptions or refills, did not skip doses, or did not take
smaller doses in comparison to females (89.7 percent versus 81.2 percent, p=0.032)
(Daniels et al. 1994).
In summary, three studies were found that examined association between gender
and unfilled prescriptions, skipping doses, and taking smaller doses (Daniels et al. 1994;
Soumerai et al. 2006; Stavropoulou 2011). All three studies reported that females were
more likely to not fill or refill prescriptions, skip doses, or take smaller doses of
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medication in comparison to males (Daniel et al. 1994; Soumerai et al. 2006;
Stavropoulou 2011).
Marital Status and Medication Adherence
Marital Status and Not Filling Prescriptions or Refills
Dunlay and associates examined associations between marital status and not
filling or refilling conventional heart failure therapy over a six month period among 209
community dwelling patients with heart failure in Olmstead County, Minnesota (Dunlay
et al. 2011). Dunlay and associates reported no association between marital status and
filling or refilling prescriptions for heart failure at least 80 percent of the time (Dunlay et
al. 2011).
In summary, only one study was found that examined the relationship between
marital status and not filling prescriptions or refills (Dunlay et al. 2011). No association
was reported between marital status and not filling prescriptions or refills (Dunlay et al.
2011).

Marital Status and Nonadherence combining Unfilled Prescriptions, Skipping Doses, and
Taking Smaller Doses
Stavropoulou examined the relationship between martial status and not filling
prescriptions, skipping doses, or taking smaller doses among Europeans who completed
the European Social Survey in 2004/2005 (Stavropoulou 2011). Married Europeans were
less likely to not fill prescriptions or refills, skip doses, or take smaller doses in
comparison to unmarried Europeans (mfx=-0.0234, p<0.01) (Stavropoulou 2011).
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Daniels and associates examined the relationship between marital status and
taking antihypertensive medicine as prescribed among 403 African Americans with
hypertension who completed the National Health and Nutrition Examination Survey
(NHANES II) (Daniels et al. 1994). No association was reported between marital status
and not filling or refilling, skip doses, or taking smaller doses of antihypertensive
medicine (Daniels et al. 1994).
In summary, two studies were found that examined the relationship between
marital status and unfilled prescriptions, skipping doses, and taking smaller doses
(Daniels et al. 1994; Stavropoulou 2011). One of the two studies reported an association
between being unmarried and having an increased likelihood of not filling prescriptions,
skipping doses, or taking smaller doses (Stavropoulou 2011). The one remaining study
reported no association between marital status and unfilled prescriptions, skipping doses,
and taking smaller doses (Daniels et al. 1994).

Education and Medication Adherence
Education and Not Filling Prescriptions or Refills
Sharkness and Snow examined education level and rates of not filling
antihypertensive prescriptions among Baltimore Veterans. No association was reported
between education level and rates of refills of 80 percent or higher and refills and refills
less than 80 percent (Sharkness and Snow 1992).
Dunlay and associates examined the association between education and not filling
prescriptions for conventional heart failure therapy over a six month period among 209
community dwelling patients with heart failure in Olmstead County, Minnesota (Dunlay
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et al. 2011). No association was reported between education level and not filling
conventional heart failure therapy medication (Dunlay et al. 2011).
In summary, two studies were found that examined the relationship between
education and filling prescriptions and refills and no associations were reported between
education and not filling a prescription or refill (Dunlay et al. 2011; Sharkness and Snow
1992).

Education and Nonadherence combining Unfilled Prescriptions, Skipping Doses, and
Taking Smaller Doses
Soumerai and associates examined associations between education and not filling
a prescription or refill, skipping to make medication last longer, or took smaller doses to
make medication last longer among 2004 Medicare beneficiaries (Soumerai et al. 2006).
No association was reported between education and not filling a prescription or refill,
skipping to make medication last longer, or took smaller doses to make medication last
longer (Soumerai et al. 2006).
Additionally, Daniels and associates examined associations between education
and not filling a prescription or refill, skipping doses, or taking smaller doses of
antihypertensive medication among 403 Black hypertensive National Health and
Nutrition Examination Survey (NHANES II) respondents (Daniels et al. 1994). A higher
percentage of respondents with one or more years of college (69%) were less adherent
with their hypertension medication therapy when compared to hypertensive patients with
a high school education or less (p=0.05) (Daniels et al. 1994).
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In summary, two studies examined associations between education and not filling
a prescription or refill, skipping doses, or taking smaller doses (Daniels et al. 1994;
Soumerai et al. 2006). One study reported that more adults with education beyond high
school did not fill a prescription or refill, skipped doses, or took smaller doses of
antihypertensive medication in comparison to adults with a high school education or less
(Daniels et al. 1994). The remaining study reported no association between education
and unfilled prescriptions, skipping doses, and taking smaller doses (Soumerai et al.
2006).

Income and Medication Adherence
Income and Not Filling Prescriptions or Refills
Kennedy, Tuleu, and Mackay examined income and not filling or refilling one or
more prescriptions among 2004 Medicare beneficiaries (Kennedy et al. 2008). Medicare
beneficiaries with annual incomes greater than $30,000 were less likely to report failureto-fill prescriptions than beneficiaries with incomes less than or equal to $30,000 (3.5
percent versus 4.9 percent, p<0.0001) (Kennedy et al. 2008).
Kennedy and Morgan assessed the association between income and not filling a
prescription due to cost using the 2002/2003 Joint Canada-US Survey of Health with a
sample of over 21 million respondents (Kennedy and Morgan 2006). Kennedy and
Morgan reported that respondents in the lowest household income quintile were three
times more likely to not fill a prescription due to cost in comparison to respondents in the
highest household income quintile (Odds ratio=3.4; 95%CI=2.4-4.8) (Kennedy and
Morgan 2006).
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In summary, the two studies that were found examined association between
income and not filling a prescription or refill reported that lower income was associated
with higher likelihood of not filling a prescription or refill (Kennedy and Morgan 2006;
Kennedy et al. 2008).

Income and Nonadherence combining Unfilled Prescriptions, Skipping Doses, and
Taking Smaller Doses
Stavropoulou examined income and not filling prescriptions, skipping doses or
taking smaller doses among participants in the 2004/2005 European Social Survey, and
reported Europeans with lower incomes (had difficulty at present income) were more
likely to not fill prescriptions, skip doses or take smaller doses in comparison to those
who had higher incomes (living comfortably) (mfx=0.0103, p<0.05) (Stavropoulou
2011).
Soumerai and associates examined the associations between income and not
filling prescriptions, skipping doses or taking smaller doses to make medication last
longer among 2004 Medicare beneficiaries (Soumerai et al. 2006). Medicare
beneficiaries with an income of less than $20,000 a year were more likely to experience
cost related nonadherence in comparison to Medicare beneficiaries with incomes higher
than $40,000 a year (Odds ratio=1.5, CI=1.2-1.9) (Soumerai et al. 2006).
Daniels and associates examined associations between income and not filling
prescriptions, skipping doses or taking smaller doses of antihypertensive medication
among 403 African Americans with hypertension who completed the National Health and
Nutrition Examination Survey (NHANES II). No association was reported between
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income level and not filling prescriptions, skipping doses or taking smaller doses
(Daniels et al. 1994).
In summary, three studies were found that examined the relationship between
income and not filling prescriptions, skipping doses or taking smaller doses (Daniels et
al. 1994; Soumerai et al. 2006; Stavropoulou 2011). Two out of three studies reported
association between lower income ($20,000 or less or having difficulty at present
income) and unfilled prescriptions, skipping doses, and taking smaller doses (Soumerai et
al. 2006; Stavropoulou 2011). One out of three studies reported no statistically
significant association between income and not filling prescriptions, skipping doses or
taking smaller doses (Daniels et al. 1994).
Perceived Health Status and Medication Adherence
Perceived Health Status and Not Filling Prescriptions or Refills
Venturini and associates examined associations between patient perceived health
status and filling prescriptions or refills for sulfonylureas among 786 patients in a
Southern California health maintenance organization (HMO), and reported that patients
who perceived their health as poor were lessnon-adherent with medication therapy (β=0.003, S.E=0.0001) (Venturini et al. 1999).

Perceived Health Status and Nonadherence combining Unfilled Prescriptions, Skipping
Doses, and Taking Smaller Doses
Soumerai and associates examined the prevalence of not filling prescriptions or
refills, skipping doses and taking smaller doses to make medication last longer among
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2004 Medicare beneficiaries prior to the implementation of Medicare Part D (Soumerai et
al. 2006). Soumerai and associates reported that Medicare beneficiaries who perceived
their health as poor were twice as likely to not fill prescriptions or refills, skip doses to
make medication last longer, or take smaller doses to make medication last longer in
comparison to beneficiaries who perceived their health as excellent (Odds ratio=2.4, 95%
CI=1.7-3.3) (Soumerai et al. 2006).
However, Stavropoulou examined of the relationship between perceived health
status and not filling prescriptions or refills, skipping doses or taking smaller doses of
prescribed medications among Europeans, and reported that Europeans who reported
their health status as bad were less likely to not fill prescriptions or refills, skip doses or
take smaller doses in comparison to those who reported their health status as good (mfx=0.0220, p<0.05) (Stavropoulou 2011).
In summary, two studies were found examining perceived health status and
nonadherence combining unfilled prescriptions, skipping doses, and taking smaller doses
and both reported worse perceived health status was associated with greater likelihood of
not filling prescriptions or refills, skipping doses or taking smaller doses (Soumerai et al.
2006; Stavropoulou 2011).

Insurance Coverage and Medication Adherence
Insurance Coverage and Not Filling Prescriptions or Refills
Kennedy and associates examined rates of not filling at least one prescription or
refill among Medicare beneficiaries (Kennedy et al. 2008). Failure to fill rates were
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higher among dual eligible Medicaid beneficiaries than for those who did not have
Medicaid coverage (6.3 percent versus 4.0 percent, p=0.010) (Kennedy et al. 2008).
Xing and associates examined the association between type of health plan and rate
of unfilled electronic antidepressant prescriptions among 267 patients enrolled in a midAtlantic managed care organization from 2006-2009 (Xing et al. 2011). No association
was reported between type of health plan (indemnity, HMO, preferred provider
organization (PPO), or Medicare Part D) and failure to fill electronic antidepressant
prescriptions (Xing et al. 2011).
Kennedy and Morgan assessed the association between age and not filling a
prescription due to cost using the 2002/2003 Joint Canada-US Survey of Health
(Kennedy and Morgan 2006). In a sample of over 21 million respondents, those who
were not insured were seven times more likely to report not filling prescriptions due to
cost in comparison to respondents with prescription benefits (Odds ratio=7.3; 95%
CI=4.6-11.5) (Kennedy and Morgan 2006). Also, respondents whose health insurance
did not cover prescription drugs were four times more likely to not fill prescriptions due
to cost in comparison to respondents with prescription benefits (Odds ratio=4.3; 95%
CI=3.0-6.0) (Kennedy and Morgan 2006).
In summary, three studies were reported that examined associations between
insurance coverage and not filling prescriptions or refills (Kennedy and Morgan 2006;
Kennedy et al. 2008; Xing et al. 2011). One of the three studies reported association
between having no insurance coverage and increased likelihood of not filling
prescriptions or refills (Kennedy and Morgan 2006). However, one of the three studies
reported that more dual eligibles (Medicare and Medicaid) failed to fill prescriptions or
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refills compared to non-dual eligibles (Kennedy et al. 2008). Additionally, one out of the
three studies reported no statistically significant association between type of insurance
plan and not filling prescriptions or refills (Xing et al. 2011).
Insurance Coverage and Nonadherence combining Unfilled Prescriptions, Skipping
Doses, and Taking Smaller Doses
Soumerai and associates examined prevalence of not filling prescriptions or
refills, skipping doses to make medication last longer, or taking smaller doses to make
medication last longer among Medicare beneficiaries prior to the implementation of
Medicare Part D (Soumerai et al. 2006). Medicare beneficiaries who had no prescription
coverage were almost three times more likely not filling prescriptions or refills, skipping
doses to make medication last longer, or taking smaller doses to make medication last
longer in comparison to Medicare beneficiaries with Medicaid prescription coverage
(Odds ratio=2.8, 95% CI=2.0-3.8) (Soumerai et al. 2006).
Number of Medications and Medication Adherence
Number of Medications and Not Filling Prescriptions or Refills
Chapman and associates examined predictors of nonadherence to concomitant
antihypertensive and lipid lowering therapies among enrollees of a US managed care
organization using proportion of days covered as the outcome measure (Chapman et al.
2008). Patients taking no other medications were almost twice as likely to be adherent
with concomitant therapy in comparison to those taking 6 or more other medications
(Odds ratio=1.96, p=<.001) (Chapman et al. 2008).
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Number of Medications and Nonadherence combining Unfilled Prescriptions, Skipping
Doses, and Taking Smaller Doses
Coons and associates examined predictors of compliance with medication among
older adults ages 55 or older in the southeastern United States (Coons et al. 1994). Older
adults who took a greater number of prescribed medications were less likely to be
adherent to medication as prescribed (β=-0.0925, p=0.0084) (Coons et al. 1994).
Gelled and associates examined association between nonadherence to medication
and number of medications among Medicare beneficiaries ages 65 or older and reported
that those taking three to four medications were more likely to be nonadherent in
comparison to those taking 1 to 2 medications (Odds ratio=1.23, p=<.001) (Gellad et al.
2007). Additionally, those taking five or more medications were more likely to be
nonadherent in comparison to those taking 1 to 2 medications (Odds ratio= 1.58,
p=<.001) (Gellad et al. 2007).
Both of the studies that examined association between number of medications and
not filling prescriptions or obtaining refills, skipping doses or taking smaller doses of
medication reported that patients taking more medications had increased likelihood of not
filling prescriptions or obtaining refills, skipping doses or taking smaller doses of
medication (Coons et al. 1994; Gellad et al. 2007).
Out of Pocket Prescription Costs and Medication Adherence
Out of Pocket Prescription Costs and Not Filling Prescriptions or Refills
Conwell and associates examined out of pocket costs and changes in adherence to
osteoporosis medication among Medicare beneficiaries who reached the Medicare Part D
coverage gap, and reported that out of pocket costs increased by $350 for teriparatide
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users with full or partial gap prescription drug plans (Conwell et al. 2011). Also, out of
pocket costs increased by $176 for nonteriparatide users with full or partial prescription
drug plans, and $151 for those with other chronic conditions with full or partial
prescription drug plans (Conwell et al. 2011). Not filling or refilling prescriptions was
more common among those with supplemental coverage upon reaching the Medicare
prescription coverage gap compared to those whose plan did not have a coverage gap
(Conwell et al. 2011). Only one study was found that examined association between out
of pocket prescription cost and not filling prescriptions or not obtaining refills (Conwell
et al. 2011).
Number of Doctor Visits and Medication Adherence
Number of Doctor Visits and Not Filling Prescriptions or Refills
Brookhart and associates examined association between physician visits and not
refilling statin medication among new statin users who did not refill their statin
prescription for at least 90 days after their first fill (Brookhart et al. 2007). They reported
that patients who visited their physician who initiated the statin were six times more
likely to return to being adherent by refilling their statin prescription within two weeks
after a visit (Odds ratio=6.1; 95% CI= 5.9-6.3). Those who had a different physician
were twice as likely to return to being adherent by refilling their statin prescription within
two weeks after a visit (Odds ratio=2.9; 95% CI=2.8-3.0) (Brookhart et al. 2007).
Chapman and associates examined predictors of nonadherence to concomitant
antihypertensive and lipid lowering therapies among enrollees of a US managed care
organization and reported no association between number of outpatient physician
encounters and adherence (Chapman et al. 2008).
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Two studies were found that examined relationships between the number of
doctor visits and not filling prescriptions or not obtaining refills. One of the two studies
reported association between having frequent doctor visits and increased likelihood of
filling prescriptions or obtaining refills (Brookhart et al. 2007). The other reported no
association between the number of doctor visits and filling or refilling prescriptions
(Chapman et al. 2008).
Comorbidities and Medication Adherence
Comorbidities and Not Filling Prescriptions or Refills
Lagu and associates assessed associations between comorbidities and not filling
prescriptions or refills for antihypertensive medication among African Americans with
hypertension enrolled in a Medicaid managed care plan, and reported no association
between having cardiovascular comorbidities and filling prescriptions or refills for
antihypertensive medication (Lagu et al. 2009). However, having five or more
noncardiovascular comorbidities was associated with filling prescriptions or refills for
antihypertensive medication in comparison to those with fewer than five
noncardiovascular comorbidities (Odds ratio=1.59, 95% CI=1.07±2.36) (Lagu et al.
2009).
Kennedy and associates examined failure to fill prescription or refill rates by
morbidity among Medicare beneficiaries (Kennedy et al. 2008). Failure to fill rates were
significantly higher among beneficiaries with psychiatric conditions (8.0 percent, p<
0.001); arthritis (5.2 percent, p< 0.001); cardiovascular disease (5.2 percent, p=0.003);
and emphysema, asthma, or chronic obstructive pulmonary disease (6.6 percent, p<
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0.001) as compared to beneficiaries who did not report those conditions (Kennedy et al.
2008). Additionally, rates were higher for beneficiaries with more self-reported chronic
conditions (Kennedy et al. 2008).
Wang and associates examined associations between depression and filling
antihypertensive medication among 496 hypertensive patients treated at a large health
maintenance organization (HMO) or a Veterans Affairs Medical Center (VAMC) in the
northeastern region of the United States over a one year period (Wang et al. 2002). Wang
and associates reported that an increase in depressive symptoms was associated with a
decrease in the likelihood of filling prescription medication (Odds ratio=0.93; 95%
CI=0.87-0.99; p=0.027) (Wang et al. 1996).
Shah and associates examined associations between comorbidities and filling
prescriptions within 30 days of the medication being prescribed (Shah et al. 2009).
Patients with two or more comorbidities were less likely to fill their prescription within
30 days in comparison to patients with no comorbidities (78 percent versus 85 percent,
p<0.0001) (Shah et al. 2009).
In summary, four studies were found that examined associations between
comorbidities and not filling prescriptions or refills (Kennedy et al. 2008; Lagu et al.
2009; Shah et al. 2009; Wang et al. 1996). One of the four studies reported having less
than five comorbidities was associated with a greater likelihood of not filling
prescriptions or refills (Lagu et al. 2009). However, two out of four studies reported a
higher percentage of not filling prescriptions among patients with more comorbidities
(Kennedy et al. 2008; Shah et al. 2009). Additionally, two studies reported that not
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filling prescriptions or refills were higher among patients with psychiatric conditions
(Wang et al. 2002; Kennedy et al. 2008).
Comorbidities and Nonadherence combining Unfilled Prescriptions, Skipping Doses, and
Taking Smaller Doses
Soumerai and associates and examined prevalence of unfilled prescriptions,
skipping doses, and taking smaller doses among Medicare beneficiaries prior to the
implementation of Medicare Part D (Soumerai et al. 2006). Soumerai and associates
reported Medicare beneficiaries age 65 or older with greater than four comorbidities had
significantly higher odds of not filling prescriptions or refills, skipping doses to make
medication last longer, or taking smaller doses to make medication last longer as
compared to beneficiaries with zero or one morbidity (Odds ratio=1.2, 95% CI=1.1-1.7)
(Soumerai et al. 2006).

Need for Research
Patient perception of physician communication and its association with
medication adherence has been examined, but the literature is limited and the findings are
mixed. Patient perception of physician knowledge has been studied qualitatively and
reported that the physician should be knowledgeable of their medication problems and
them as a whole, and the physician’s knowledge of them is important when it comes to
medication use. Patient perceptions of physician competence has been studied
qualitatively and reported that physician expertise was a determinant in medication
adherence among patients. Patient’s perception of their physician , or the physician-
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patient relationship, can have an impact on how a patient will respond after their
experience with their physician. Prior qualitative studies, patient’s perception of his/her
physician’s knowledge and competence may influence their decision to adhere to
medication therapy.
Measures examining patients’ perceptions of physicians are limited. To our
knowledge, there have been no patient perceptions of physicians measures developed
from large claims databases or a nationally representative samples of older adults.
Additionally, there have been no prior studies to examine association between patient
perceptions of physicians and medication adherence using a large claims data or a
nationally representative sample of older adults. Therefore, the purpose of this study was
to examine the association between patient perceptions of physicians and medication
adherence among Medicare beneficiaries enrolled in Medicare Part D.

Objectives
The aim of this study was to assess association between patient perceptions of
physicians and medication adherence. The specific research objectives were: (1) to
develop an scale to assess patient perceptions of physicians based on Medicare Current
Beneficiary Survey (MCBS) items, (2) to examine adherence to antihypertensive
medication among Medicare beneficiaries enrolled in Medicare Part D, and (3) to assess
associations between patient perceptions of physicians and adherence to antihypertensive
medication among Medicare beneficiaries enrolled in Medicare Part D.
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METHODS

Objectives
The aim of this study was to assess associations between patient perceptions of
physicians and medication adherence. The specific research objectives of this study
were: (1) to develop a scale to assess patient perceptions of physicians based on Medicare
Current Beneficiary Survey (MCBS) items, (2) to examine adherence to antihypertensive
medication among Medicare beneficiaries enrolled in Medicare Part D, and (3) to assess
association between patient perceptions of physicians and adherence to antihypertensive
medication among Medicare beneficiaries enrolled in Medicare Part D. It was
hypothesized that beneficiaries with more favorable perceptions of their physician were
more likely to be adherent to their antihypertensive medications.
Data Sources
The data source utilized for this study was the Medicare Current Beneficiary
Survey (MCBS). The MCBS is a survey of a nationally representative sample of
Medicare beneficiaries maintained by the Center for Medicare and Medicaid Services
(CMS). The data consist of both survey items and Medicare claims. The 2007 survey
items that ask questions about patient perceptions of physicians and the 2008 Medicare
Part D claims were utilized for this study.
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Each Medicare beneficiary in the MCBS has a unique identifier that is used to
track survey items and Medicare claims. Each beneficiary has a record with responses to
items included in survey. The Medicare Part D claims contain records for each
prescription fill that was reimbursed by Medicare. The Medicare Part D claims contain
the drug name, drug strength, quantity dispensed, amount paid by Medicare, amount paid
out-of-pocket, and prescription fill date.

Ethical Considerations
Application for human subjects research was submitted for approval to the
Institutional Review Board at Purdue University, West Lafayette, IN. Research
proceeded upon approval.

Study Design
An observational study of Medicare beneficiaries enrolled in Medicare Part D
with a diagnosis of hypertension was conducted to assess patient perceptions of
physicians and medication adherence to antihypertensive medications. Survey items
assessing patient perceptions of physicians were linked to Medicare Part D claims using
the beneficiary unique identifier. The study was conducted using the 2007 and 2008
MCBS data.
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Study Sample

Inclusion Criteria
To be included in the sample, respondents had to be age 65 or older in 2007,
reside in the community, have been previously diagnosed with hypertension, enrolled in
Medicare Part D for 12 months in 2008, and have Medicare Part D claims for an
antihypertensive medication in 2008.
Exclusion Criteria
Respondents were excluded: if they were eligible for Medicare due to end-stage
renal disease or disability, resided in a long term care facility, had a diagnosis of
Alzheimer’s disease or dementia, or had a proxy responder. Medicare does not just cover
beneficiaries who are age 65 years or older. There are some individuals who are under
65 years old who may have end-stage renal disease or disability. Beneficiaries who were
eligible for Medicare due to end-stage renal disease must enroll in Medicare specifically
under an end-stage renal disease category for appropriate coverage for treatment of the
condition, which may include dialysis or kidney transplant. Beneficiaries who are
disabled must also enroll in Medicare specifically under a disabled category for
appropriate coverage. Also, beneficiaries with end-stage renal disease or disability are
more likely to have help from someone with taking their medication due to the severity of
their condition, and therefore, were excluded. Those in long term care facilities were
excluded because they are not likely to be administering their own medications while
residing in the facility. Beneficiaries with proxy responders were excluded due to a
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greater likelihood of inaccurate responses from the proxy on behalf of the beneficiary.
Since prior research has shown that proxies may not be useful in providing an accurate
assessment on behalf of a patient (Blazeby et al. 1995; Pierre et al. 1998; Slevin et al.
1988). Beneficiaries with Alzheimer’s disease/dementia were excluded due to a greater
likelihood of providing inaccurate responses due to memory loss.
Identification of Hypertension
Beneficiaries with hypertension were identified based on two self-reported
measures. The self-reported survey measures were: (1) “Has your doctor ever told you
that you have/had hypertension, sometimes called high blood pressure?” and (2) “Since a
year ago, did your doctor tell you that you still had hypertension or high blood pressure?”
If a beneficiary responded yes to at least one of these questions, he/she was identified as
having hypertension.

Identification of Antihypertensive Medications
Beneficiaries with hypertension were also required have taken antihypertensive
medications to assess medication adherence. A list of antihypertensive drugs was created
by identifying all drugs with an indication for the treatment of hypertension using Facts
and Comparison eAnswers and Micromedex 2.0 (Facts and Comparison Online 2012;
Micromedex 2012). The list included both single and combination therapies. If a drug
had an indication for a condition other than hypertension, it was assumed that the patient
was using it to treat hypertension since they were identified as having a diagnosis of
hypertension. Antihypertensive medication use was identified from the Medicare Part D
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prescription claims, using First Databank Generic Name, for any drug that was included
in the created list of antihypertensive medications. The list of antihypertensive drugs
identified is presented in Table 1.
Study Variables
Patient Perceptions of Physicians
MCBS survey items were examined to identify items that asked about patient
perceptions of the physician from whom they generally receive care. Some examples of
items identified included: “Your doctor answers all of your questions,” “Your doctor has
a good understanding of your medical history,” “Your doctor is competent and well
trained,” and “You have great confidence in your doctor.”
For each item, responses were coded so that “1” indicated strongly disagree, “2”
indicated disagree, “3” indicated agree, and “4” indicated strongly agree. Items that were
negatively worded; “Your doctor often does not explain your medical problems to you,”
“You often have health problems that should be discussed but are not,” “Your doctor
often acts as though he/she was doing you a favor by talking to you;” and “Your doctor
seems to be in a hurry” were reverse coded so that “4” indicated strongly disagree, “3”
indicated disagree, “2” indicated agree, and “1” indicated strongly agree. All values were
summed to create an overall patient perception of physician scale. Higher scores
indicated more positive perceptions of the physician. A complete list of identified items,
in the MCBS, that asked about patient perceptions of their physician is reported in Table
2.
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Table 1. Antihypertensive Medications
__________________________________________________________________
Therapeutic Drug Class
Drug
__________________________________________________________________
Thiazide diuretics
Chlorothiazide
Chlorthalidone
Hydrocholorothiazide
Polythiazide
Indapamide
Metolazone
Methyclothiazide
Loop diuretics
Bumetanide
Furosemide
Torsemide
Potassium-sparing diuretics
Amiloride Hydrochloride
Triamterene
ACE Inhibitors
Benazepril Hydrochloride
Captopril
Enalapril
Fosinopril Sodium
Lisinopril
Moexipril Hydrochloride
Perindopril Erbumine
Quinapril Hydrochloride
Ramipril
Trandolapril
ACE Inhibitor Combination Therapies
Benazepril Hydrochloride/ Hydrocholorothiazide
Captopril/ Hydrocholorothiazide
Enalapril Maleate/ Hydrocholorothiazide
Fosinopril Sodium/ Hydrocholorothiazide
Lisinopril/ Hydrocholorothiazide
Trandolapril/Verapamil Hydrochloride
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Table 1. Continued
__________________________________________________________________
Therapeutic Drug Class
Drug
__________________________________________________________________
Aldosterone Receptor Blockers
Eplerenone
Spironolactone
Beta Blockers
Acebutolol Hydrochloride
Atenolol
Betaxolol Hydrochloride
Bisoprolol Fumarate
Esmolol Hydrochloride
Metoprolol Succinate
Metoprolol Tartrate
Nadolol
Nebivolol
Penbutolol Sulfate
Pindolol
Propranolol Hydrochloride
Timolol
Beta Blocker Combination Therapies
Atenolol/Chlorthalidone
Bisoprolol Fumerate/ Hydrocholorothiazide
Metoprolol Tartrate/ Hydrocholorothiazide
Nadolol/Bendroflumethiazide
Propranolol Hydrochloride/ Hydrocholorothiazide
Nondihydropyridine Calcium Channel Blockers
Diltiazem Hydrochloride
Verapamil Hydrochloride
Dihydropyridine Calcium Channel Blockers
Amlodipine Besylate
Felodipine
Isradipine
Nicardipine Hydrochloride
Nifedipine
Nisoldipine
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Table 1. Continued
__________________________________________________________________
Therapeutic Drug Class
Drug
__________________________________________________________________
Dihydropyridine Calcium Channel Blockers Combination Therapies
Amlodipine/Atorvastatin
Amlodipine/Benazepril Hydrochloride
Amlodipine/Olmesartan Medoxomil
Amlodipine/Valsartan
Alpha Blocker
Doxazosin
Prazosin Hydrochloride
Terazosin Hydrochloride
Combined Alpha Blocker and Beta Blocker
Carvedilol
Labetalol Hydrochloride
Angiotensin II Receptor Blockers
Azilsartan Medoxomil
Candesartan Cilexetil
Eprosartan Mesylate
Irbesartan
Losartan Potassium
Olmesartan Medoxomil
Telmisartan
Valsartan
Angiotensin II Receptor Blocker Combination Therapies
Candesartan Cilexetil/ Hydrocholorothiazide
Eprosartan Mesylate/ Hydrocholorothiazide
Irbesartan/ Hydrocholorothiazide
Losartan Potassium/ Hydrocholorothiazide
Olmesartan Medoxomil/ Hydrocholorothiazide
Telmisartan/Amlodipine
Telmisartan/ Hydrocholorothiazide
Valsartan/ Hydrocholorothiazide
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Table 1. Continued
__________________________________________________________________
Therapeutic Drug Class
Drug
__________________________________________________________________
Central Alpha-2 Agonist or Other Centrally Acting Agent
Clonidine Hydrochloride
Methyldopa
Reserpine
Guanfacine Hydrochloride
Central Alpha-2 Agonist or Other Centrally Acting Agent Combination Therapies
Clonidine Hydrochloride/Chlorthalidone
Methyldopa and Methyldopate Hydrochloride
Methyldopa/HCTZ
Direct Vasodilator
Hydralazine Hydrochloride
Minoxidil
Renin Inhibitor
Aliskiren
Renin Inhibitor Combination Therapies
Aliskiren Hemifumarate/Amlodipine Besylate
Aliskiren Hemifumarate/Amlodipine Besylate/ Hydrocholorothiazide
Aliskiren Hemifumarate/Valsartan
Aliskiren Hemifumarate/ Hydrocholorothiazide
__________________________________________________________________
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Table 2. Questions Used to Develop Patient Perception of Physician scale1
________________________________________________________________________
Patient Perception of Physician Items
Your doctor answers all of your questions.
Your doctor often does not explain your medical problems to you.
You often have health problems that should be discussed but are not.
Your doctor often acts as though he/she was doing you a favor by talking
to you.
Your doctor tells you all you want to know about your condition and
treatment.
Your doctor has a good understanding of your medical history.
Your doctor has a complete understanding of the things that are wrong
with you.
Your doctor is very careful to check everything when examining you.
Your doctor is competent and well trained.
You depend on your doctor to feel better physically and emotionally.
You have great confidence in your doctor.
Your doctor seems to be in a hurry.
________________________________________________________________________
1

Responses to the questions above were strongly agree, agree, disagree, strongly disagree.
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Medication Adherence (Proportion of Days Covered)

Proportion of days covered (PDC) was used to assess association between patient
perceptions of physicians and medication adherence. In comparison to other methods of
calculating medication adherence, PDC is a conservative estimate that does not
overestimate switching between drugs or the use of multiple medications for one
condition (Martin et al. 2009; Nau 2012).
PDC was calculated for all antihypertensive medications taken by each
beneficiary. PDC is calculated as the number of days with medication on hand divided
by the number of days in a specified time interval (Benner et al. 2002; Peterson et al.
2007). If a medication was dispensed prior to the end of the previous medication being
completed, it was assumed that the new refill was not started until the previous
medication was completed. This shift of the medication refill accounts for the overlap in
days supply. It was assumed that the patient completed the prior prescription before
starting to take the refilled prescription.
For beneficiaries taking only one antihypertensive medication during the year,
PDC was calculated as number of days of antihypertensive medication on-hand divided
by the number of days in the study interval. If a beneficiary was taking more than one
antihypertensive medication throughout the entire study interval, an average PDC was
calculated. For each medication, PDC was calculated as the number of days of
antihypertensive medication on-hand divided by the number of days in the study interval.
Each PDC was summed and divided by the total number of antihypertensive medications
to get an average.
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Calculations of PDC were adjusted for those who switched between
antihypertensive medications during the year. A switch was identified if a beneficiary
filled an antihypertensive medication prescription, then filled a second antihypertensive
medication prescription but did not refill the first antihypertensive medication. If a
switch was identified, PDC for the first medication was calculated as the number of days
on the first medication divided by the number of days from the start of the first
medication to the start of the second medication. PDC for the second medication was
calculated as the number of days from the start of the second medication to the end of last
refill of the medication or end of the study interval divided by the number of days from
the start of the second medication to the last fill or end of the study interval. A weighted
average was calculated by multiplying PDC, for each medication, by the number of days
the medication was to be taken divided by the number of days in the study interval for
each antihypertensive medication, then adding the results for each antihypertensive
medication together. If there were multiple switches, PDC was calculated as described
above for each medication. The weighted average was calculated by multiplying PDC,
for each medication, by the number of days the medication was to be taken divided by the
number of days in the study interval for each antihypertensive medication, then adding
the results for each antihypertensive medication together.
For beneficiaries who added an antihypertensive medication, PDC was calculated
as a weighted average of each antihypertensive medication. Adding an antihypertensive
medication was identified when another antihypertensive medication was started in
addition to the current antihypertensive medication already taken. For the added therapy,
PDC was calculated as the number of days on medication from the start date of the
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medication to end date of the last refill of the medication or end of study interval divided
by the number of days between start date of the medication to the end of last refill of the
medication or to the end of the study interval. A weighted average was calculated by
multiplying PDC for each medication by the number of days the medication was to be
taken divided by the number of days in the study interval for each antihypertensive
medication, then adding the results for each antihypertensive medication together.
For beneficiaries who may have switched antihypertensive medications and added
antihypertensive medications, a weighted average was calculated for each
antihypertensive medication. PDC for each medication was multiplied by the number of
days the medication was to be taken divided by the number of days in the study interval
for each antihypertensive medication, then the results for each antihypertensive
medication were added together.
The PDC study interval was one year (2008). If PDC was 80 percent or higher,
the beneficiary was considered adherent to antihypertensive therapy. If PDC was less
than 80 percent, the beneficiary was considered to be nonadherent. A PDC of 80 percent
has been used in prior outcomes research (Hansen et al. 2009; Wu et al. 2009; Zedler et
al. 2011) and is the cut off selected by the Pharmacy Quality Alliance as the commonly
used threshold for performance measures and for most classes of drugs used to treat
chronic diseases (Nau 2012).
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Demographic Variables
Age, gender, race, education, income, and marital status were the demographic
variables identified for each beneficiary. For time sensitive variables, the values were
based on their status as of December 2007. Age was categorized into five categories: 65
to 69 years, 70 to 74 years, 75 to 79 years, 80 to 84 years, and 85 years or older. Race
categories in the raw data included Caucasian, African American, Asian, Native
Hawaiian or Pacific Islander, American Indian or Alaska Native, Other Race, or More
than One Race. Race was recoded as White or non-White. The non-White category
included all racial and ethnic groups that did not identify as Caucasian. The White
category included Caucasian only. Marital status categories in the raw data included
never married, widowed, separated, divorced or married. Marital status was recoded as
married or not married. Not married included all categories except married.
Education in the raw data included no school, nursery to grade 8, grades 9 to 12
no diploma, high school graduate, vocational/technical/business, some college no degree,
associates, bachelors, and post graduate degree. Education was recoded as five
categories: less than high school, high school graduate, some college/vocational/
Associates degree, and Bachelor’s degree or higher.
Income in the raw data had 13 categories, and all categories were mutually
exclusive. The raw income categories were $5,000 or less, $5,001 to $10,000, $10,001 to
$15,000, $15,000 to $20,000, $20,001 to $25,000, $25,001 to $30,000, $30,001 to
$35,000, $35,001 to $40,000, $40,001 to $45,000, $45,001 to $50,000, $50,001 or more,
less than $25,000, and $25,000 or more. If a beneficiary did not know or want to report
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their specific income level, they were asked if their income was less than $25,000 or
$25,000 or more. Because the income variable was categorized including less than
$25,000 or $25,000 or more as mutually exclusive categories along with the other income
categories, income was recoded into 7 categories: $10,000 or less, $10,001 to $20,000,
$20,001 to $30,000, $30,001 to $40,000, $40,001 to $50,000, $50,001 or more, and
missing. Beneficiaries who reported income as less than $25,000 or more than $25,000
were grouped in the missing category.
Perceived health status was based on the survey item, “Compared to other people
your age, would you say that your health is excellent, very good, good, fair or poor?”
The perceived health status variable had five categories: excellent, very good, good, fair,
or poor.
In addition to Medicare, some beneficiaries had additional insurance coverage,
such as private insurance or Medicaid. The private insurance variable, in the raw data,
had five categories: no entitlement, self-purchased, employer-sponsored, both self-purchased
employer-sponsored, or unknown. The private insurance variable was recoded as private

insurance or no private insurance. Private insurance included all beneficiaries who had
self-purchased, employer-sponsored insurance, or both in 2008. Months of Medicaid
coverage in 2008 was calculated by summing the number of months that beneficiaries
indicated enrollment in Medicaid in 2008. Medicaid was categorized as having Medicaid
or not. Beneficiaries with zero months of Medicaid were considered to not have
Medicaid and those with any months of Medicaid were identified as having Medicaid.
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Clinical Variables
Number of unique medications taken by each individual was calculated by
identifying the number of medications that were survey reported and/or from claims in
2008. Each unique prescription medication was identified and all duplicates were
excluded. The number of unique medications for each beneficiary was then summed to
get the total number of unique medications. The number of medications filled may be
used as an indicator of polypharmacy, and was categorized into five groups. Number of
unique medications categories was used to assess bivariate associations with medication
adherence status, as well as, patient perceptions of physicians, using chi-square tests.
The number of doctor visits for each individual was calculated from medical
provider event claims in 2008. Claims for medical doctors were extracted and limited to
only physician claims that were non-institutional or community. Any duplicate claims
were excluded. The number of doctor visits for each beneficiary was summed as the total
number of non-institutional or community medical doctor claims in 2008. The number of
doctor visits may be used as an indicator of illness severity and was categorized into six
groups. Number of doctor visits was categorized to assess bivariate associations with
medication adherence status, as well as, patient perception of physicians using chi-square
tests.
Total out of pocket prescription costs were calculated by summing the total
amount of out-of-pocket costs for all prescriptions filled in 2008. Total out-of-pocket
costs were used to determine if a beneficiary reached the Medicare Part D prescription
coverage gap, also known as the “doughnut hole.” If total out-of-pocket costs reached
$2,510, then the beneficiary reached the Medicare Part D coverage gap.
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Two indicators for patient comorbidities were developed. One was for ten selfreported conditions and the other was the Charlson Comorbidity Index. Comorbidities
were identified using survey items in the 2007 MCBS data for ten clinical conditions:
heart disease, heart failure, stroke, non-skin cancers, diabetes, rheumatoid arthritis,
depression, osteoporosis, Parkinson’s disease, and respiratory diseases (emphysema,
COPD, asthma). For each disease/condition, beneficiaries were asked: (1) if they had
ever been told by their doctor that they had a diagnosis of the specific disease/condition,
and (2) in the past year, had they been told by their doctor that they had a diagnosis of the
specific disease/condition. If the beneficiary answered yes to either of the two questions,
they were identified as having that disease/condition. These items were used to
determine whether the patient had the clinical conditions prior to 2007. This resulted in
ten variables, one for each disease/condition, indicating whether a beneficiary had the
disease/condition or not.
The Charlson Comorbidity Index is used to assess the likelihood of mortality for
patients with comorbid conditions. The Charlson Comorbidity Index scores were created
from 2007 Medicare inpatient and outpatient claims using an algorithm by Romano and
colleagues (Romano, Roos, and Jollis 1993).
Statistical Analysis
Data were analyzed using SAS version 9.3 for the Unix environment. An a priori
alpha level of 0.05 was used to evaluate significance for all analyses.
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Sample Characteristics
PROC FREQ procedure in SAS was used to develop frequency tabulations on
each of the study variables: age, gender, race, income, marital status, education,
perceived health status, private insurance, Medicaid, number of medications, Medicare
prescription drug coverage gap (doughnut hole), number of doctor visits, comorbidities
(heart disease, heart failure, stroke, non-skin cancers, diabetes, rheumatoid arthritis,
Alzheimer’s disease/dementia, depression, osteoporosis, Parkinson’s disease, and
respiratory conditions (i.e., asthma, emphysema, and chronic obstructive pulmonary
disease) and Charlson Comorbidity Index.
Age was categorized as five categories: 65 to 69 years, 70 to 74 years, 75 to 79
years, 80 to 84 years, and 85 years or older. Gender was categorized as male or female.
Race was categorized as White or non-White. Non-White included all racial and ethnic
groups that did not identify as Caucasian. Marital status was categorized as married or
not married. The not married group included those who were single, widowed, separated,
or divorced. Education was categorized into five categories: less than high school
education, high school graduate or GED, some college/vocational school/Associates
degree, and Bachelor’s degree or higher. Income was categorized into six categories,
$10,000 or less, $10,001 to $20,000, $20,001 to $30,000, $30,001 to $40,000, $40,001 to
$50,000, $50,001 or more and missing. Perceived health status was categorized as five
categories: excellent, very good, good, fair, and poor. Frequency tabulations were
developed for each of these demographic variables.
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Since all beneficiaries had Medicare, additional insurance coverage was defined
by two binary variables: (1) private insurance and (2) Medicaid. Private insurance
included employer sponsored insurance and/or self-purchased insurance. Those with
private insurance were given a value of ‘1’ and those without were given a value of ‘0’.
If a beneficiary had Medicaid, a value was ‘1’ was assigned and if not, a value of ‘0’ was
assigned. Frequency tabulations were developed for the private insurance and Medicaid
variables.
Number of unique medications was categorized into five categories: 1 to 5, 6 to 9,
10 to 15, 16 to 20, and 21 or more. Number of doctor visits was categorized into six
categories: 0, 1 to 4, 5 to 9, 10 to 14, 15 to 18, and 19 or more. Frequency tabulations
were developed for number of unique medications variable and the number of doctor
visits variable.
Out of pocket prescription costs were used to determine if a beneficiary reached
the Medicare Part D prescription drug coverage gap, also referred to as the “doughnut
hole” during the 2008 year. If a beneficiary had out of pocket costs over $2,510 then
they were identified as falling in the “doughnut hole” and given a ‘1’. If out of pocket
costs were less than $2,510, beneficiaries were assigned a ‘0’. Frequency tabulations
were developed for the Medicare Part D prescription drug coverage gap variable.
Comorbidities were determined based on if the beneficiary ever or in the past year
had been told by their physician that they had a diagnosis of a disease/condition.
Diseases and conditions analyzed included: heart disease, heart failure, stroke, non-skin
cancers, diabetes, rheumatoid arthritis, depression, osteoporosis, Parkinson’s disease, and
respiratory diseases (emphysema, COPD, asthma). If the beneficiary responded yes to
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either of the two questions regarding diagnosis of the above listed conditions in the past
year or ever, a ‘1’ was assigned indicating a diagnosis of the disease and ‘0’ indicating
not having a diagnosis of the disease. Charlson Comorbidity Index was calculated from
inpatient and outpatient claims and categorized into three categories: 0, 1, and 2 or more.
Frequency tabulations were developed for each of the ten clinical conditions and for the
Charlson Comorbidity Index.

Development of Patient Perceptions of Physicians Scale
Item-total Correlation and Reliability
All of the items identified in the MCBS that asked questions about patient
perceptions of physicians were assessed for correlation with each other. To determine
correlation among the identified items, item-total correlations and change in Cronbach’s
Alpha if a specific item was deleted was used to determine if an item was to be deleted.
If item-total correlation for an item was less than 0.50, the item was deleted. All items
retained were summed to create an overall patient perception of physician scale.
Cronbach’s Alpha was used to assess internal consistency reliability. A scale with a
Cronbach’s Alpha of 0.8 or greater was considered to have good internal consistency
reliability.
Factor Analysis
Factor analysis was used to determine if there were any subscales that existed
among the overall patient perceptions of physician scale. Principal components analysis
with varimax rotation was used to determine factors with eigenvalues greater than or
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equal to 1. Factors were retained if the eigenvalue was greater than or equal to 1. Items
were assigned to factors based on loading at 0.40 or higher on a particular factor. Each
factor was considered to represent a subscale. Subscale scores were calculated by
summing the responses to each item included each of the subscales.
Convergent Validity
Prior literature indicated that having private insurance, perceived health status,
and patient satisfaction were associated with patient perception of physician
communication (DiMatteo and Hays 1980; Rutten, Augustson, and Wanke 2006;
Wanzer, Booth-Butterfield, and Gruber 2004).

Convergent validity was evaluated by

assessing association between the overall patient perceptions of physician scale,
subscales, and the selected convergent validity variables. Spearman correlation was used
to assess association between patient perceptions of physicians and selected convergent
validity variables.
Bivariate Associations between Patient Perceptions of Physicians and Demographic
Variables
Individual cross tabulations were developed for patient perceptions of physician
scale by all demographic variables. The demographic variables were age, gender, race,
education, income, and martial status. Chi-square tests will be used to assess associations
between variables in the cross tabulations.
Bivariate Associations between Patient Perceptions of Physicians and Clinical Variables
Individual cross tabulations were developed for patient perceptions of physician
scale by clinical variables. The clinical variables were perceived health status, insurance
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coverage, comorbidities, number of doctor visits, number of medications, and Medicare
Part D prescription coverage gap. Chi-square tests were used to assess associations
between variables in the cross tabulations.

Medication Adherence
Proportion of days covered was calculated for each beneficiary. Beneficiaries
were considered to be adherent if PDC was 80 percent or higher. If PDC was less than
80 percent, the beneficiary was considered to be nonadherent. A dichotomous variable
was created for adherence status. Adherence was ‘1’ if the proportion of days covered
was 80 percent or higher, and ‘0’ if the proportion of days covered was less than 80
percent.
PROC UNIVARIATE in SAS was used to develop the mean and standard
deviation for proportion of days covered. PROC FREQ procedure in SAS was used to
develop frequency tabulations for adherence status.

Bivariate Associations between Medication Adherence and Demographic Variables
Individual cross tabulations were developed for medication adherence by
demographic variables (age, gender, race, education, income, martial status). PROC
FREQ procedure in SAS was used to develop frequency tabulations for medication
adherence by each demographic variable. Chi-square tests were used to assess
associations between variables in the cross tabulations.
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Bivariate Associations between Medication Adherence and Clinical Variables
Individual cross tabulations were developed for adherence by clinical variables
(perceived health status, insurance coverage, comorbidities, number of doctor visits,
number of medications, Medicare Part D prescription coverage gap). PROC FREQ
procedure in SAS was used to develop frequency tabulations for medication adherence by
each clinical variable. Chi-square tests were used to assess associations between
variables in the cross tabulations.

Association between Patient Perceptions of Physicians and Medication Adherence
Bivariate Associations between Patient Perceptions of Physicians and Medication
Adherence
Overall Patient Perception of Physicians Scale
Individual cross tabulations were developed for the overall patient perceptions of
physician scale by adherence status. PROC FREQ procedure in SAS was used to
develop frequency tabulations for the overall patient perceptions of physician scale by
medication adherence. Chi-square tests were used to assess association between all of the
variables in the crosstabs.
Subscales
Individual cross tabulations were developed for any subscales determined from
factor analysis by adherence status. PROC FREQ procedure in SAS was used to develop
frequency tabulations for subscales by adherence status. Chi-square tests were used to
assess association between the variables in the crosstabs.
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Association between Patient Perception of Physicians and Medication Adherence after
Adjusting for Risk Factors
Overall Patient Perception of Physicians Scale
A multiple logistic regression model using stepwise selection was used to assess
associations between the overall patient perceptions of physicians scale and likelihood of
being adherent to antihypertensive medication. PROC LOGISTIC procedure in SAS was
used to run the logistic regression model. A binomial dependent variable was created for
the adherence status, and the predictor variable was patient perceptions of physicians.
Covariates in the regression model included: age, gender, race, education, perceived
health status, income, marital status, insurance coverage (private and Medicare),
Medicare Part D prescription coverage gap, number of doctor visits, number of
medications, heart disease, heart failure, stroke, non-skin cancers, diabetes, rheumatoid
arthritis, depression, osteoporosis, Parkinson’s disease, and respiratory diseases
(emphysema, COPD, asthma), and Charlson Comorbidity Index.
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RESULTS
Study Sample
The MCBS is nationally representative sample of Medicare beneficiaries. In the
MCBS, there were a total of 13,009 Medicare beneficiaries age 65 years or older in 2007.
Among those beneficiaries, 12,191 were dwelling in the community. Medicare includes
beneficiaries who are aged, who have end-stage renal disease, and who are disabled.
Beneficiaries without end-stage renal disease or disability makeup almost 85 percent of
the Medicare population (MedPAC 2012). Beneficiaries who have end-stage renal
disease or disability were excluded due to the fact that those beneficiaries are typically
under 65 years old. End-stage renal disease or disabled beneficiaries are also likely to
have assistance with medication use. Among the 12,191 beneficiaries who were 65 years
or older and community dwellers, 12,084 were eligible for Medicare due to age (no endstage renal disease or disability), and 8,108 of those had been diagnosed with
hypertension.
For inclusion in the sample, beneficiaries were required to have 12 months of
Medicare Part D coverage to permit examination of medication adherence. Among the
8,108 individuals with diagnosed hypertension, there were 3,087 who had twelve months
of Medicare Part D coverage in 2008. In addition to having Medicare Part D coverage,
beneficiaries were required to have Medicare Part D claims for antihypertensive
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medications for inclusion in the sample. In order to identify antihypertensive
medications, a list of antihypertensive drugs was created to determine all medications
indicated for the treatment of hypertension. The list of antihypertensive drugs was
created by identifying all drugs with an indication for the treatment of hypertension using
Facts and Comparison eAnswers and Micromedex 2.0 (Facts and Comparison Online
2012; Micromedex 2012). The list of antihypertensive medications, including both single
and combination therapies, is provided in Table 1. Among the 3,087 beneficiaries with
12 months of Medicare Part D coverage, 2,798 beneficiaries had at least one Part D claim
for an antihypertensive medication.
Beneficiaries with Alzheimer’s disease/dementia have a likelihood of providing
inaccurate responses to the survey items due to memory loss, and proxy responders have
a likelihood of providing inaccurate information on behalf of the beneficiary. Therefore,
beneficiaries with a diagnosis of Alzheimer’s disease/dementia and beneficiaries with
proxy responders were excluded. Of the 2,798 beneficiaries remaining, 2,694 had not
been diagnosed with Alzheimer’s disease or dementia, and among those, 2,510 did not
have a proxy responder to the survey questions. After applying inclusion and exclusion
criteria, 2,510 beneficiaries remained in the sample. The sample selection results are
presented in Figure 1.
Sample Demographic Characteristics
Age
The mean age was 76.38 years with a standard deviation of 6.88. Twenty-two
percent were ages 65 to 69, and 44 percent were in their seventies (70 to 79).
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Number of Medicare beneficiaries in 2007
15,806

Beneficiaries ages 65 or older
13,009

Medicare beneficiaries under 65
2,797
Beneficiaries residing
in a facility
818

Beneficiaries who were community dwellers
12,191

Beneficiaries who were eligible for Medicare
due to age, not end stage renal disease or
disability
12,084

Beneficiaries with hypertension
8,108

Beneficiaries with 12 months
Medicare Part D coverage in 2008
3,087

Beneficiaries with at least one Part D claim
for antihypertensive medication in 2008
2,798

Beneficiaries with Medicare
due to end stage renal disease or
disability
107
Beneficiaries without
hypertension
3,976
Beneficiaries with less than
12 months Medicare Part D
coverage in 2008
5,021
Beneficiaries without Part D
claims for hypertension
medications in 2008
289

Beneficiaries with Alzheimer’s
disease/dementia
104

Beneficiaries without Alzheimer’s
disease/dementia
2,694

Beneficiaries without proxy responders
2,510
Figure 1. Sample Selection Results

Beneficiaries with proxy
responders
184
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Approximately 34 percent of the sample was age 80 or older. The sample distribution by
age is presented in Table 3.
Gender
In the general Medicare population, approximately 55 percent are female
(MedPAC 2012). As shown in Table 4, over three-fifths, or 65 percent of the sample was
female, and 35 percent was male.
Race
Racial groups in the MCBS included: Caucasian, African American, Asian,
Native Hawaiian or Pacific Islander, American Indian or Alaska Native, other race, or
more than one race. These groups were recoded as White and non-White. Non-White
included all racial groups except Caucasian. As shown in Table 5, over 80 percent of the
sample was White.
Marital Status
Marital status, in the raw data, had five categories. The categories were married,
never married, divorced, widowed or separated. Marital status was recoded as married or
not married. Not married included beneficiaries who were never married, divorced,
widowed or separated. As shown in Table 6, over one-half, or 53 percent of the sample
was not married.
Education
Education was categorized into four categories. The categories were less than
high school education, high school graduate, some college/vocational/Associate’s degree,
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Table 3. Sample Distribution by Age
________________________________________________________________________
Number of
Individuals
Percent
n=2,510
________________________________________________________________________
Age

65 to 69

550

21.91

70 to 74

522

20.80

75 to 79

579

23.07

80 to 84

501

19.96

85 and older
358
14.26
________________________________________________________________________
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Table 4. Sample Distribution by Gender
________________________________________________________________________
Number of
Individuals
Percent
n=2,510
________________________________________________________________________
Gender

Female

1,637

65.22

Male
873
34.78
________________________________________________________________________
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Table 5. Sample Distribution by Race
________________________________________________________________________
Number of
Individuals
Percent
n=2,510
________________________________________________________________________
Race

Non-White1

427

17.01

White
2,083
82.99
________________________________________________________________________
1

Non-White includes: African American, Asian, Native Hawaiian or Pacific Islander,
American Indian or Alaska Native, Other Race, and More than One Race.
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Table 6. Sample Distribution by Marital Status
________________________________________________________________________
Marital
Status

Number of
Individuals
Percent
n=2,510
________________________________________________________________________
Married

1,175

46.81

Not Married1
1,335
53.19
________________________________________________________________________
1

The “Not Married” category includes: never married, divorced, widowed, and
separated.
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and Bachelor’s degree or higher. Approximately 30 percent of the Medicare population
have only a high school education (MedPAC 2012). Almost one-third, or 32 percent of
the sample were high school graduates. An additional one-third, or 31 percent had less
than high school level of education. Thirteen percent had a Bachelor’s degree or higher.
The sample distribution by education is presented in Table 7.
Income
In the MCBS, income was individual income if not married. If married, income
included the income of the beneficiary and spouse. Income was categorized as six
categories, $10,000 or less, $10,001 to $20,000, $20,001 to $30,000, $30,001 to $40,000,
$40,001 to $50,000, and $50,001 or more. Approximately 12 percent of the sample did
not report a specific income in the categories listed above. These individuals reported
income as less than $25,000 or $25,000 or more.
Approximately 16 percent of the Medicare population had income below the
poverty line which is about $10,326 for a single person and $13,030 for married couples
in 2008 (MedPAC 2012). Almost one-fifth, or 18 percent of the sample, had income of
$10,000 or less. Forty-four percent of the sample had an income between $10,001 and
$30,000, and 4 percent had income greater than $50,000. The sample distribution by
income is presented in Table 8.
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Table 7. Sample Distribution by Education
________________________________________________________________________
Number of 1
Education
Individuals
Percent
n=2,504
________________________________________________________________________
Less than high school

779

31.11

High school graduate

803

32.07

Some college/Vocational/Assoc

584

23.32

Bachelor’s degree or higher

338

13.50

Missing

----

------

_______________________________________________________________________
1

Number of individuals missing response on education was 11 or less and values were
removed as required by data use agreement.
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Table 8. Sample Distribution by Income
________________________________________________________________________
Number of 1
Income
Individuals
Percent
n=2,510
________________________________________________________________________
$10,000 or less

459

18.29

$10,001 to $20,000

683

27.21

$20,001 to $30,000

408

16.25

$30,001 to $40,000

334

13.31

$40,001 to $50,000

219

8.73

$50,001 or more

100

3.98

Missing
307
12.23
________________________________________________________________________
1

Number of individuals missing income did not provide an income level in an above
listed category. Income was provided as less than $25,000 or $25,000 or more.
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Sample Clinical Characteristics
Supplemental Insurance
Everyone in the sample was a Medicare beneficiary. In addition to Medicare,
beneficiaries could have supplemental insurance coverage, such as private insurance or
Medicaid. Private insurance could be employer sponsored or self purchased.
Beneficiaries with Medicaid supplemental coverage are considered to be dual-eligibles
and can be enrolled in Medicaid if they meet specific income requirements or have high
medical bills (MedPAC 2004). Forty-nine percent the sample had private insurance, and
51 percent did not have private insurance. Almost one-fifth, or 18 percent, were dual
eligibles with Medicare and Medicaid coverage. The sample distribution by insurance
coverage is presented in Table 9.

Medicare Part D Prescription Coverage Gap
The Medicare Part D prescription coverage gap is often referred to as the
“doughnut hole.” The prescription coverage gap is the period of time between initial
coverage ending and catastrophic coverage beginning. In 2008, the amount of out of
pocket cost to reach the coverage gap was $2,510 (Q1 Group LLC 2013). The mean and
standard deviation for out of pocket costs was $745.45. The standard deviation was
$920.61. As shown in Table 10, among beneficiaries included in the sample, only five
percent reached the coverage gap limit. This means that only 5 percent had out of pocket
costs of $2,510 or more in 2008.
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Table 9. Sample Distribution by Supplemental Insurance Type
________________________________________________________________________
Number of
Individuals
Percent
n=2,510
________________________________________________________________________
Insurance Type

Private Insurance
Yes
No

Medicaid
Yes

1,231

49.04

1,279

50.96

447

17.81

No
2,063
82.19
________________________________________________________________________
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Table 10. Sample Distribution by Medicare Part D Prescription Coverage Gap
________________________________________________________________________
Number of
Individuals
Medicare Part D Prescription Coverage Gap
n=2,510
Percent
________________________________________________________________________
Medicare Part D Prescription
Coverage Gap Status
Coverage Gap Reached

129

5.14

Coverage Gap Not Reached
2,381
94.86
________________________________________________________________________
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Perceived Health Status
An item in the MCBS on perceived health status had five categories: excellent,
very good, good, fair, and poor. Over 50 percent of the sample perceived their health
status to be very good or good. Approximately 12 percent perceived their health to be
poor. The sample distribution by perceived health status is presented in Table 11.
Number of Unique Medications
The number of unique medications taken by individuals in the sample ranged
from one to thirty-nine. The mean for number of unique medications was 11.17 with a
standard deviation of 6.09. Approximately 33 percent took between ten and fifteen
different medications in 2008. About 8 percent took 21 or more different medications in
2008. The sample distribution by number of unique medications taken is presented in
Table 12.
Number of Doctor Visits
The number of doctor visits made by individuals in the sample ranged from 0 to
142. This included all medical doctor visits, not just visits to the primary care physician.
The mean number of doctor visits was 14.17 with a standard deviation of 13.91. Five
percent of the sample had no doctor visits in 2008. Forty-two percent of the sample had
one to nine doctor visits in 2008. Twenty-six percent had nineteen or more doctor visits
in 2008. The sample distribution by number of doctor visits is presented in Table 13.
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Table 11. Sample Distribution by Beneficiary Perceived Health Status
________________________________________________________________________
Perceived
Number of 1
Health
Individuals
Status
n=2,501
Percent
________________________________________________________________________
Excellent

130

5.20

Very Good

506

20.23

Good

892

35.67

Fair

684

27.35

Poor

289

11.56

Missing
-------________________________________________________________________________
1
Number of people missing response on perceived health status was 11 or less
and values were removed as required by data use agreement.
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Table 12. Sample Distribution by Number of Unique Medications
________________________________________________________________________
Number of
Number of
Unique
Individuals
Medications
n=2,510
Percent
________________________________________________________________________
1 to 5

419

16.69

6 to 9

728

29.00

10 to 15

828

32.99

16 to 20

339

13.51

21 or more
196
7.81
________________________________________________________________________
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Table 13. Sample Distribution by Number of Doctor Visits
________________________________________________________________________
Number of
Number of
Doctor
Individuals
Visits
n=2,510
Percent
________________________________________________________________________
0

119

4.74

1 to 4

450

17.93

5 to 9

614

24.46

10 to 14

431

17.17

15 to 18

235

9.37

19 or more
661
26.33
________________________________________________________________________
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Clinical Conditions
The sample distribution by presence of ten individual clinical conditions including
heart disease, heart failure, stroke, diabetes, osteoporosis, rheumatoid arthritis,
depression, Parkinson’s disease, non-skin cancers, and respiratory conditions
(emphysema, asthma, and chronic obstructive pulmonary disease) is presented in Table
14. Presence of ten clinical conditions that were chronic conditions impacting older
adults were examined based on patient self-report of having the being diagnosed with the
condition in the past year or ever. Forty-six percent of the sample had been diagnosed
with heart disease, and 33 percent had been diagnosed with diabetes. Approximately 25
percent had osteoporosis, and 20 percent had non-skin cancers. Less than 15 percent had
been diagnosed with heart failure, rheumatoid arthritis, depression, or stroke. Seventeen
percent had respiratory conditions with included asthma, emphysema, and/or chronic
obstructive pulmonary disease.

Charlson Comorbidity Index
The Charlson Comorbidity Index is used to assess the likelihood of mortality.
The Charlson Comorbidity Index was derived based on 2007 Medicare inpatient and
outpatient claims. Eighty-four percent of the sample had a Charlson Comorbidity Index
score of 0, and 7 percent had a scores of 2 or higher. Higher scores indicated greater
comorbidity. The sample distribution by Charlson Comorbidity Index is presented in
Table 15.
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Table 14. Sample Distribution by Individual Clinical Conditions
________________________________________________________________________
Number of
Individuals
Percent
n=2,510
________________________________________________________________________
Clinical Conditions

Heart Disease
Yes
No

1,154
1,356

45.98
54.02

Heart Failure
Yes
No

232
2,278

9.24
90.76

Stroke
Yes
No

324
2,186

12.91
87.09

Non-Skin Cancers
Yes
No

474
2,036

18.88
81.12

Diabetes
Yes
No

817
1,693

32.55
67.45

Rheumatoid Arthritis
Yes
No

331
2,179

13.19
86.81

Depression
Yes
No

347
2,163

13.82
86.18

Osteoporosis
Yes
No

604
1,906

24.06
75.94

Parkinson’s Disease
Yes
No

33
2,477

1.31
98.69

________________________________________________________________________
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Table 14. Continued
________________________________________________________________________
Number of
Clinical Conditions
Individuals
Percent
n=2,510
________________________________________________________________________
Respiratory Conditions (i.e, Asthma,
Emphysema, and/or COPD)
Yes
432
17.21
No
2,078
82.79
______________________________________________________________________
1
COPD is Chronic Obstructive Pulmonary Disease
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Table 15. Sample Distribution by Charlson Comorbidity Index
________________________________________________________________________
Number of
Charlson Comorbidity
Individuals
Percent
Index Score
n=2,510
________________________________________________________________________
0

2,117

84.34

1

213

8.49

2 or more

180

7.17

________________________________________________________________________
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Patient Perceptions of Physicians
Development of Patient Perceptions of Physician Scale
Sample
Twelve items in the MCBS were examined for development of a scale as a
measure of patient perceptions of physicians. Of the 2,510 beneficiaries in the sample,
220 beneficiaries were excluded due to missing responses on any of the 12 items. Four
variables were identified in the MCBS for use in assessing convergent validity of the
scale that would be developed. Forty-two beneficiaries were excluded due to missing
values on the variables selected to assess convergent validity of the scale. This resulted
in a sample of 2,248 beneficiaries.
Item-total Correlation and Reliability
Overall Patient Perceptions of Physician Scale
There were twelve items in the MCBS that asked questions about patient
perceptions of physicians. Item-total correlation and Cronbach’s Alpha if item were
deleted were used to determine item retention in the scale to be developed. If item-total
correlation for an item was less than 0.50, the item was deleted from the scale. After
examining the item-total correlations and Cronbach’s Alphas, all twelve items were
retained. All twelve items were summed to create the patient perceptions of physician
scale. The scale had a theoretical range of twelve to forty-eight, and the actual range was
fifteen to forty-eight. Higher scores indicated more positive perception of the physicianpatient relationship.
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Item-total correlation for items included in the overall patient perceptions of
physician scale ranged from 0.52 to 0.77. The Cronbach’s Alpha coefficient for the
patient perceptions of physician scale was 0.92 indicating good reliability. The overall
patient perceptions of physician scale had a mean score of 38.79 and a standard deviation
of 5.013. Observed scores ranged from 15 to 48. The mean, standard deviation,
Cronbach’s Alpha, and item-total correlation results for the overall patient perceptions of
physician scale are presented in Table 16.
Factor Analysis and Subscale Identification
Factor analysis was used to examine if there were any subscales within the patient
perceptions of physician scale. Factors with eigenvalues greater than or equal to one
were retained. Principal components analysis with varimax rotation yielded two factors
with eigenvalues greater than or equal to one. The proportion of total variance explained
among the 12 items in the patient perceptions of physicians scale was 59 percent.
Factor 1 (Perceived physician knowledge about the patient subscale)
Of the twelve items, eight items loaded onto Factor 1 (perceived physician
knowledge about the patient). Factor 1 included eight of the twelve items in the overall
patient perception of physician scale. Factor 1 had an eigenvalue of 4.49 and accounted
for 62.78 percent of the variance explained. Item-total correlation for items included in
Factor 1 ranged from 0.58 to 0.80. The Cronbach’s Alpha coefficient for the subscale
based on Factor 1 was 0.92 indicating good reliability. The subscale based on Factor 1
had a mean score of 26.28 with a standard deviation of 3.680.

Table 16. Mean, Standard Deviation, Cronbach’s Alpha Reliability, and Item-Total Correlation Range for the Overall Perception of
Physicians Scale, Perceived Physician Knowledge about the Patient Subscale (Factor 1), and Perceived Concern Subscale (Factor 2)
____________________________________________________________________________________________________________
Mean
Standard
Min
Max
Cronbach’s
Item-total
Index
Score
Deviation
Alpha
Correlation
n=2,248
Range
____________________________________________________________________________________________________________
Overall Perception of
Physicians Index
Perceived Physician Knowledge
about the Patient Subscale
(Factor 1)

38.79

5.01

15

48

0.92

0.52- 0.77

26.28

3.68

8

32

0.92

0.58 - 0.80

Perceived Concern Subscale
(Factor 2)
12.51
1.91
4
16
0.84
0.59 - 0.76
____________________________________________________________________________________________________________
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Scores ranged from eight to thirty-two. The mean, standard deviation, and Cronbach’s
Alpha for Factor 1 are presented in Table 16.
Factor 2 (Perceived concern subscale)
Factor 2 included the remaining four of the twelve items in the overall patient
perceptions of physician scale. Factor 2 had an eigenvalue of 2.67and accounted for
37.32 percent of the variance explained. Item-total correlation for items included in
Factor 2 ranged from 0.59 to 0.76, and the Cronbach’s Alpha coefficient was 0.84
indicating good reliability. The mean score was 12.51 with a standard deviation of 1.906.
Scores ranged from 4 to 16. The mean, standard deviation, and Cronbach’s Alpha results
for Factor 2 are presented in Table 16.
The items loaded to each factor were summed to create two subscales. The Factor
1 (Perceived physician knowledge about the patient) subscale had a theoretical range of 8
to 32, and the Factor 2 (perceived concern) subscale had a theoretical range of 4 to 16.
Higher scores indicated more positive perceptions of physicians. Table 17 presents the
factor loadings for each factor.
Examination of Overall Patient Perception of Physician Scale Convergent Validity
Distribution of Convergent Validity Variables
Private insurance, perceived health status, patient satisfaction with information
received, and patient satisfaction with doctor’s concern were selected to examine
convergent validity because previous literature identified each as being associated with
the patient perception of physician communication (DiMatteo and Hays 1980; Rutten,
Augustson, and Wanke 2006; Wanzer, Booth-Butterfield, and Gruber 2004). Forty-nine

Table 17. Factor Loading for Patient Perceptions of Physician Subscales (n=2,248)
____________________________________________________________________________________________________________
Factors

Loading
______________________________

(Factor 1)
(Factor 2)
Perceived Physician Perceived
Knowledge
Concern
about the Patient
Subscale
Subscale
____________________________________________________________________________________________________________
Factor 1 (Perceived Physician Knowledge about the Patient)
1. Your doctor answers all of your questions.
2. Your doctor tells you all you want to know about your condition and treatment
3. Your doctor has a good understanding of your medical history.
4. Your doctor has a complete understanding of the things that are wrong with you
5. Your doctor is very careful to check everything when examining you.
6. Your doctor is competent and well trained.
7. You depend on your doctor to feel better physically and emotionally.
8. You have great confidence in your doctor.

0.69174
0.63507
0.83042
0.81455
0.71792
0.78392
0.57431
0.73464

0.37008
0.36364
0.22853
0.24445
0.27248
0.23609
0.18127
0.34959

Factor 2 (Perceived Concern)
9. Your doctor often does not explain your medical problems to you.
10. You often have health problems that should be discussed but are not.
11. Your doctor often acts as though he/she was doing you a favor by talking to you
12. Your doctor seems to be in a hurry

0.21488
0.26741
0.29929
0.23018

0.75583
0.78317
0.66409
0.61160

____________________________________________________________________________________________________________
1

Total proportion of variance explained was 59 percent.
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percent of beneficiaries in the sample had private insurance. Over 60 percent perceived
their health to be good or better. Three quarters, 77 percent, of the sample were satisfied
with information provided about their health, and 72 percent were satisfied with their
physician’s concern about their health. The distribution of each variable used for
convergent validity assessment is presented in Table 18.
Overall Patient Perceptions of Physicians
Because private insurance, perceived health status, and patient satisfaction were
reported to be associated with patient perceptions of physician communication in prior
literature (DiMatteo and Hays 1980; Rutten et al. 2006; Wanzer et al. 2004), private
insurance, perceived health status, patient satisfaction with information provided, and
patient satisfaction with doctor’s concern were selected to examine convergent validity of
the patient perceptions of physician scale. All four convergent validity variables,
perceived health status (r=0.13, p=<.0001), having private insurance (r=0.08, p=<.0001),
patient satisfaction with information provided about their health (r=0.29 p=<.0001), and
patient satisfaction with their doctor’s concern for their health (r=0.32, p=<.0001), had
positive correlations with the patient perceptions of physician scale. Spearman
correlation coefficients for association between the patient perceptions of physician scale
and the convergent validity variables are presented in Table 19.
Patient Perception of Physician Subscales
Factor 1 (perceived physician knowledge about the patient) had positive
correlations with patient satisfaction with information received about health (r=0.28,
p=<.0001), patient satisfaction with their doctor’s concern for their health (r=0.31,

96

Table 18. Sample Characteristics for Convergent Validity Variables
________________________________________________________________________
Number of
Individuals
Percent
n=2,248
________________________________________________________________________
Variable

Private Insurance
Yes
No
Perceived health status
Excellent
Very good
Good
Fair
Poor
Satisfaction with information provided
about your health1
Very Dissatisfied
Dissatisfied
Satisfied
Very Satisfied

1,100
1,148

48.93
51.07

116
456
813
609
254

5.16
20.28
36.17
27.09
11.30

--74
1,715
450

--3.31
76.60
20.09

Satisfaction with doctor’s concern about
your health1
Very Dissatisfied
----Dissatisfied
71
3.17
Satisfied
1,602
71.62
Very Satisfied
564
25.21
________________________________________________________________________
1

Satisfaction with information provided about your health and satisfaction with doctor’s
concern about your health response option, very dissatisfied, had a cell size of 11 or less
and values were removed as required by data use agreement.

Table 19. Spearman Correlation Coefficients for Association between the Overall Patient Perceptions of
Physicians Scale and Convergent Validity Variables
___________________________________________________________________________________________
Overall Patient
Hypothesized
Patient Perceptions of
Variable
Relationship
Physicians Scale
p-value
n=2,248
___________________________________________________________________________________________
Private Insurance1

Positive Association

0.083

<.0001

Perceived health status1

Positive Association

0.126

<.0001

Satisfaction with information
provided about your health2

Positive Association

0.287

<.0001

Satisfaction with doctor’s
Concern about your health2,3
Positive Association
0.324
<.0001
___________________________________________________________________________________________
1

Rutten, Lila J. Finney, Erik Augustson, and Kay Wanke. 2006. Factors associated with patients' perceptions of
health care providers' communication behavior. Journal of Health Communication 11 Suppl 1: 135-146.

2

Wanzer, Melissa Bekelja, Melanie Booth-Butterfield, and Kelly Gruber. 2004. Perceptions of health care
providers' communication: relationships between patient-centered communication and satisfaction.
Health Communication 16(3): 363-383.

3

DiMatteo, M. Robin, and Ron Hays. 1980. The significance of patients' perceptions of physician conduct:
a study of patient satisfaction in a family practice center. Journal of Community Health 6(1): 18-34.
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p=<.0001), having private insurance (r=0.07, p=0.0005), and perceived health status
(r=0.12, p=<.0001) as hypothesized. Spearman correlation coefficients for association
between Factor 1 (perceived physician knowledge about the patient) and the convergent
validity variables are presented in Table 20.
Factor 2 (perceived concern) had positive correlations with patient satisfaction
with information received about health (r=0.23, p=<.0001), patient satisfaction with their
doctor’s concern for their health (r=0.25, p=<.0001), having private insurance (r=0.07,
p=0.0005), and with perceived health status (r=0.11, p=<.0001). Spearman correlation
coefficients for association between patient perception of physician competence and the
convergent validity variables are presented in Table 21.
Bivariate Associations between Demographic Variables and Patient Perceptions of
Physicians
The distribution of the patient perceptions of physician scores had a theoretical
range of 12 to 48, and an actual range of 15 to 48. The perception scores had a median of
37. The scores were dichotomized to distinguish between more favorable perceptions of
physicians and less favorable perceptions of physicians. A cutoff of 37 was determined,
indicating scores of 37 or higher represented more favorable perceptions and scores less
than 37 represented less favorable perceptions. Bivariate associations between patient
perceptions of physicians and demographic and clinical categories were assessed utilizing
these categories.

Table 20. Spearman Correlation Coefficients for Association between Perceived Physician Knowledge of Patient
Subscale (Factor 1) and Convergent Validity Variables
___________________________________________________________________________________________
Perceived Physician
Knowledge of Patient
p-value
Subscale (Factor 1)
n=2,248
___________________________________________________________________________________________
Variable

Hypothesized
Relationship

Private Insurance1

Positive Association

0.073

0.0005

Perceived health status1

Positive Association

0.118

<.0001

Satisfaction with information
provided about your health2

Positive Association

0.278

<.0001

Satisfaction with doctor’s
Positive Association
0.313
<.0001
Concern about your health2,3
___________________________________________________________________________________________
1

Rutten, Lila J. Finney, Erik Augustson, and Kay Wanke. 2006. Factors associated with patients' perceptions of
health care providers' communication behavior. Journal of Health Communication 11 Suppl 1: 135-146.

2

Wanzer, Melissa Bekelja, Melanie Booth-Butterfield, and Kelly Gruber. 2004. Perceptions of health care
providers' communication: relationships between patient-centered communication and satisfaction.
Health Communication 16(3): 363-383.

3

DiMatteo, M. Robin, and Ron Hays. 1980. The significance of patients' perceptions of physician conduct:
a study of patient satisfaction in a family practice center. Journal of Community Health 6(1): 18-34.
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Table 21. Spearman Correlation Coefficients for Association between the Perceived Concern Subscale (Factor 2)
and Convergent Validity Variables
___________________________________________________________________________________________
Hypothesized
Relationship

Perceived Concern
Variable
Subscale (Factor 2)
p-value
n=2,248
___________________________________________________________________________________________
Private Insurance1

Positive Association

0.073

0.0005

Perceived health status1

Positive Association

0.114

<.0001

Satisfaction with information
provided about your health2

Positive Association

0.226

<.0001

Satisfaction with doctor’s
Concern about your health2,3
Positive Association
0.253
<.0001
___________________________________________________________________________________________
1

Rutten, Lila J. Finney, Erik Augustson, and Kay Wanke. 2006. Factors associated with patients' perceptions of
health care providers' communication behavior. Journal of Health Communication 11 Suppl 1: 135-146.

2

Wanzer, Melissa Bekelja, Melanie Booth-Butterfield, and Kelly Gruber. 2004. Perceptions of health care
providers' communication: relationships between patient-centered communication and satisfaction.
Health Communication 16(3): 363-383.

3

DiMatteo, M. Robin, and Ron Hays. 1980. The significance of patients' perceptions of physician conduct:
a study of patient satisfaction in a family practice center. Journal of Community Health 6(1): 18-34.
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Bivariate Association between Age and Patient Perceptions of Physicians
Among beneficiaries ages 65 to 69 years of age, twenty-three percent of
beneficiaries had scale scores of 37 or higher, and 20 percent had scores less than 37 (23
percent versus 20 percent, p-value=0.1240). Forty-four percent of beneficiaries had scale
scores of 37 or higher were ages 70 to 79 compared to 42 percent of beneficiaries who
had scores less than 37 (44 percent versus 42 percent, p-value=0.1240). Thirty-three
percent of beneficiaries with scale scores of 37 or higher were ages 80 or older in
comparison to 36 percent of beneficiaries who had scale scores of less than 37 (33
percent versus 36 percent, p-value=0.1240). There were no significant associations
between age and the patient perceptions of physician scale. Table 22 shows the bivariate
association between age and patient perceptions of physicians.
Bivariate Association between Gender and Patient Perceptions of Physicians
Sixty-six percent of beneficiaries who had the patient perceptions of physician
scale scores of 37 or higher were female, and 66 percent of beneficiaries who had patient
perceptions of physician scale scores less than 37 (66 percent versus 66 percent,
p=0.918). There was no significant association between gender and the patient
perceptions of physician scale. Table 23 shows the bivariate association between gender
and patient perceptions of physicians.
Bivariate Association between Race and Patient Perceptions of Physicians
Seventy-nine percent of beneficiaries who had patient perceptions of physician
scale scores less than 37 were White compared to 87 percent who had scores of 37 or

Table 22. Bivariate Association between Age and Overall Patient Perceptions of Physicians Scale
____________________________________________________________________________________________________________
Overall Patient Perceptions of Physicians Scale
_________________________________________________
Total
(n=2,189)
_________________

Less than 37
(n=987)
_________________

37 or higher
(n=1,202)
_________________

Number Percent
Number Percent
Number Percent
p-value1
____________________________________________________________________________________________________________
Age Category

0.1240

65 to 69 years

470

21.47

193

19.55

277

23.04

70 to 74 years

458

20.92

218

22.09

240

19.97

75 to 79 years

511

23.34

220

22.29

291

24.21

80 to 84 years

439

20.05

204

20.67

235

19.55

85 years or older

311

14.21

152

15.40

159

13.23

____________________________________________________________________________________________________________
1

p-value determined based on Chi-square. p-value ≤ 0.05 indicates significance.
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Table 23. Bivariate Association between Gender and Overall Patient Perceptions of Physicians Scale
____________________________________________________________________________________________________________
Overall Patient Perceptions of Physicians Scale
_________________________________________________
Total
(n=2,189)
_________________

Less than 37
(n=987)
_________________

37 or higher
(n=1,202)
_________________

Number Percent
Number Percent
Number Percent
p-value1
____________________________________________________________________________________________________________
Gender
Female

0.987
1,442

65.87

650

65.85

792

65.89

Male
747
34.13
337
34.14
410
34.11
____________________________________________________________________________________________________________
p-value determined based on Chi-square. p-value ≤ 0.05 indicates significance.

1
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higher (79 percent versus 87 percent, p-value=<.0001). A higher percentage of
beneficiaries who had scores less than 37 were non-White in comparison to beneficiaries
who had scores of 37 or higher (21 percent versus 13 percent, p-value=<.0001). Table 24
shows the bivariate association between race and patient perceptions of physicians.
Bivariate Association between Marital Status and Patient Perceptions of Physicians
Fifty-six percent of beneficiaries with perceptions of physician scale scores less
than 37 were not married in comparison to 51 percent had scores of 37 or greater (56
percent versus 51 percent, p=0.0462). A higher percentage of beneficiaries with scale
scores of 37 or higher were married in comparison to those who had scores of less than
37 (49 percent versus 44 percent, p-value=0.046). Table 25 shows the bivariate
association between marital status and patient perceptions of physicians.
Bivariate Association between Education and Patient Perceptions of Physicians
Sixty-one percent of beneficiaries with patient perceptions of physician scale
scores of 37 or higher had a high school education or less in comparison to 68 percent
had scores less than 37 (61 percent versus 68 percent, p<.0001). Sixteen percent of
beneficiaries with scale scores of 37 or higher had a Bachelor’s degree or higher in
comparison to 10 percent of beneficiaries with scores of 37 or less (16 percent versus 10
percent, p-value<.0001). Table 26 shows the bivariate association between education and
patient perceptions of physicians.

Table 24. Bivariate Association between Race and Overall Patient Perceptions of Physicians Scale
____________________________________________________________________________________________________________
Overall Patient Perceptions of Physicians Scale
_________________________________________________
Total
(n=2,189)
_________________

Less than 37
(n=987)
_________________

37 or higher
(n=1,202)
_________________

Number Percent
Number Percent
Number Percent
p-value1
____________________________________________________________________________________________________________
<.00012

Race
White
Non-White

1,825

83.37

783

79.33

1,042

86.69

364

16.63

204

20.67

160

13.31

____________________________________________________________________________________________________________
1
2

p-value determined based on Chi-square.
p-value ≤ 0.05 indicates significance.
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Table 25. Bivariate Association between Marital Status and Overall Patient Perceptions of Physicians Scale
____________________________________________________________________________________________________________
Overall Patient Perceptions of Physicians Scale
_________________________________________________
Total
(n=2,189)
_________________

Less than 37
(n=987)
_________________

37 or higher
(n=1,202)
_________________

Number Percent
Number Percent
Number Percent
p-value1
____________________________________________________________________________________________________________
0.0462

Marital Status
Married

1,025

46.83

439

44.48

586

48.75

Not Married

1,164

53.17

548

55.52

616

51.25

____________________________________________________________________________________________________________
1
2

p-value determined based on Chi-square.
p-value ≤ 0.05 indicates significance.
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Table 26. Bivariate Association between Education and Overall Patient Perceptions of Physicians Scale
_________________________________________________________________________________________________________
Overall Patient Perceptions of Physicians Scale
_________________________________________________
Total
(n=2,184)
_________________

Less than 37
(n=985)
_________________

37 or higher
(n=1,199)
_________________

Number Percent
Number Percent
Number Percent
p-value1
_________________________________________________________________________________________________________
<.00012

Education
Less than high school

679

31.09

352

35.74

327

27.27

High school graduate

720

32.97

318

32.28

402

33.53

Some college/Vocational
/Associates

496

22.71

212

21.52

284

23.69

Bachelor’s
or higher

289

13.23

103

10.46

186

15.51

Missing3
---------------------_________________________________________________________________________________________________________
1

p-value determined based on Chi-square.
p-value ≤ 0.05 indicates significance.
3
Missing had cell sizes of 11 or less and values were removed as required by data use agreement.
2
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Bivariate Association between Income and Patient Perceptions of Physicians
Among beneficiaries with patient perceptions of physician scale scores of 37 or
higher, 60 percent had income of $30,000 or less in comparison to 67 percent of
beneficiaries who had patient perceptions of physician scale scores of less than 37 (60
percent versus 67 percent, p<.0001). Among beneficiaries with patient perceptions of
physician scale scores of 37 or higher, 14 percent had income greater than $40,000, in
comparison to 11 percent who had patient perceptions of physician scale scores of less
than 37 (14 percent versus 11 percent, p<.0001). Table 27 shows the bivariate
association between income and patient perceptions of physicians.

Bivariate Associations between Clinical Variables and Patient Perceptions of Physicians
Bivariate Association between Insurance and Patient Perceptions of Physicians
Forty-four percent of beneficiaries with patient perceptions of physician scale
scores less than 37had private insurance, in comparison to 53 percent of beneficiaries
with scores of 37 (44 percent versus 53 percent, p-value=0.0001). Fifty-six percent of
beneficiaries with perception of physician scale scores less than 37 did not have private
insurance, in comparison to 47 percent with scores of 37 or higher (56 percent versus 47
percent, p-value=0.0001). Twenty-one percent of beneficiaries with perception of
physician scale scores less than 37 had Medicaid in addition to Medicare in comparison
to 15 percent of beneficiaries with scores of 37 or higher (21 percent versus 15 percent,
p=0.0006). Table 28 shows bivariate association results between insurance type and the
patient perceptions of physicians.

Table 27. Bivariate Association between Income and Overall Patient Perceptions of Physicians Scale
____________________________________________________________________________________________________________
Overall Patient Perceptions of Physicians Scale
_________________________________________________
Total
(n=2,189)
_________________

Less than 37
(n=987)
_________________

37 or higher
(n=1,202)
_________________

Number Percent
Number Percent
Number Percent
p-value1
____________________________________________________________________________________________________________
<.00012

Income
$10,000 or less

403

18.41

217

21.99

186

15.47

$10,001 to $20,000

606

27.68

277

28.06

329

27.37

$20,001 to $30,000

366

16.72

162

16.41

204

16.97

$30,001 to $40,000

287

13.11

97

9.83

190

15.81

$40,001 to $50,000

195

8.91

73

7.40

122

10.15

79

3.61

31

3.14

48

3.99

$50,001 or more

253
11.56
130
13.17
123
10.23
Missing3
____________________________________________________________________________________________________________
1

p-value determined based on Chi-square.
p-value ≤ 0.05 indicates significance.
3
Number of individuals missing income did not provide an income level in an above listed category. Income was provided as
less than $25,000 or $25,000 or more.
2
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Table 28. Bivariate Association between Insurance and Overall Patient Perceptions of Physicians Scale
____________________________________________________________________________________________________________
Overall Patient Perceptions of Physicians Scale
_________________________________________________
Total
(n=2,189)
_________________

Less than 37
(n=987)
_________________

37 or higher
(n=1,202)
_________________

Number Percent
Number Percent
Number Percent
p-value1
____________________________________________________________________________________________________________
0.00012

Insurance
Private
Yes
No

Medicaid
Yes
No

1,069

48.84

437

44.28

632

52.58

1,120

51.16

550

55.72

570

47.42
0.00062

391

17.86

184

15.31

207

20.97

1,798

82.14

1,018

84.69

708

79.03

____________________________________________________________________________________________________________
1
2

p-value determined based on Chi-square.
p-value ≤ 0.05 indicates significance.
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Bivariate Association between Medicare Part D Prescription Coverage Gap and Patient
Perceptions of Physicians
To reach the Medicare Part D prescription coverage gap, beneficiaries had to have
$2,510 out of pocket cost for prescriptions filled in 2008 (Q1 Group LLC, 2013). Six
percent of beneficiaries with patient perceptions of physician scale scores less than 37,
reached the coverage gap in comparison to 5 percent of beneficiaries with scores of 37 or
higher (6 percent versus 5 percent, p=0.646). There was no significant association
between Medicare Part D coverage gap and the patient perception of physician scale
scores. Table 29 reports the bivariate association results for reaching the Medicare Part
D prescription coverage gap and patient perceptions of physicians.

Bivariate Association between Perceived Health Status and Patient Perceptions of
Physicians
Sixty-six percent of beneficiaries with patient perceptions of physician scale
scores less than 37 perceived their health status as good or better compared to 58 percent
of beneficiaries with scores of 37 or higher, perceived their health status to be good or
better (66 percent versus 58 percent, p=0.0005). Nine percent of beneficiaries with
patient perceptions of physician scale scores less than 37 perceived their health status as
poor compared to 13 percent with scores of 37 or higher (9 percent versus 13 percent,
p=0.0005). Table 30 reports the bivariate association results for perceived health status
and patient perceptions of physicians.

Table 29. Bivariate Association between Medicare Part D Prescription Coverage Gap and Overall Patient Perceptions of Physicians
Scale
____________________________________________________________________________________________________________
Overall Patient Perceptions of Physicians Scale
_________________________________________________
Total
(n=2,189)
_________________

Less than 37
(n=987)
_________________

37 or higher
(n=1,202)
_________________

Number Percent
Number Percent
Number Percent
p-value1
____________________________________________________________________________________________________________
Medicare Part D Prescription
Coverage Gap

Coverage Gap Reached
Coverage Gap Not
Reached

0.646

121

5.53

57

5.78

64

5.32

2,068

94.47

930

94.22

1,138

94.68

____________________________________________________________________________________________________________
1

p-value determined based on Chi-square. p-value ≤ 0.05 indicates significance.
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Table 30. Bivariate Association between Perceived Health Status and Overall Patient Perceptions of Physicians Scale
_________________________________________________________________________________________________________
Overall Patient Perceptions of Physicians Scale
_________________________________________________
Total
(n=2,189)
_________________

Less than 37
(n=987)
_________________

37 or higher
(n=1,202)
_________________

Number Percent
Number Percent
Number Percent
p-value1
_________________________________________________________________________________________________________
Perceived
Health Status

0.00052

Excellent

112

5.12

60

6.08

52

4.33

Very Good

446

20.37

225

22.80

221

18.39

Good

795

36.32

366

37.08

429

35.69

Fair

591

27.00

249

25.23

342

28.45

Poor
245
11.19
87
8.81
158
13.14
_________________________________________________________________________________________________________
1
2

p-value determined based on Chi-square.
p-value ≤ 0.05 indicates significance.
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Bivariate Association between Number of Doctor Visits and Patient Perceptions of
Physicians
Thirty-five percent of beneficiaries with patient perceptions of physician scale
scores less than 37 had 15 or more doctor visits in 2008 compared to 36 percent of
beneficiaries with scores of 37 or higher (35 percent versus 36 percent, p=0.139). Five
percent of beneficiaries with patient perceptions of physician scale scores less than 37 did
not have any doctor visits in 2008 compared to 4 percent of beneficiaries with scores of
37 or higher (5 percent versus 4 percent, p=0.139). There was no significant association
between number of doctor visits and the patient perception of physician scores. Table 31
reports the bivariate association results for number of doctor visits and patient
perceptions of physicians.

Bivariate Association between Number of Unique Medications and Patient Perceptions of
Physicians
Nine percent of beneficiaries with patient perceptions of physician scale scores
less than 37 filled 21 or more different medications in 2008 compared to 8 percent of
beneficiaries with scores of 37 or higher, (9 percent versus 8 percent, p=0.316). Thirtyfive percent of beneficiaries with patient perceptions of physician scale scores less than
37 filled 10 to 15 different medications in 2008 compared to 33 percent of beneficiaries
with scores of 37 or higher, (35 percent versus 33 percent, p=0.316). There was no
significant association between number of unique medications and perception of
physician scores. Table 32 reports the bivariate association results for number of
medications and the patient perceptions of physicians.

Table 31. Bivariate Association between Number of Doctor Visits and Overall Patient Perceptions of Physicians Scale
_________________________________________________________________________________________________________
Overall Patient Perceptions of Physicians Scale
_________________________________________________
Total
(n=2,189)
_________________

Less than 37
(n=987)
_________________

37 or higher
(n=1,202)
_________________

Number Percent
Number Percent
Number Percent
p-value1
_________________________________________________________________________________________________________
Number of
Doctor Visits

0.139

0

105

4.80

51

5.17

54

4.49

1 to 4

384

17.54

174

17.63

210

17.47

5 to 9

540

24.67

248

25.13

292

24.29

10 to 14

376

17.18

165

16.72

211

17.55

15 to 18

199

9.09

105

10.64

94

7.82

19 or more

585

26.72

244

24.72

341

28.37

_________________________________________________________________________________________________________
1

p-value determined based on Chi-square. p-value ≤ 0.05 indicates significance.
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Table 32. Bivariate Association between Number of Unique Medications and Overall Patient Perceptions of Physicians Scale
_________________________________________________________________________________________________________
Overall Patient Perceptions of Physicians Scale
_________________________________________________
Total
(n=2,189)
_________________

Less than 37
(n=987)
_________________

37 or higher
(n=1,202)
_________________

Number Percent
Number Percent
Number Percent
p-value1
_________________________________________________________________________________________________________
Number of
Unique
Medications

0.316

1 to 5

343

15.67

140

14.18

203

16.89

6 to 9

622

28.41

274

27.76

348

28.95

10 to 15

740

33.81

342

34.65

398

33.11

16 to 20

301

13.75

146

14.79

155

12.90

21 or more
183
8.36
85
8.61
98
8.15
_________________________________________________________________________________________________________
1

p-value determined based on Chi-square. p-value ≤ 0.05 indicates significance.
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Bivariate Association between Clinical Conditions and Patient Perceptions of Physicians
Bivariate association between clinical conditions and patient perception of
physicians were assessed. The clinical conditions were heart disease, heart failure, stroke,
osteoporosis, depression, non-skin cancers, diabetes, rheumatoid arthritis, Parkinson’s
disease, and respiratory conditions (asthma, emphysema, or COPD). There were no
significant associations between any of the clinical conditions and the perception of
physician scores. Table 33 reports results for bivariate association between the clinical
conditions and patient perceptions of physicians.

Bivariate Association between Charlson Comorbidity Index and Patient Perceptions of
Physicians
Eighty-four percent of beneficiaries with patient perceptions of physician scale
scores less than 37 had a Charlson Comorbidity Index score of zero compared to 84
percent of beneficiaries with scores of 37 or higher, (84 percent versus 84 percent,
p=0.987). There was no significant association between Charlson Comorbidity Index
scores and patient perceptions of physician scale scores. Table 34 reports results for
bivariate association between Charlson Comorbidity Index scores and patient perceptions
of physician scale scores.

Table 33. Bivariate Association between Clinical Conditions and Overall Patient Perceptions of Physicians Scale
_________________________________________________________________________________________________________
Overall Patient Perceptions of Physicians Scale
_________________________________________________
Total
(n=2,189)
_________________

Less than 37
(n=987)
_________________

37 or higher
(n=1,202)
_________________

Number Percent
Number Percent
Number Percent
p-value1
_________________________________________________________________________________________________________
Clinical
Condition
Heart Disease
Yes
No

Heart Failure
Yes
No

Stroke
Yes
No

0.764
1,028
1,161

46.96
53.04

467
520

47.32
52.68

561
641

46.67
53.33

0.707
116
1,086

9.87
90.13

100
887

10.13
89.87

116
1,086

9.65
90.35

0.296
290
1,899

13.25
86.75

139
848

14.08
85.92

151
1,051

12.56
87.44
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Table 33. Continued
_________________________________________________________________________________________________________
Overall Patient Perceptions of Physicians Scale
_________________________________________________
Total
(n=2,189)
_________________

Less than 37
(n=987)
_________________

37 or higher
(n=1,202)
_________________

Number Percent
Number Percent
Number Percent
p-value1
_________________________________________________________________________________________________________
Non-Skin
Cancer
Yes
No

Diabetes
Yes
No

Rheumatoid
Arthritis
Yes
No

0.663
417
1,772

19.05
80.95

192
795

19.45
80.55

225
977

18.72
81.28

0.270
736
1,453

33.62
66.38

344
643

34.85
65.15

392
810

32.61
67.39

0.191
292
1,897

13.34
86.66

142
845

14.39
85.61

150
1,052

12.48
87.52
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Table 33. Continued
_________________________________________________________________________________________________________
Overall Patient Perceptions of Physicians Scale
_________________________________________________
Total
(n=2,189)
_________________

Less than 37
(n=987)
_________________

37 or higher
(n=1,202)
_________________

Number Percent
Number Percent
Number Percent
p-value1
_________________________________________________________________________________________________________
Depression
Yes
No

Osteoporosis
Yes
No
Parkinson’s
Disease
Yes
No

0.497
305
1,884

13.93
86.07

143
844

14.49
85.51

162
1,040

13.48
86.52

23.62
76.38

765
222

77.51
22.49

907
295

75.46
24.54

0.261
517
1,672

0.357
32
2,157

1.46
98.54

17
970

1.72
98.28

15
1,187

1.25
98.75
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Table 33. Continued
_________________________________________________________________________________________________________
Overall Patient Perceptions of Physicians Scale
_________________________________________________
Total
(n=2,189)
_________________

Less than 37
(n=987)
_________________

37 or higher
(n=1,202)
_________________

Number
Percent
Number Percent
Number Percent
p-value1
_________________________________________________________________________________________________________
Respiratory
Conditions
(i.e. Asthma,
Emphysema,
COPD) 3
Yes
No

0.420
384
1,805

17.54
82.46

166
821

16.82
83.18

218
984

18.14
81.86

_________________________________________________________________________________________________________
1

p-value determined based on Chi-square.
p-value ≤ 0.05 indicates significance.
3
COPD is Chronic Obstructive Pulmonary Disease
2
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Table 34. Bivariate Association between Charlson Comorbidity Index and Overall Patient Perceptions of Physicians Scale
_________________________________________________________________________________________________________
Overall Patient Perceptions of Physicians Scale
_________________________________________________
Total
(n=2,189)
_________________

Less than 37
(n=987)
_________________

37 or higher
(n=1,202)
_________________

Number Percent
Number Percent
Number Percent
p-value1
_________________________________________________________________________________________________________
Charlson
Comorbidity
Index

0.987

0

1,836

83.87

829

83.99

1,007

83.78

1

189

8.63

85

8.61

104

8.65

2 or more

164

7.49

73

7.40

91

7.57

_________________________________________________________________________________________________________
1

p-value determined based on Chi-square. p-value ≤ 0.05 indicates significance.

122

123

Medication Adherence
Sample
Beneficiaries were required to have filled prescriptions for antihypertensive
medications using their Medicare Part D prescription coverage for inclusion in the
sample. The study sample included 2,510 beneficiaries. In developing the patient
perceptions of physician scale, there were 220 beneficiaries missing responses on the
patient perception of physician items, and 42 beneficiaries who were excluded due to
missing responses on the selected convergent validity variables. Among the 2,248
beneficiaries in the sample after developing the patient perception of physician indices,
59 beneficiaries were removed due to only having one prescription fill for every unique
antihypertensive medication filled in 2008. This resulted in a sample of 2,189
beneficiaries.

Proportion of Days Covered (PDC)
The proportion of days covered (PDC) may have values between 0 and 1. PDC
ranged from 0.13 to 1. The mean was 0.82 with a standard deviation of 0.236. The
distribution of proportion of days covered is reported in Table 35. PDC was converted to
a binary variable to indicate whether a beneficiary was adherent or not. If PDC was 0.80
or higher, the beneficiary was considered to be adherent. If PDC was less than 0.80, the
beneficiary was non-adherent. Sixty-five percent of the sample was adherent in filling
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Table 35. Distribution of Proportion of Days Covered
________________________________________________________________________

Variable

Standard
Deviation

Mean
n=2,189
________________________________________________________________________
Proportion of Days Covered
0.82
0.236
________________________________________________________________________
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their antihypertensive medication. The distribution for medication adherence status is
reported in Table 36.
Bivariate Associations between Demographic Variables and Medication Adherence
Bivariate Association between Age and Medication Adherence
Forty-four percent of the sample was in their seventies, 70 to 79 years old.
Among those who were adherent, 22 percent were ages 65 to 69, 45 percent were ages 70
to 79 years, and almost one-third, or 32 percent of those who were adherent, were age 80
years or older. Forty-five percent of beneficiaries who were adherent and 42 percent of
beneficiaries who were non-adherent were in their seventies (45 percent versus 42
percent, p=0.079). There was no association between age and medication adherence.
Bivariate association between age and medication adherence are reported in Table 37.
Bivariate Association between Gender and Medication Adherence
Sixty-six percent of the overall sample was female, and 34 percent male. Among
female beneficiaries, 65 percent were adherent compared to 68 percent of those who were
non-adherent (65 percent versus 68 percent, p=0.077). There was no association between
gender and medication adherence. Table 38 describes the bivariate association between
gender and medication adherence.
Bivariate Association between Race and Medication Adherence
Eighty-three percent of the overall sample was White, and 17 percent were nonWhite. Among White beneficiaries, a higher percentage of beneficiaries were adherent in
comparison to beneficiaries who were non-adherent (85 percent versus 81 percent,
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Table 36. Distribution of Medication Adherence
________________________________________________________________________
Number of
Variable
Individuals
Percent
n=2,189
________________________________________________________________________
Medication Adherence Status
Adherent

1,419

64.82

Non-Adherent
770
35.18
________________________________________________________________________

Table 37. Bivariate Association between Age Category and Medication Adherence
_________________________________________________________________________________________________________
Total

Adherent

Non-Adherent

(n=2,189)
_________________

(n=1,419)
_______________

(n=770)
_______________

Number
Percent
Number Percent
Number Percent
p-value1
_________________________________________________________________________________________________________
Age Category

0.079

65 to 69

470

21.47

317

22.34

153

19.87

70 to 74

458

20.92

311

21.92

147

19.09

75 to 79

511

23.34

334

23.54

177

22.99

80 to 84

439

20.05

268

18.89

171

22.21

85 and older
311
14.21
189
13.32
122
15.84
_________________________________________________________________________________________________________
p-value determined based on Chi-square test. p-value ≤ 0.05 indicates significance.
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Table 38. Bivariate Association between Gender and Medication Adherence
_________________________________________________________________________________________________________
Total
(n=2,189)
_________________

Adherent

Non-Adherent

(n=1,419)
_______________

(n=770)
_______________

Number
Percent
Number Percent
Number Percent
p-value1
_________________________________________________________________________________________________________
Gender
Female

0.077
1,422

65.87

916

64.55

526

68.31

Male
747
34.13
503
35.45
244
31.69
_________________________________________________________________________________________________________
1
p-value determined based on Chi-square test. p-value ≤ 0.05 indicates significance

128

129
p-value=0.02). Table 39 describes the bivariate association between medication
adherence and race.
Bivariate Association between Marital Status and Medication Adherence
A little over one-half, or 53 percent of the sample was not married. Fifty-two
percent of those who were adherent were not married, and 56 percent of those who were
non-adherent were not married (52 percent versus 56 percent, p-value=0.0652). There
was no significant association between marital status and medication adherence. Table
40 shows the bivariate association between medication adherence and marital status.
Bivariate Association between Education and Medication Adherence
Sixty-four percent of the sample had a high school education or less. Among
those who were adherent, almost two-thirds, or 63 percent had a high school education or
less, and almost 13 percent had a Bachelor’s degree or higher. One-third, or 67 percent
of those who were non-adherent had a high school education or less, and 12 percent had a
Bachelor’s degree or higher. There was no association between education level and
medication adherence. Table 41 describes bivariate association between education and
medication adherence.
Bivariate association between missing education and medication adherence status
was assessed using chi-square tests to determine if missing education may influence
adherence. Missing education had cell sizes less than 11 and therefore results were not
reported. There was no significant association between missing education and adherence.
Additionally, bivariate association between missing education and Medicaid status was
assessed to determine if there may have been a potential influence on adherence. Missing

Table 39. Bivariate Association between Race and Medication Adherence
_________________________________________________________________________________________________________
Total

Adherent

Non-Adherent

(n=2,189)
_________________

(n=1,419)
_______________

(n=770)
_______________

Number
Percent
Number Percent
Number Percent
p-value
_________________________________________________________________________________________________________
0.0231

Race
White

1,825

83.37

1,202

84.71

623

80.91

Non-White2
364
16.63
217
15.29
147
19.09
_________________________________________________________________________________________________________
p-value determined based on Chi-square. p-value ≤ 0.05 indicates significance.
Non-White includes: African American, Asian, Native Hawaiian or Pacific Islander, American Indian or Alaska Native,
other race, and more than one race.

1
2
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Table 40. Bivariate Association between Marital Status and Medication Adherence
_________________________________________________________________________________________________________
Total

Adherent

Non-Adherent

(n=2,189)
_________________

(n=1,419)
_______________

(n=770)
_______________

Number
Percent
Number Percent
Number Percent
p-value1
_________________________________________________________________________________________________________
Marital Status
Married

0.065
1,025

46.83

685

48.27

340

44.16

Not married
1,164
53.17
734
51.73
430
55.84
_________________________________________________________________________________________________________
p-value determined based on Chi-square test. p-value ≤ 0.05 indicates significance.
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Table 41. Bivariate Association between Education and Medication Adherence
_________________________________________________________________________________________________________
Total

Adherent

Non-Adherent

(n=2,184)
_________________

(n=1,415)
_______________

(n=769)
_______________

Number
Percent
Number Percent
Number Percent
p-value1
_________________________________________________________________________________________________________
Education

0.125

Less than
high school

679

31.09

418

29.54

261

33.94

High school
graduate

720

32.97

467

33.00

253

32.90

Some college/
Vocational/
Associate’s degree 496

22.71

333

23.53

163

21.20

Bachelor’s degree
or higher

13.23

197

13.92

92

11.96

289

Missing2
------------------------_________________________________________________________________________________________________________
p-value determined based on Chi-square test. p-value ≤ 0.05 indicates significance.
Missing had cell sizes of 11 or less and values were removed as required by data use agreement.

1
2
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education had cell sizes less than 11 and therefore results were not reported. There was
no significant association between missing education and adherence.
Bivariate Association between Income and Medication Adherence
Forty-six percent of the sample had income of $20,000 or less, and 22 percent had
income greater than $40,000. Forty-five percent of those who were adherent and 48
percent of those who were non-adherent had an income of $20,000 or less. Thirty
percent of those who were adherent and 29 percent of those who were non-adherent had
an income between $20,001 and $40,000. Fourteen percent of those who were adherent
and 10 percent of those who were non-adherent had an income greater than $40,000 per
year. There was no significant association between income and medication adherence.
Table 42 shows the bivariate association between medication adherence and income.
Bivariate association between missing income and medication adherence was
assessed using chi-square tests. These associations were assessed to determine if missing
income may influence adherence. There were 253 beneficiaries who were missing
income, 155 were adherent and 98 were non-adherent. Eleven percent of those who were
adherent compared to 13 percent of those who were non-adherent were missing income
(11 percent versus 13 percent, p=0.2074). There was no significant association between
missing income and adherence. Additionally, bivariate association between missing
income and Medicaid status was assessed to determine if this association may potentially
have an influence on adherence. Thirty-one of the 253 beneficiaries missing income had
Medicaid. Eight percent of beneficiaries with Medicaid in comparison to 12 percent
without Medicaid were missing income (8 percent versus 12 percent, p=0.0133). A lower

Table 42. Bivariate Association between Income and Medication Adherence
_________________________________________________________________________________________________________
Total

Adherent

Non-Adherent

(n=2,189)
_________________

(n=1,419)
_______________

(n=770)
_______________

Number
Percent
Number Percent
Number Percent
p-value1
_________________________________________________________________________________________________________
Income

0.158

$10,000 or less

403

18.41

249

17.55

154

20.00

$10,001 to $20,000

606

27.68

391

27.55

215

27.92

$20,001 to $30,000

366

16.72

240

16.91

126

16.36

$30,001 to $40,000

287

13.11

187

13.18

100

12.99

$40,001 to $50,000

195

8.91

139

9.80

56

7.27

79

3.61

58

4.09

21

2.73

$50,001 or more

Missing2
253
11.56
155
10.92
98
12.73
_________________________________________________________________________________________________________
p-value determined based on Chi-square test. p-value ≤ 0.05 indicates significance.
Number of individuals missing income did not provide an income level in an above listed category. Income was provided as
less than $25,000 or $25,000 or more.

1
2
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percentage of those with Medicaid were missing income. Because missing income may
potentially have an influence on adherence, in further analysis adjusting for risk factors,
the models were run with and without income in the model.

Bivariate Associations between Clinical Variables and Medication Adherence
Bivariate Association between Insurance Coverage and Medication Adherence
Forty-nine percent of the sample had private insurance in addition to Medicare.
Among those who were adherent, one-half, or 51 percent had private insurance. Among
those who were non-adherent, 45 percent had private insurance. Medication adherence
differed significantly based on private insurance (50 percent versus 45 percent, pvalue=0.016). Eighteen percent of the sample were dual-eligibles having Medicaid
coverage in addition to Medicare. Among those who were adherent, 17 percent were
dual eligibles, 20 percent of those who were non-adherent were dual eligibles (17 percent
versus 20 percent, p-value=0.116). There was no association between having Medicaid
and medication adherence. Table 43 reports the bivariate association between medication
adherence and insurance coverage type (private insurance and Medicaid).

Table 43. Bivariate Association between Insurance and Medication Adherence
_________________________________________________________________________________________________________
Total

Adherent

Non-Adherent

(n=2,189)
_________________

(n=1,419)
_______________

(n=770)
_______________

Number
Percent
Number Percent
Number Percent
p-value
_________________________________________________________________________________________________________
Insurance Type
0.0121

Private Insurance
Yes

1,069

48.84

720

50.74

349

45.32

No

1,120

51.16

699

49.26

421

54.68

Medicaid
Yes

0.116
391

17.86

240

16.91

151

19.61

No
1,798
82.14
1,179
83.09
619
80.39
_________________________________________________________________________________________________________
1

p-value determined based on Chi-square test. p-value ≤0.05 indicates significance.

136

137

Bivariate Association between Medicare Part D Prescription Coverage Gap and
Medication Adherence
The Medicare Part D prescription coverage gap is also referred to as reaching the
coverage gap. If a beneficiary had $2,510 in out of pocket prescription costs, they
reached the coverage gap. In the overall sample, 6 percent of the sample reached the
Medicare Part D prescription coverage gap. Among those who were adherent, 5 percent
reached the coverage gap, and among those who were non-adherent, 6 percent reached
the coverage gap (5 percent versus 6 percent, p-value=0.041). Table 44 shows the results
from analysis of bivariate association between medication adherence and the Medicare
Part D prescription coverage gap.

Bivariate Association between Perceived Health Status and Medication Adherence
Beneficiaries rated their health status as excellent, very good, good, fair or poor.
Sixty-two percent of the sample perceived their health to be good or better. Among those
who were adherent, 58 percent perceived their health status to be good or better, while 68
percent of those who were non adherent perceived their health status to be good or better
(58 percent versus 68 percent, p-value=<.0001). Among those who were adherent, 42
percent perceived their health status was fair or poor, while 32 percent of those who were
non adherent perceived their health status as fair or poor (42 percent versus 32 percent, pvalue=<.0001). See Table 45 for bivariate association between medication adherence and
perceived health status.

Table 44. Bivariate Association between Medicare Part D Prescription Coverage Gap and Medication Adherence
_________________________________________________________________________________________________________
Total

Adherent

Non-Adherent

(n=2,189)
_________________

(n=1,419)
_______________

(n=770)
_______________

Number
Percent
Number Percent
Number Percent
p-value
_________________________________________________________________________________________________________
Medicare Part D
Prescription
Coverage Gap Status
Coverage Gap
Reached

0.0411

121

5.53

68

4.79

53

6.88

Coverage Gap
Not Reached
2,068
94.47
1,351
95.21
717
93.12
_________________________________________________________________________________________________________
p-value determined based on Chi-square test. p-value ≤ 0.05 indicates significance.
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Table 45. Bivariate Association between Perceived Health Status and Medication Adherence
_________________________________________________________________________________________________________
Total

Adherent

Non-Adherent

(n=2,189)
_________________

(n=1,419)
_______________

(n=770)
_______________

Number
Percent
Number Percent
Number Percent
p-value1
_________________________________________________________________________________________________________
Perceived Health
Status

<.00012

Excellent

112

5.12

54

3.81

58

7.53

Very good

446

20.37

247

17.41

199

25.84

Good

795

36.32

526

37.07

269

34.94

Fair

591

27.00

415

29.25

176

22.86

Poor

245

11.19

177

12.47

68

8.83

_________________________________________________________________________________________________________
1

p-value determined based on Chi-square test.

2

p-value ≤ 0.05 indicates significance.
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Bivariate Association between Number of Unique Medications and Medication
Adherence
Sixteen percent of the overall sample filled 1 to 5 unique medications, and 8
percent filled 21 or more unique medications. One-fifth, or 20 percent of those who were
adherent filled between 1 and 5 unique medications in 2008, and 8 percent of those who
were non-adherent filled between 1 and 5 unique medications in 2008 (20 percent versus
8 percent, p-value=<.0001). Five percent of those who were adherent filled 21 or more
unique medication, and 16 percent of those who were nonadherent filled 21 or more
unique medications (5 percent versus 16 percent, p-value=<.0001). See Table 46 for the
bivariate association between medication adherence and number of unique medications.

Bivariate Association between Number of Doctor Visits and Medication Adherence
In the overall sample, 5 percent of individuals had zero doctor visits and 27
percent had 19 or more doctor visits. Among those who were adherent, 22 percent had
19 or more doctor visits in 2008 compared to 35 percent of those who were non-adherent
(22 percent versus 35 percent, p=<.0001). Among those who were adherent, 5 percent
did not have any doctor visits in 2008 compared to 6 percent of those who were nonadherent (5 percent versus 6 percent, p=<.0001). Table 47 presents the bivariate
association between medication adherence and number of doctor visits.

Table 46. Bivariate Association between Number of Unique Medications and Adherence
_________________________________________________________________________________________________________
Total

Adherent

Non-Adherent

(n=2,189)
_________________

(n=1,419)
_______________

(n=770)
_______________

Number
Percent
Number Percent
Number Percent
p-value1
_________________________________________________________________________________________________________
Number of
Unique Medications

<.00012

1 to 5

343

15.67

282

19.87

61

7.92

6 to 9

622

28.41

463

32.63

159

20.65

10 to 15

740

33.81

455

32.06

285

37.01

16 to 20

301

13.75

156

10.99

145

18.83

21 or more
183
8.36
63
4.44
120
15.58
_________________________________________________________________________________________________________
1

p-value determined based on Chi-square test.
p-value < 0.05 indicates significance.
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Table 47. Bivariate Association between Number of Doctor Visits and Medication Adherence
_________________________________________________________________________________________________________
Total

Adherent

Non-Adherent

(n=2,189)
_________________

(n=1,419)
_______________

(n=770)
_______________

Number
Percent
Number Percent
Number Percent
p-value1
_________________________________________________________________________________________________________
Number of
Doctor Visits

<.00012

0

105

4.80

59

4.16

46

5.97

1 to 4

384

17.54

293

20.65

91

11.82

5 to 9

540

24.67

368

25.93

172

22.34

10 to 14

376

17.18

248

17.48

128

16.62

15 to 18

199

9.09

136

9.58

63

8.18

19 or more
585
26.72
315
22.20
270
35.06
_________________________________________________________________________________________________________
1

p-value determined based on Chi-square test.
p-value < 0.05 indicates significance.

2
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Bivariate Association between Clinical Conditions and Medication Adherence

Variables were created for ten clinical conditions, including heart disease, heart
failure, diabetes, stroke, non-skin cancers, rheumatoid arthritis, depression, Parkinson’s
disease, osteoporosis, and respiratory conditions, indicating whether they had ever been
told by their physician that they had the condition or if they were told within the past
year. Table 48 describes the bivariate association between medication adherence and
clinical conditions.
Among those who had heart disease, 43 percent were adherent compared to 54
percent who were non-adherent (43 percent versus 54 percent, p-value<.0001). Among
those who had heart failure, 8 percent were adherent compared to 14 percent of those
who were non-adherent (8 percent versus 14 percent, p-value<.0001). Among those who
had a stroke, 12 percent were adherent compared to 16 percent of those who were nonadherent (12 percent versus 16 percent, p-value=0.008). Among beneficiaries who had a
non-skin cancer, One-fifth, or 20 percent were adherent compared to 17 percent of those
who were non-adherent (20 percent versus 17 percent, p-value=0.044).
Among those with diabetes, 32 percent were adherent in comparison to 38 percent
who were non-adherent (32 percent versus 38 percent, p-value=0.036). Among
beneficiaries who had rheumatoid arthritis 12 percent were adherent in comparison to

Table 48. Bivariate Association between Clinical Conditions and Medication Adherence
_________________________________________________________________________________________________________
Total

Adherent

Non-Adherent

(n=2,189)
_________________

(n=1,419)
_______________

(n=770)
_______________

Number
Percent
Number Percent
Number Percent
p-value
_________________________________________________________________________________________________________
Heart Disease
Yes
No
Heart Failure
Yes
No
Diabetes
Yes
No
Stroke
Yes
No
Non-Skin Cancers
Yes
No

<.00011
1,028
1,161

46.96
53.04

610
809

42.99
57.01

418
352

54.29
45.71
<.00011

216
1,973

9.87
90.13

112
1,307

7.89
92.11

104
666

13.51
86.49
0.0361

736
1,453

33.62
66.38

455
964

32.06
67.94

281
489

36.49
63.51
0.0081

290
1,899

13.25
86.75

168
1,251

11.84
88.16

122
648

15.84
84.16
0.0441

417
1,772

19.05
80.95

288
1,131

20.30
79.70

129
641

16.75
83.25
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Table 48. Continued
_________________________________________________________________________________________________________
Total

Adherent

(n=2,189)
_________________

(n=1,419)
_______________

Non-Adherent
(n=770)
_______________

Number Percent
Number Percent
Number Percent
p-value
_________________________________________________________________________________________________________
Rheumatoid Arthritis
Yes
No

0.0021
292
1,897

13.34
86.66

166
1,253

11.70
88.30

126
644

16.36
83.64
0.0071

Depression
Yes
No

305
1,884

13.93
86.07

177
1,242

12.47
87.53

128
642

16.62
83.38

Parkinson’s Disease
Yes
No

32
2,157

1.46
98.54

18
1,401

1.27
98.73

14
756

1.82
98.18

Osteoporosis
Yes
No

517
1,672

23.62
76.38

318
1,101

22.41
77.59

199
571

25.84
74.16

Respiratory Conditions (i.e., Asthma
Emphysema, and COPD) 2
Yes
No

384
1,805

17.54
82.46

243
1,176

17.12
82.88

141
629

18.31
81.69

0.306

0.071

0.486

145

_________________________________________________________________________________________________________
1
2

p-value determined based on Chi-square. p-value ≤ 0.05 indicates significance.
COPD is Chronic Obstructive Pulmonary Disease.
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16 percent who were non-adherent (12 percent versus 16 percent, p-value 0.002). A
lower percentage of beneficiaries who had depression were adherent in comparison to
those who were non-adherent and had depression (12 percent versus 17 percent, pvalue=0.007).
Bivariate Association between Charlson Comorbidity Index and Medication Adherence
Among beneficiaries with a Charlson Comorbidity Index score of 2 or greater, 7
percent were adherent compared to 9 percent who were non-adherent (7 percent versus 9
percent, p-value=0.053). Among beneficiaries with a Charlson Comorbidity Index score
of 0, 85 percent were adherent compared to 81 percent who were non-adherent (85
percent versus 81 percent, p-value=0.053). Table 49 describes the bivariate association
between Charlson Comorbidity Index scores and medication adherence.
Association between Patient Perception of Physicians and Medication Adherence
Bivariate Association between Patient Perceptions of Physicians and Medication
Adherence
Overall Patient Perception of Physicians Scale

Sixty-five percent of the sample were adherent to antihypertensive medications,
and 35 percent were non-adherent to their antihypertensive medications. Among
beneficiaries with perception scores of 37 or higher, 58 percent were adherent compared
to 50 percent who were non-adherent (58 percent versus 50 percent, p-value=0.0009).

Table 49. Bivariate Association between Charlson Comorbidity Index and Medication Adherence
_________________________________________________________________________________________________________
Total

Adherent

(n=2,189)
_________________

Non-Adherent

(n=1,419)
_______________

(n=770)
_______________

Number
Percent
Number Percent
Number Percent
p-value
_________________________________________________________________________________________________________
0.0531

Charlson Comorbidity Index
0

1,836

83.87

1,209

85.20

627

81.43

1

189

8.63

116

8.17

73

9.48

2 or more
164
7.49
94
6.62
70
9.09
_________________________________________________________________________________________________________
1

p-value determined based on Chi-square test. p-value < 0.05 indicates significance.
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Among beneficiaries with perception scores less than 37, 61 percent were adherent
compared to 68 percent who had scores of 37 or higher (61 percent versus 68 percent, pvalue=0.0009). Table 50 describes the bivariate association between the overall patient
perceptions of physician scale and medication adherence.

Subscales
Bivariate association between perceived physician knowledge about the patient
(Factor 1) subscale and medication adherence was assessed. Among beneficiaries who
had perceived physician knowledge about the patient subscale scores less than 25, 62
percent were adherent compared to 67 percent who had scores at 25 or higher (62 percent
versus 67 percent, p-value=0.014). Table A1 shows analysis results for bivariate
association between perceived physician knowledge about the patient (Factor 1) subscale
and medication adherence.
Bivariate association between perceived concern (Factor 2) subscale and
medication adherence was assessed. Among beneficiaries who had perceived concern
(Factor 2) subscale scores less than 13, 63 percent were adherent compared to 68 percent
who had scores at 13 or higher (63 percent versus 68 percent, p-value=0.052). Table A2
reports results for bivariate association between perceived concern (Factor 2) subscale
and medication adherence.

Table 50. Bivariate Association between the Overall Patient Perceptions of Physicians Scale and Adherence
_________________________________________________________________________________________________________
Overall Patient Perceptions of Physicians Scale
_________________________________________________
Total
(n=2,189)
_________________

Less than 37
(n=987)
_________________

37 or higher
(n=1,202)
_________________

Number Percent
Number Percent
Number Percent
p-value
_________________________________________________________________________________________________________
0.00091

Adherence Status
Adherent

987

64.82

603

61.09

816

67.89

Non-Adherent
1,202
35.18
384
38.91
386
32.11
_________________________________________________________________________________________________________
1

p-value determined based on Chi-square. p-value ≤ 0.05 indicates significance.
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Association between Patient Perception of Physicians and Medication Adherence after
Adjusting for Risk Factors

Overall Patient Perception of Physicians Scale
A multiple logistic regression model using stepwise selection was developed to
assess association between the patient perception of physicians and medication adherence
to antihypertensive medication. In the initial model, the predictor variable was the
patient perceptions of physician scale as a continuous variable. The response variable
was medication adherence status dichotomized from the proportion of days covered
variable with “1” indicating adherent, PDC=80 percent or higher, and “0” indicating nonadherent, PDC less than 80 percent. The predictor variable (patient perceptions of
physician scale scores) did not enter the regression model indicating no significant
association between patient perceptions of physicians and adherence to antihypertensive
medications. The significant covariates included age, respiratory conditions, non-skin
cancers, and number of unique medications.
The predictor variable was further examined as a categorical variable in the
logistic regression model. The frequency distribution of the patient perceptions of
physicians scale scores was evaluated to determine a cutoff point for more favorable
perceptions versus less favorable perceptions. With scores ranging from 15 to 48, the
median was 37. To determine a cutoff point for more favorable perceptions versus less
favorable perceptions, logistic regression with the Receiver Operator Characteristics
(ROC) option was used to determine a cutoff for the perception scores. The cut-off
identified from the ROC curve was 37. Scores of 37 or higher represented more
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favorable perceptions and scores less than 37 represented less favorable perceptions.
Sensitivity analysis was conducted by using various cut-offs ranging from 36 to 38 to
determine the robustness of the model using the cut-off selected. Using cut-off points at
36 to 38, there were no differences in predicting the association between perceptions of
physicians and medication adherence.
A multiple logistic regression model using stepwise selection was developed to
assess association between the patient perception of physicians and medication adherence
to antihypertensive medication. The predictor variable was the patient perceptions of
physician scale as a categorical variable with 2 categories, less than 37 and 37 or higher.
The response variable was medication adherence status dichotomized from the proportion
of days covered variable with “1” indicating adherent, PDC=80 percent or higher, and
“0” indicating non-adherent, PDC less than 80 percent. There were 254 beneficiaries
who were missing education and/or income and were excluded from the multiple logistic
regression model so that the number of observations in the model was 1,935. The model
adjusted for demographic and clinical characteristics and all two-way interactions. The
demographic variables included age, gender, race, education, and income. The clinical
variables included insurance coverage (private and Medicaid), reaching the Medicare Part
D prescription coverage gap, perceived health status, number of unique medications,
number of doctor visits, Charlson Comorbidity Index, and clinical conditions (heart
disease, heart failure, diabetes, stroke, non-skin cancers, rheumatoid arthritis, depression,
Parkinson’s disease, osteoporosis, and respiratory conditions.
Using stepwise selection, the first variable to enter the model was number of
unique medications (Chi-square=132.546, df=4, p-value=<.0001). The patient
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perceptions of physician scale was the second variable to enter the model (Chisquare=8.515, df=1, p-value=0.035). Having a respiratory condition was the third
variable to enter the model (Chi-square=4.968, df=1, p-value=0.026). Having a non-skin
cancer was fourth to enter the model (Chi-square=5.897, df=1, p-value=0.015). Age
category was the last variable to enter the model (Chi-square=10.498, df=4, pvalue=0.033). There were no additional effects that met the alpha=0.05 significance level
for model entry.
The global likelihood ratio test was significant indicating the model was a good fit
for the data (Likelihood ratio, Chi-Square=171.52, df=11, p-value<.0001). The Hosmer
Lemeshow test was not significant indicating good model fit (Chi-Square=8.603, df=8, pvalue=0.377). Table 51 presents the results of the multiple logistic regression model
results for association between patient perceptions of physicians and likelihood of being
adherent to antihypertensive medication.
Beneficiaries with patient perceptions of physician scale scores of 37 or higher
were more likely to be adherent to antihypertensive medications in comparison to
beneficiaries with scores less than 37 (Odds ratio=1.341, 95 percent CI=1.101-1.632, pvalue=0.0035). Other significant covariates in the regression model included: age,
respiratory conditions, non-skin cancers, and number of medications. Beneficiaries with
respiratory conditions were more likely to be adherent to antihypertensive medications in
comparison to beneficiaries without respiratory conditions (Odds ratio=1.356, 95 percent
CI=1.037-1.772, p-value=0.0258). Beneficiaries with non-skin cancers were more likely
to be adherent to antihypertensive medications in comparison to beneficiaries without
non-skin cancers (Odds ratio=1.377, 95 percent CI=1.064-1.783, p-value=0.0152).

Table 51. Multiple Logistic Regression Examining Association between the Overall Patient Perceptions of Physicians Scale and
Medication Adherence
_________________________________________________________________________________________________________
Parameter
Standard
Odds
95% Confidence
Variable3
n=1,935
Estimate
Error
Ratio
Interval
p-value
_________________________________________________________________________________________________________
Overall Patient Perceptions
of Physicians Scale
Less than 37
857
37 or higher
1,078
Age
65 to 69 years
70 to 74 years
75 to 79 years
80 to 84 years
85 years or older

reference group
0.2931

0.1005

1.341

1.101 - 1.632

0.00351
0.03281

412
401
464
390
268

reference group
0.0183
-0.1006
-0.3966
-0.2832

Respiratory Conditions2
Yes
No

342
1,593

Non-skin Cancer
Yes
No

365
1,570

0.1583
0.1508
0.1545
0.1729

1.018
0.904
0.673
0.753

0.747 - 1.389
0.673 - 1.215
0.497 - 0.911
0.537 - 1.057

0.9080
0.5046
0.01031
0.1015

0.3045
reference group

0.1366

1.356

1.037 - 1.772

0.02581

0.3200
reference group

0.1318

1.377

1.064 - 1.783

0.01521
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Table 51. Continued
_________________________________________________________________________________________________________

Variable

n=1,935

Parameter
Estimate

Standard
Error

Odds
Ratio

95% Confidence
Interval

p-value

_________________________________________________________________________________________________________
Number of unique medications
<.00011
1 to 5
302
reference group
6 to 9
546
-0.3737
0.1797
0.688
0.482 - 0.974
0.03751
10 to 15
662
-1.0342
0.1705
0.355
0.252 - 0.491
<.00011
16 to 20
270
-1.4378
0.1966
0.237
0.160 - 0.345
<.00011
21 or more
155
-2.1962
0.2324
0.111
0.070 - 0.175
<.00011
_________________________________________________________________________________________________________
1
p-value ≤ 0.05 indicates significance.
2
Respiratory conditions include Emphysema, COPD, and Asthma.
3
The following variables were eligible to enter regression model: patient perception of physician scale, age, gender, race,
education,
income, private insurance, Medicaid, reaching the Medicare Part D prescription coverage gap, perceived health status, number of
unique medications, number of doctor visits, Charlson Comorbidity Index, and clinical conditions (heart disease, heart failure,
diabetes, stroke, non-skin cancers, rheumatoid arthritis, depression, Parkinson’s disease, osteoporosis, and respiratory conditions).
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Beneficiaries ages 80 to 84 were less likely to be adherent to antihypertensive
medications in comparison to beneficiaries ages 65 to 69 (Odds ratio=0.753, 95 percent
CI=0.537-1.057, p-value=0.0103). Beneficiaries who filled 21 or more medications were
less likely to be adherent to antihypertensive medications in comparison to beneficiaries
who filled 1 to 5 medications (Odds ratio=0.111, 95 percent CI=0.071-0.175, pvalue<.0001).
The stepwise logistic regression model was also run without education and
income as covariates in the regression model in order to include those who were missing
income and education in the analysis. When running the regression model without
education and income as covariates, the results remained consistent. Beneficiaries with
patient perceptions of physician scale scores of 37 or higher were more likely to be
adherent to antihypertensive medications in comparison to beneficiaries with scores less
than 37 (Odds ratio=1.343, 95 percent CI=1.115-1.617, p-value=0.0019).

Subscales
The frequency distribution of the Factor 1 and Factor 2 subscales were evaluated.
Factor 1 with scores ranging from 8 to 32, the median was 25. To determine a cutoff
point for more favorable perceptions versus less favorable perceptions, logistic regression
with the Receiver Operator Characteristics (ROC) option was used to create an ROC
curve to determine a cutoff for the perceived physician knowledge about the patient
(Factor 1) subscale scores and the perceived concern (Factor 2) subscale scores. The cutoff identified from the ROC curve was 25 for the Factor 1 subscale. A dichotomous
variable was created with scores of 25 or higher represented more favorable perceptions
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and scores less than 25 represented less favorable perceptions. The same process was
used for the Factor 2 subscale, and a dichotomous variable was created with scores of 13
or higher representing more favorable perceptions and scores less than 13 representing
less favorable perceptions.
A multiple logistic regression model using stepwise selection was developed to
assess association between the perceived physician knowledge about the patient (Factor
1) subscale and medication adherence to antihypertensive medication. Beneficiaries with
perceived physician knowledge about the patient (Factor 1) subscale scores of 25 or
higher were more likely to be adherent to antihypertensive medications in comparison to
beneficiaries with scores less than 25 (Odds ratio=1.222, 95 percent CI=1.004-1.487, pvalue<.0001). The significant covariates in the regression model included age,
respiratory conditions, non-skin cancers, and number of medications. Table B1 presents
the results of the multiple logistic regression model results for association between
perceived physician knowledge about the patient (Factor 1) subscale and likelihood to be
adherent to antihypertensive medication.
A multiple logistic regression model using stepwise selection was developed to
assess association between the perceived concern (Factor 2) subscale and medication
adherence to antihypertensive medication. The predictor variable did not enter the
regression model indicating no significant association between the perceived concern
(Factor 2) subscale and medication adherence to antihypertensive medications. The
significant covariates in the regression model included: age, respiratory conditions, nonskin cancers, and number of unique medications. Table B2 presents the results of the
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multiple logistic regression model results for association between the perceived concern
(Factor 2) subscale and adherence to antihypertensive medication.
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SUMMARY AND CONCLUSIONS

Background
The quality of the patient provider relationship has been identified as an
important factor in improving patient outcomes (Kaplan, Greenfield, and Ware 1989;
Roter and Hall 2009; Von Korff et al. 1997). Particularly among older adults, the
patient-physician relationship has also been identified as a potential barrier to
medication adherence.
Objectives
The objectives of this study were to: (1) develop a scale to assess patient
perceptions of physicians based on MCBS items, (2) examine adherence to
antihypertensive medication among Medicare beneficiaries enrolled in Medicare Part
D, and (3) assess associations between patient perceptions of physicians and
adherence to antihypertensive medication among Medicare beneficiaries enrolled in
Medicare Part D.
Methods
Data from the 2007 and 2008 Medicare Current Beneficiary Survey was used
to assess associations between patient perceptions of physicians and medication
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adherence among Medicare Part D beneficiaries with hypertension. Beneficiaries
were included if they were 65 years or older, dwelling in the community, had a
diagnosis of hypertension, enrolled in Medicare Part D for twelve months, and had
Medicare Part D claims for antihypertensive medication. Beneficiaries were
excluded if they had end-stage renal disease or disability, resided in a long term care
facility, had a proxy responder, or had a diagnosis of Alzheimer’s disease or
dementia.
Beneficiaries were identified as having hypertension if they answered “yes” to
at least one of two self-reported measures. The self-reported survey measures were:
(1) “Has your doctor ever told you that you have/had hypertension, sometimes called
high blood pressure?” and (2) “Since a year ago, did your doctor tell you that you
still had hypertension or high blood pressure?” A list of antihypertensive drugs was
created by identifying all drugs with an indication for the treatment of hypertension
using Facts and Comparison eAnswers and Micromedex 2.0 (Facts and Comparison
Online 2012; Micromedex 2012). Antihypertensive medication use was identified
from the Medicare Part D prescription claims, using First Databank Generic Name,
for any drug that was included in the created list of antihypertensive medications.

Study Variables
Patient Perceptions of Physicians
MCBS survey items were examined to identify items that ask about patient
perceptions of the physician from whom they generally receive care. Some examples
of items identified included: “Your doctor answers all of your questions,” “Your
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doctor has a good understanding of your medical history,” “Your doctor is competent
and well trained,” and “You have great confidence in your doctor.” For each item,
responses were coded so that “1” indicated strongly disagree, “2” indicated disagree,
“3” indicated agree, and “4” indicated strongly agree. Any items that were negatively
worded were reverse coded so that “4” indicated strongly disagree and “1” indicated
strongly agree.
Medication Adherence (Proportion of Days Covered)
Proportion of days covered (PDC) is calculated as the number of days with
medication on hand divided by the number of days in an interval (Benner et al. 2002;
Nau 2012; Peterson et al. 2007). PDC was calculated for all antihypertensive
medications taken by each beneficiary. If a medication was dispensed prior to the
end of the previous medication being completed, it was assumed that the new refill
was not started until the previous medication was completed. This shift of the
medication refill credits for the overlap in days supply.
The PDC study interval was one year (2008). If PDC was 80 percent or
higher, the beneficiary was considered adherent to antihypertensive therapy. If PDC
was less than 80 percent, the beneficiary was considered to be nonadherent.
Demographic Variables
Demographic variables for each beneficiary were derived based on their status
in December 2007. Demographic variables included: age, gender, race, education,
income, and marital status.
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Clinical Variables
Clinical variables examined included: number of medications, number of
doctor visits, Medicare Part D prescription coverage gap, Charlson Comorbidity
Index, and ten clinical conditions. The ten clinical conditions were heart disease,
heart failure, stroke, non-skin cancers, diabetes, rheumatoid arthritis, depression,
osteoporosis, Parkinson’s disease, and respiratory diseases (emphysema, COPD,
asthma).
Statistical Analysis
SAS® version 9.3 for the Unix environment was used for data analysis. An a
priori alpha level of 0.05 was used to evaluate significance for all analyses. Sample
distribution for all study variables was developed using the PROC FREQ procedure
in SAS®.
Patient Perception of Physician Scale Development
Item-total correlations and Cronbach’s Alpha if each item was deleted were
used to determine item retention. All retained items were summed to create a patient
perception of physician scale. Higher scores indicated more positive perception of
the physician.
Factor analysis was used to determine if there were any subscales that existed
among the patient perceptions of physician scale. Factors were retained if its
eigenvalue was greater than or equal to 1. Each factor represented a subscale and
subscale scores were calculated by summing the responses to each item included in
the each of the subscales.
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Spearman correlation was utilized to assess convergent validity by examining
association between the scale and subscale scores with four convergent validity
variables selected based on prior literature showing evidence of having positive
associations with patient perceptions of physician communication (DiMatteo and
Hays 1980; Rutten, Augustson, and Wanke 2006; Wanzer, Booth-Butterfield, and
Gruber 2004). The convergent validity variables included private insurance,
perceived health status, patient satisfaction with information provided about their
health, and patient satisfaction with doctor’s concern about their health.
Bivariate associations between patient perceptions of physicians and
demographic variables and clinical variables were assessed. Individual cross
tabulations were developed for patient perceptions of physician by demographic
variables and clinical variables. Chi-square tests were used to assess associations
between variables in the cross tabulations.
Medication Adherence
Proportion of days covered was calculated for each beneficiary.

Mean and

standard deviation were calculated for proportion of days covered. Frequency
tabulations were developed for medication adherence status. Beneficiaries were
considered to be adherent if PDC was 80 percent or higher. If PDC was less than 80
percent the beneficiary was considered to be nonadherent.
Bivariate associations between medication adherence and demographic
variables and clinical variables were assessed. Individual cross tabulations were
developed for medication adherence status by demographic variables and clinical
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variables. Chi-square tests were used to assess associations between variables in the
cross tabulations.
Association between Patient Perception of Physicians and Medication Adherence
Bivariate association between patient perceptions of physicians and
medication adherence was assessed. Individual cross tabulations were developed for
the overall patient perceptions of physician scale by medication adherence status.
Bivariate association between perceived physician knowledge about the patient
(Factor 1) and medication adherence status was assessed, as well as, bivariate
association between perceived concern (Factor 2) and medication adherence status.
Chi-square tests were used to assess association between all of the variables in the
crosstabs.
Association between patient perception of physicians and medication
adherence after adjusting for risk factors was assessed using stepwise multiple
logistic regression. Covariates in the regression model included age, gender, race,
education, perceived health status, income, marital status, insurance coverage (private
and Medicare), Medicare Part D prescription coverage gap, number of doctor visits,
number of medications, heart disease, heart failure, stroke, non-skin cancers, diabetes,
rheumatoid arthritis, depression, osteoporosis, Parkinson’s disease, and respiratory
diseases (emphysema, COPD, asthma), and Charlson Comorbidity Index.
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Results and Discussion
Sample Characteristics
After applying inclusion and exclusion criteria, 2,510 beneficiaries were
included in the sample. Forty-four percent were between ages 70 and 79 years. A
majority of the sample was female, White, not married, had a high school education
or less, and had income less than $30,000. Forty-nine percent had private insurance,
18 percent had Medicaid, and 5 percent reached the Medicare Part D prescription
coverage gap. Over 50 percent perceived their health to been “good” or “very good.”
Thirty-four percent filled 10 to 15 unique medications in 2008, and 42 percent had 1
to 9 doctor visits in 2008. The most common survey reported comorbid conditions
were heart disease, diabetes, osteoporosis, respiratory conditions, depression, and
non-skin cancers. Using 2007 Medicare inpatient and outpatient claims, 84 percent
had a Charlson Comorbidity Index of 0.

Patient Perceptions of Physician Scale Development
A patient perception of physician scale was created from the patient
perception of physician items in the MCBS. Upon developing the patient perceptions
of physician scale, 220 beneficiaries were excluded due to missing responses on
questions included in indices and 42 were excluded due to missing responses on
convergent validity variables. This resulted in a sample of 2,248 beneficiaries.
Item-total correlation and Cronbach’s Alpha if each item was deleted were
used to assess item retention. If item-total correlation was less than 0.50 for an item,
the item was removed. After examining item-total correlation, all 12 patient
perceptions of physician items were retained. All 12 items were summed to create a
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patient perceptions of physician scale. The theoretical range for the patient
perceptions of physician scale was 12 to 48.
Factor analysis was used to determine if there were any subscales within the
patient perception of physician scale. Principal components analysis with varimax
rotation on the patient perceptions of physician scale yielded two factors with
eigenvalues greater than or equal to 1. The total proportion of variance explained was
59 percent. Factor 1 included 8 of the 12 items, and factor 2 included 4 of the 12
items. Sixty-three percent of the variance was account for by Factor 1 and Factor 2
accounted for 37 percent of the variance.
The overall patient perceptions of physician scale had a theoretical range of 12
to 48, and an actual range of 15 to 48. The mean for the patient perception of
physician scale was 38.79 (s.d. 5.013). Factor 1 (perceived physician knowledge of
patient subscale) had a theoretical and actual range of 8 to 32, and the mean was
26.28 (s.d. 3.680). Factor 2 (perceived concern subscale) had a theoretical and actual
range of 4 to 16, and the mean was 12.51 (s.d. 1.906).
The overall patient perception of physicians scale, Factor 1 (perceived
physician knowledge of the patient subscale), and Factor 2 (perceived concern
subscale) all showed evidence of reliability. The overall perception of physicians
scale and subscales each had a Cronbach’s Alpha greater than 0.80. The Cronbach’s
Alpha for the overall patient perception of physicians scale was α=0.92, Factor 1 was
α=0.92, and Factor 2 was α=0.84.
Convergent validity was evaluated using Spearman correlation to assess
association between the patient perceptions of physicians and selected variables
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previously reported as having positive correlations with patient perceptions of
physician communication. The convergent validity variables were private insurance,
perceived health status, satisfaction with information provided about your health, and
satisfaction with doctor’s concern about your health. All four variables were found to
be correlated with the overall patient perceptions of physician scale, Factor 1
(perceived physician knowledge of patient subscale), and Factor 2 (perceived concern
subscale). The overall patient perception of physicians scale (r=0.32, p=<.0001),
Factor 1 (r=0.31, p=<.0001), and Factor 2 (r=0.25, p=<.0001) had positive
correlations with patient satisfaction with information received about health. The
overall patient perception of physicians scale (r=0.29, p=<.0001), Factor 1 (r=0.28,
p=<.0001), and Factor 2 (r=0.23, p=<.0001) also had positive correlations with
patient satisfaction with their doctor’s concern for their health.
Bivariate Association between Patient Perception of Physicians and Demographic and
Clinical Variables
Several demographic/clinical variables were examined for association with the
overall patient perceptions of physician scale. The overall patient perception of
physician scale was associated with race, marital status, education, and income. The
overall patient perception of physician scale differed significantly by the following
clinical variables: private insurance, Medicaid, and perceived health status.
Medication Adherence
Medication adherence referred to adherence to antihypertensive medications.
Upon developing the patient perceptions of physician scale, the sample was 2,248. In
calculating the proportion of days covered (PDC) variable, 59 beneficiaries were
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excluded due having no more than 1 prescription fill for every unique
antihypertensive medication filled in 2008. This resulted in a sample of 2,189
beneficiaries.
Proportion of days covered (PDC) among the beneficiaries ranged from 0.13
to 1. The mean was 0.82 with a standard deviation of 0.236. If PDC was 0.80 or
higher, the beneficiary was considered to be adherent. If PDC was less than 0.80, the
beneficiary was considered to be non-adherent. Sixty-five percent of the sample was
adherent.

Bivariate Association between Medication Adherence and Demographic and Clinical
Variables
Demographic variables were examined for association with medication
adherence. The only demographic variable that was associated with medication
adherence in the bivariate analysis was race. Several clinical variables were
associated with medication adherence in the bivariate analyses. They included:
private insurance, Medicare Part D prescription coverage gap, perceived health status,
number of unique medications, number of doctor visits, heart disease, heart failure,
diabetes, stroke, non-skin cancers, rheumatoid arthritis, depression, and Charlson
Comorbidity Index.

170

Association between Patient Perceptions of Physicians and Medication Adherence
Bivariate Association between Patient Perceptions of Physicians and Medication
Adherence

Overall Patient Perceptions of Physician Scale
Prior to controlling for covariates in a multiple logistic model, the bivariate
association between the overall patient perceptions of physician scale and adherence
was examined. A higher percentage of beneficiaries with perception scores of 37 or
higher were adherent compared to beneficiaries with perception scores less than 37
(68 percent versus 61 percent, p-value=0.0009).

Subscales
Bivariate association between the perceived physician knowledge about the
patient (Factor 1) subscale and medication adherence was assessed. A higher
percentage of beneficiaries with perceived physician knowledge about the patient
(Factor 1) scores at 25 or higher were adherent compared to beneficiaries with scores
of 25 or less (67 percent versus 62 percent, p-value=0.014).
Bivariate association between the perceived concern (Factor 2) subscale and
medication adherence was assessed. A higher percentage of beneficiaries with
perceived concern (Factor 2) scores of 13 or higher were adherent compared to
beneficiaries with scores less than 13 (68 percent versus 63 percent, p-value=0.052).
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Association between Patient Perception of Physicians and Medication Adherence
after Adjusting for Risk Factors

Overall Patient Perceptions of Physician Scale
A multiple logistic regression model using stepwise selection was developed
to assess association between the patient perception of physicians and medication
adherence to antihypertensive medication. The predictor variable was the patient
perceptions of physician scale as a categorical variable with 2 categories (less than 37
and 37 or higher), and the response variable, medication adherence status, was
dichotomized from the proportion of days covered variable with “1” indicating
adherent (PDC=80 percent or higher) and “0” indicating non-adherent (PDC>80
percent). The sample size for the regression model was reduced to 1,935 due to 254
beneficiaries who were missing education and/or income and were excluded from the
multiple logistic regression model.
The model adjusted for demographic and clinical characteristics and all two
way interactions. The demographic and clinical characteristics included age, gender,
race, marital status, education, income, private and Medicaid insurance, reaching the
Medicare Part D prescription coverage gap, number of unique medications, number
of doctors visits, Charlson Comorbidity Index, heart disease, heart failure, stroke,
non-skin cancers, diabetes, rheumatoid arthritis, depression, osteoporosis, Parkinson’s
disease, and respiratory conditions (i.e., asthma, emphysema, and chronic obstructive
pulmonary disease). Using stepwise selection, the following variables entered the
model and remained: overall patient perceptions of physician scale, age category,
respiratory conditions, non-skin cancers, and number of unique medications.
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Beneficiaries with patient perceptions of physician scale scores of 37 or higher were
more likely to be adherent to antihypertensive medications in comparison to
beneficiaries with scores less than 37 (Odds ratio=1.341, 95% CI=1.101-1.632, pvalue=0.0035). Other significant variables in the model were age, respiratory
conditions, non-skin cancers, and number of medications. Beneficiaries with
respiratory conditions were more likely to be adherent to antihypertensive
medications in comparison to beneficiaries without respiratory conditions (Odds
ratio=1.356, 95% CI=1.037-1.772, p-value=0.0258). Beneficiaries with non-skin
cancers were more likely to be adherent to antihypertensive medications in
comparison to beneficiaries without non-skin cancers (Odds ratio=1.377, 95%
CI=1.064-1.783, p-value=0.0152). Older beneficiaries were less likely to be adherent
to antihypertensive medications in comparison to those 65 to 69. Beneficiaries age 80
to 84 years were less likely to be adherent to antihypertensive medications in
comparison to beneficiaries ages 65 years to 69 years (Odds ratio=0.673, 95%
CI=0.497-0.911, p-value=0.0103). Beneficiaries who filled more medications were
less likely to be adherent to antihypertensive medications in comparison to
beneficiaries who filled 1 to 5 medications. Beneficiaries who filled 21 or more
medications were less likely to be adherent to antihypertensive medications in
comparison to beneficiaries who filled 1 to 5 medications (Odds ratio=0.111, 95%
CI=0.070-0.175, p-value<.0001).
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Study Limitations
There are several limitations to this study. Given the study aims and data
source, potential items for inclusion in the overall patient perceptions of physician
scale was limited to those available in the MCBS, and the scale could only be derived
with these items. The study was limited to the use of Medicare Part D claims only.
Although all medication use was reported, there was only claim information for the
Medicare Part D claims and only those were used to estimate medication
adherenceLastly, the sample was limited to persons with hypertension since that
population was the focus of the study. However, we have no a priori reason to think
that the beneficiaries in the sample would differ greatly from other MCBS
beneficiaries on patient perceptions of physicians.

Conclusions and Implications
This study examined patient perceptions of physicians and medication
adherence among Medicare beneficiaries enrolled in Medicare Part D. An overall
patient perceptions of physician scale was developed from MCBS items. Two
subscales within the scale were also derived using factor analysis. The overall scale
and two subscales are showed good reliability and validity. The overall patient
perceptions of physician scale and the two subscales should be valuable as measures
of important components of the physician-patient relationship. The overall scale and
subscales may facilitate use of the MCBS in research to better understand the patientphysician relationship, what affects the relationship, and how the relationship affects
care and outcomes.
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Medicare adherence to antihypertensive medications was examined among the
Medicare beneficiaries enrolled in Medicare Part D. Over one-third of the Medicare
beneficiaries enrolled in Medicare Part D were not adherent to their antihypertensive
medications. Beneficiaries with patient perceptions of physician scale scores of 37 or
higher were more likely to be adherent to antihypertensive medications in comparison
to beneficiaries with scores less than 37. These findings indicate that patient
perceptions of their physician have an impact on the patient’s willingness to adhere to
medication therapy. Additionally, the findings provide some evidence that the
physician patient relationship is important in medication adherence.
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Appendix A
Bivariate Association between Patient Perceptions of Physician Subscales and
Medication Adherence

Table A1. Bivariate Association between the Perceived Physician Knowledge of Patient (Factor 1) Subscale and Adherence
____________________________________________________________________________________________________________
Perceived Physician Knowledge of Patient (Factor 1) Subscale
____________________________________________________
Total
Less than 25
25 or higher
p-value1
(n=2,189)
(n=1,039)
(n=1,150)
_________________
_________________
_________________
Number Percent
Number Percent
Number Percent
____________________________________________________________________________________________________________
0.0142

Adherence Status
Adherent

1,419

64.82

646

62.18

773

67.22

Non-Adherent
770
35.18
393
37.82
377
32.78
____________________________________________________________________________________________________________
1
p-value determined based on Chi-square.
2
p-value ≤ 0.05 indicates significance.
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Table A2. Bivariate Association between the Perceived Concern (Factor 2) Subscale and Adherence
_________________________________________________________________________________________________________
Perceived Concern (Factor 2) Subscale
_________________________________________________
Total
(n=2,189)
_________________

Less than 13
(n=1,489)
_________________

13 or higher
(n=700)
_________________

p-value1

Number Percent
Number Percent
Number Percent
_________________________________________________________________________________________________________
0.0522

Adherence Status
Adherent

1,419

64.82

945

63.47

474

67.71

Non-Adherent
770
35.18
544
36.53
226
32.29
_________________________________________________________________________________________________________
1

p-value determined based on Chi-square.
p-value ≤ 0.05 indicates significance.
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Appendix B
Association between Patient Perceptions of Physician Subscales and Medication
Adherence after Adjusting for Risk Factors

Table B1. Multiple Logistic Regression Examining Association between Perceived Physician Knowledge about the Patient (Factor 1)
Subscale and Medication Adherence
_________________________________________________________________________________________________________
Parameter
Standard
Odds
95% Confidence
Variable3
n=1,935
Estimate
Error
Ratio
Interval
p-value
_________________________________________________________________________________________________________
Factor 1 Subscale
Less than 25
25 or higher
Age
65 to 69 years
70 to 74 years
75 to 79 years
80 to 84 years
85 years or older

906
1,029

reference group
0.2003

0.1001

1.222

1.004 - 1.487

0.04531
0.03111

412
401
464
390
268

reference group
0.0096
-0.1073
-0.4015
-0.2944

Respiratory Conditions2
Yes
No

342
1,593

Non-skin Cancer
Yes
No

365
1,570

0.1582
0.1505
0.1544
0.1726

1.010
0.898
0.669
0.745

0.741 - 1.377
0.669 - 1.206
0.495 - 0.906
0.531 - 1.045

0.9514
0.4758
0.00931
0.0881

0.3064
reference group

0.1364

1.359

1.040 - 1.775

0.02471

0.3113
reference group

0.1315

1.365

1.055 - 1.767

0.01791
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Table B1. Continued
_________________________________________________________________________________________________________
Parameter
Standard
Odds
95% Confidence
Variable
n=1,935
Estimate
Error
Ratio
Interval
p-value
_________________________________________________________________________________________________________
Number of unique medications
<.00011
1 to 5
302
reference group
6 to 9
546
-0.3786
0.1795
0.685
0.484 - 0.979
0.03491
10 to 15
662
-1.0447
0.1703
0.352
0.255 - 0.497
<.00011
16 to 20
270
-1.4478
0.1964
0.235
0.161 - 0.349
<.00011
21 or more
155
-2.1993
0.2321
0.111
0.071 - 0.175
<.00011
_________________________________________________________________________________________________________
1
p-value ≤ 0.05 indicates significance.
2
Respiratory conditions include Emphysema, COPD, and Asthma.
3
The following variables were eligible to enter regression model: patient perception of physician scale, age, gender, race, education,
income, private insurance, Medicaid, reaching the Medicare Part D prescription coverage gap, perceived health status, number of
unique medications, number of doctor visits, Charlson Comorbidity Index, and clinical conditions (heart disease, heart failure,
diabetes, stroke, non-skin cancers, rheumatoid arthritis, depression, Parkinson’s disease, osteoporosis, and respiratory conditions).
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Table B2. Multiple Logistic Regression Examining Association between Perceived Concern Subscale (Factor 2) Subscale and
Medication Adherence
_________________________________________________________________________________________________________
Parameter
Standard
Odds
95% Confidence
Variable4
n=1,935
Estimate
Error
Ratio
Interval
p-value
_________________________________________________________________________________________________________
Factor 2 Subscale2
Less than 13
13 or higher
Age
65 to 69 years
70 to 74 years
75 to 79 years
80 to 84 years
85 years or older

1,306
629

------

------

------

------

-----0.02771

412
401
464
390
268

reference group
-0.0057
-0.1156
-0.4128
-0.3076

Respiratory Conditions3
Yes
No

342
1,593

Non-skin Cancer
Yes
No

365
1,570

0.1579
0.1503
0.1541
0.1724

0.994
0.891
0.662
0.735

0.730 - 1.355
0.664 - 1.196
0.489 - 0.895
0.524 - 1.031

0.9713
0.4419
0.00741
0.0744

0.3138
reference group

0.1361

1.369

1.048 - 1.787

0.02121

0.3109
reference group

0.1313

1.365

1.055 - 1.765

0.01791
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Table B2. Continued
_________________________________________________________________________________________________________
Variable

n=1,935

Parameter
Estimate

Standard
Error

Odds
Ratio

95% Confidence
Interval

p-value

_________________________________________________________________________________________________________
Number of unique medications
<.00011
1 to 5
302
reference group
6 to 9
546
-0.3830
0.1793
0.682
0.480 - 0.969
0.03271
10 to 15
662
-1.0478
0.1701
0.351
0.251 - 0.489
<.00011
16 to 20
270
-1.4568
0.1961
0.233
0.159 - 0.342
<.00011
21 or more
155
-2.2096
0.2318
0.110
0.070 - 0.173
<.00011
_________________________________________________________________________________________________________
1
p-value ≤ 0.05 indicates significance.
2
The Factor 2 subscale does not have estimates due to elimination in stepwise regression.
3
Respiratory conditions include Emphysema, COPD, and Asthma.
4
The following variables were eligible to enter regression model: patient perception of physician scale, age, gender, race,
education, income, private insurance, Medicaid, reaching the Medicare Part D prescription coverage gap, perceived health status,
number of unique medications, number of doctor visits, Charlson Comorbidity Index, and clinical conditions (heart disease, heart
failure, diabetes, stroke, non-skin cancers, rheumatoid arthritis, depression, Parkinson’s disease, osteoporosis, and respiratory
conditions).
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